{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Analysis of how technology has revolunized clinical trials"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# BUSINESS UNDERSTANDING"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Data Understanding"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 306,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     C:\\Users\\USER\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n",
      "[nltk_data] Downloading package stopwords to\n",
      "[nltk_data]     C:\\Users\\USER\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package stopwords is already up-to-date!\n",
      "[nltk_data] Downloading package averaged_perceptron_tagger to\n",
      "[nltk_data]     C:\\Users\\USER\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package averaged_perceptron_tagger is already up-to-\n",
      "[nltk_data]       date!\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package wordnet to\n",
      "[nltk_data]     C:\\Users\\USER\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package wordnet is already up-to-date!\n"
     ]
    }
   ],
   "source": [
    "#importing libraries\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import pycountry\n",
    "import re\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "import seaborn as sns\n",
    "import warnings\n",
    "import contractions\n",
    "import string\n",
    "import spacy\n",
    "import nltk\n",
    "#nlp =spacy.load(\"en_core_web_sm\")\n",
    "nltk.download('punkt')\n",
    "nltk.download(\"stopwords\")\n",
    "warnings.filterwarnings(\"ignore\")\n",
    "nltk.download('averaged_perceptron_tagger')\n",
    "import numpy as np\n",
    "nlp =spacy.load(\"en_core_web_sm\")\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "from sklearn.model_selection import train_test_split\n",
    "from sklearn.linear_model import LogisticRegressionCV\n",
    "from sklearn.metrics import *\n",
    "from sklearn.multioutput import MultiOutputClassifier\n",
    "from sklearn.pipeline import Pipeline\n",
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "import matplotlib.cm as cm\n",
    "from matplotlib.colors import Normalize\n",
    "from nltk.tokenize import RegexpTokenizer\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from nltk.stem import WordNetLemmatizer\n",
    "nltk.download('wordnet')\n",
    "from sklearn.ensemble import GradientBoostingClassifier\n",
    "from nltk.tokenize import word_tokenize\n",
    "from sklearn.feature_extraction.text import TfidfTransformer\n",
    "from sklearn.linear_model import LogisticRegression\n",
    "import gensim\n",
    "from gensim.models import Word2Vec\n",
    "from nltk.tokenize import word_tokenize"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 307,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>PROACT</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2005-01|G050208</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2006-02-14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>A4070417|2U54MD007600-31</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-04-30</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2018-02-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03176225</td>\n",
       "      <td>Evaluate Safety and Effectiveness of XenoSure ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03176225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The purpose of this clinical trial is to colle...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Diseases</td>\n",
       "      <td>PROCEDURE: Open heart surgery to address the h...</td>\n",
       "      <td>Leakage rate at 6 month post-procedure measure...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>P15077-1</td>\n",
       "      <td>2017-08-15</td>\n",
       "      <td>2025-11-15</td>\n",
       "      <td>2026-02-15</td>\n",
       "      <td>2017-06-05</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-03-10</td>\n",
       "      <td>Chinese PLA General Hospital, Beijing, Beijing...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00199225</td>\n",
       "      <td>Evaluation of Possible Effects on the QT/ QTc ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00199225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This phase I trial will evaluate the effects o...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Human Experimentation (Human Volunteers)</td>\n",
       "      <td>DRUG: Rupatadine|DRUG: moxifloxacin|PROCEDURE:...</td>\n",
       "      <td>To assess whether administration of a repeated...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>IC012RUP/1/04</td>\n",
       "      <td>2005-02</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2005-07</td>\n",
       "      <td>2005-09-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2005-12-15</td>\n",
       "      <td>Centre de Investigaci√≥ de Medicaments-Intitut ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT05724225</td>\n",
       "      <td>\"Atriogenic Tricuspid Selected, Omics Profile,...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05724225</td>\n",
       "      <td>ATOMIC</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The aim of our study is to investigate the mol...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Tricuspid Valve Insufficiency</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Protein expression, Evaluation of the protein ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>4424</td>\n",
       "      <td>2021-10-06</td>\n",
       "      <td>2022-11-07</td>\n",
       "      <td>2023-12-29</td>\n",
       "      <td>2023-02-13</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-02-15</td>\n",
       "      <td>Istituto Auxologico Italiano IRCSS Ospedale Sa...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "2  NCT03176225  Evaluate Safety and Effectiveness of XenoSure ...   \n",
       "3  NCT00199225  Evaluation of Possible Effects on the QT/ QTc ...   \n",
       "4  NCT05724225  \"Atriogenic Tricuspid Selected, Omics Profile,...   \n",
       "\n",
       "                                      Study URL Acronym  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  PROACT   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325     NaN   \n",
       "2  https://clinicaltrials.gov/study/NCT03176225     NaN   \n",
       "3  https://clinicaltrials.gov/study/NCT00199225     NaN   \n",
       "4  https://clinicaltrials.gov/study/NCT05724225  ATOMIC   \n",
       "\n",
       "            Study Status                                      Brief Summary  \\\n",
       "0  ACTIVE_NOT_RECRUITING  Various patient groups with the On-X Valve can...   \n",
       "1  ACTIVE_NOT_RECRUITING  Clopidogrel is a prescription medicine used to...   \n",
       "2             RECRUITING  The purpose of this clinical trial is to colle...   \n",
       "3              COMPLETED  This phase I trial will evaluate the effects o...   \n",
       "4  ACTIVE_NOT_RECRUITING  The aim of our study is to investigate the mol...   \n",
       "\n",
       "  Study Results                                         Conditions  \\\n",
       "0            NO                                Heart Valve Disease   \n",
       "1            NO  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "2            NO                                     Heart Diseases   \n",
       "3            NO           Human Experimentation (Human Volunteers)   \n",
       "4            NO                      Tricuspid Valve Insufficiency   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "2  PROCEDURE: Open heart surgery to address the h...   \n",
       "3  DRUG: Rupatadine|DRUG: moxifloxacin|PROCEDURE:...   \n",
       "4                                                NaN   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...  ...   \n",
       "1  Major adverse cardiovascular events (MACE) red...  ...   \n",
       "2  Leakage rate at 6 month post-procedure measure...  ...   \n",
       "3  To assess whether administration of a repeated...  ...   \n",
       "4  Protein expression, Evaluation of the protein ...  ...   \n",
       "\n",
       "                                        Study Design  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "2  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "4          Observational Model: |Time Perspective: p   \n",
       "\n",
       "                  Other IDs  Start Date Primary Completion Date  \\\n",
       "0           2005-01|G050208  2006-06-06              2022-12-31   \n",
       "1  A4070417|2U54MD007600-31  2020-09-01              2023-04-30   \n",
       "2                  P15077-1  2017-08-15              2025-11-15   \n",
       "3             IC012RUP/1/04     2005-02                     NaN   \n",
       "4                      4424  2021-10-06              2022-11-07   \n",
       "\n",
       "  Completion Date First Posted Results First Posted  Last Update Posted  \\\n",
       "0      2022-12-31   2006-02-14                  NaN          2022-09-14   \n",
       "1      2023-12-30   2018-02-01                  NaN          2023-05-30   \n",
       "2      2026-02-15   2017-06-05                  NaN          2023-03-10   \n",
       "3         2005-07   2005-09-20                  NaN          2005-12-15   \n",
       "4      2023-12-29   2023-02-13                  NaN          2023-02-15   \n",
       "\n",
       "                                           Locations Study Documents  \n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...             NaN  \n",
       "1  University Hospital at Carolina, Carolina, 009...             NaN  \n",
       "2  Chinese PLA General Hospital, Beijing, Beijing...             NaN  \n",
       "3  Centre de Investigaci√≥ de Medicaments-Intitut ...             NaN  \n",
       "4  Istituto Auxologico Italiano IRCSS Ospedale Sa...             NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 307,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# loading the heart dataset\n",
    "heart = pd.read_csv(\"Heart.csv\")\n",
    "heart.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 308,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02426125</td>\n",
       "      <td>A Study of Ramucirumab (LY3009806) Plus Doceta...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02426125</td>\n",
       "      <td>RANGE</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The main purpose of this study is to evaluate ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Urothelial Carcinoma</td>\n",
       "      <td>DRUG: Ramucirumab|DRUG: Docetaxel|DRUG: Placebo</td>\n",
       "      <td>Progression Free Survival (PFS), PFS defined a...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>15679|I4T-MC-JVDC|2014-003655-66</td>\n",
       "      <td>2015-07-13</td>\n",
       "      <td>2017-04-21</td>\n",
       "      <td>2022-07-26</td>\n",
       "      <td>2015-04-24</td>\n",
       "      <td>2019-01-25</td>\n",
       "      <td>2023-08-21</td>\n",
       "      <td>Highlands Oncology Group, Fayetteville, Arkans...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT04910425</td>\n",
       "      <td>PSMA-Targeted 18F-DCFPyL PET/MRI for the Detec...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04910425</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>This phase II trial studies how well 18F-DCFPy...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Prostate Carcinoma</td>\n",
       "      <td>DRUG: Fluorine F 18 DCFPyL|DRUG: Gadobenate Di...</td>\n",
       "      <td>18-F-DCFPyL positron emission tomography (PET)...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>NU 19U05|NCI-2021-05593|STU00212326|NU 19U05|P...</td>\n",
       "      <td>2023-06-17</td>\n",
       "      <td>2026-06-17</td>\n",
       "      <td>2028-07</td>\n",
       "      <td>2021-06-02</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-08-03</td>\n",
       "      <td>Northwestern University, Chicago, Illinois, 60...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT04116125</td>\n",
       "      <td>Omitting Biopsy of SEntinel Lymph Node With Ra...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04116125</td>\n",
       "      <td>OBSERB</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>The OBSERB study is a multi-center, non-blinde...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Neoplasm Female|Lymphatic Metastasis</td>\n",
       "      <td>PROCEDURE: Radiotherapy</td>\n",
       "      <td>Disease-free survival, Disease free survival i...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: SIN...</td>\n",
       "      <td>2019-09-023</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2023-06-30</td>\n",
       "      <td>2025-06-30</td>\n",
       "      <td>2019-10-04</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-10-04</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03566225</td>\n",
       "      <td>Pioglitazone Versus Metformin as First Treatme...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03566225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Participants with PCOS will be divided into tw...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Pioglitazone</td>\n",
       "      <td>DRUG: Pioglitazone|DRUG: Metformin|DRUG: Clomi...</td>\n",
       "      <td>Clinical pregnancy rate, Pregnancy rate diagno...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: SIN...</td>\n",
       "      <td>AinShamaU</td>\n",
       "      <td>2018-01-30</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2021-03-30</td>\n",
       "      <td>2018-06-25</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-06-02</td>\n",
       "      <td>Ain Shams Univerisity, Cairo, Egypt</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01756625</td>\n",
       "      <td>PREMIUM, Observational Study</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01756625</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>PREMIUM is an observational pharmaco-epidemiol...</td>\n",
       "      <td>NO</td>\n",
       "      <td>First Line WT KRAS mCRC</td>\n",
       "      <td>NaN</td>\n",
       "      <td>To compare PFS rate at 1 year with PFS in clin...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>PREMIUM</td>\n",
       "      <td>2010-01</td>\n",
       "      <td>2012-03</td>\n",
       "      <td>2013-06</td>\n",
       "      <td>2012-12-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2012-12-27</td>\n",
       "      <td>Institut Sainte-Catherine, Avignon, Vaucluse, ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT02426125  A Study of Ramucirumab (LY3009806) Plus Doceta...   \n",
       "1  NCT04910425  PSMA-Targeted 18F-DCFPyL PET/MRI for the Detec...   \n",
       "2  NCT04116125  Omitting Biopsy of SEntinel Lymph Node With Ra...   \n",
       "3  NCT03566225  Pioglitazone Versus Metformin as First Treatme...   \n",
       "4  NCT01756625                       PREMIUM, Observational Study   \n",
       "\n",
       "                                      Study URL Acronym        Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT02426125   RANGE           COMPLETED   \n",
       "1  https://clinicaltrials.gov/study/NCT04910425     NaN  NOT_YET_RECRUITING   \n",
       "2  https://clinicaltrials.gov/study/NCT04116125  OBSERB  NOT_YET_RECRUITING   \n",
       "3  https://clinicaltrials.gov/study/NCT03566225     NaN           COMPLETED   \n",
       "4  https://clinicaltrials.gov/study/NCT01756625     NaN             UNKNOWN   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  The main purpose of this study is to evaluate ...           YES   \n",
       "1  This phase II trial studies how well 18F-DCFPy...            NO   \n",
       "2  The OBSERB study is a multi-center, non-blinde...            NO   \n",
       "3  Participants with PCOS will be divided into tw...            NO   \n",
       "4  PREMIUM is an observational pharmaco-epidemiol...            NO   \n",
       "\n",
       "                                    Conditions  \\\n",
       "0                         Urothelial Carcinoma   \n",
       "1                           Prostate Carcinoma   \n",
       "2  Breast Neoplasm Female|Lymphatic Metastasis   \n",
       "3                                 Pioglitazone   \n",
       "4                      First Line WT KRAS mCRC   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0    DRUG: Ramucirumab|DRUG: Docetaxel|DRUG: Placebo   \n",
       "1  DRUG: Fluorine F 18 DCFPyL|DRUG: Gadobenate Di...   \n",
       "2                            PROCEDURE: Radiotherapy   \n",
       "3  DRUG: Pioglitazone|DRUG: Metformin|DRUG: Clomi...   \n",
       "4                                                NaN   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  Progression Free Survival (PFS), PFS defined a...  ...   \n",
       "1  18-F-DCFPyL positron emission tomography (PET)...  ...   \n",
       "2  Disease-free survival, Disease free survival i...  ...   \n",
       "3  Clinical pregnancy rate, Pregnancy rate diagno...  ...   \n",
       "4  To compare PFS rate at 1 year with PFS in clin...  ...   \n",
       "\n",
       "                                        Study Design  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "2  Allocation: RANDOMIZED|Intervention Model: SIN...   \n",
       "3  Allocation: RANDOMIZED|Intervention Model: SIN...   \n",
       "4          Observational Model: |Time Perspective: p   \n",
       "\n",
       "                                           Other IDs  Start Date  \\\n",
       "0                   15679|I4T-MC-JVDC|2014-003655-66  2015-07-13   \n",
       "1  NU 19U05|NCI-2021-05593|STU00212326|NU 19U05|P...  2023-06-17   \n",
       "2                                        2019-09-023  2020-07-01   \n",
       "3                                          AinShamaU  2018-01-30   \n",
       "4                                            PREMIUM     2010-01   \n",
       "\n",
       "  Primary Completion Date Completion Date First Posted Results First Posted  \\\n",
       "0              2017-04-21      2022-07-26   2015-04-24           2019-01-25   \n",
       "1              2026-06-17         2028-07   2021-06-02                  NaN   \n",
       "2              2023-06-30      2025-06-30   2019-10-04                  NaN   \n",
       "3              2021-02-28      2021-03-30   2018-06-25                  NaN   \n",
       "4                 2012-03         2013-06   2012-12-27                  NaN   \n",
       "\n",
       "   Last Update Posted                                          Locations  \\\n",
       "0          2023-08-21  Highlands Oncology Group, Fayetteville, Arkans...   \n",
       "1          2022-08-03  Northwestern University, Chicago, Illinois, 60...   \n",
       "2          2019-10-04                                                NaN   \n",
       "3          2021-06-02                Ain Shams Univerisity, Cairo, Egypt   \n",
       "4          2012-12-27  Institut Sainte-Catherine, Avignon, Vaucluse, ...   \n",
       "\n",
       "                            Study Documents  \n",
       "0  Study Protocol|Statistical Analysis Plan  \n",
       "1                                       NaN  \n",
       "2                                       NaN  \n",
       "3                                       NaN  \n",
       "4                                       NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 308,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# loading the cancer dataset\n",
    "can = pd.read_csv(\"Cancer-studies.csv\")\n",
    "can.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 309,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT04614025</td>\n",
       "      <td>Open-label Multicenter Study to Evaluate the E...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04614025</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This clinical trial will examine if a new trea...</td>\n",
       "      <td>NO</td>\n",
       "      <td>COVID|ARDS</td>\n",
       "      <td>BIOLOGICAL: PLX-PAD</td>\n",
       "      <td>Number of ventilator-free days, 28 days</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>PLX-COV-03</td>\n",
       "      <td>2020-10-19</td>\n",
       "      <td>2021-08-04</td>\n",
       "      <td>2023-01</td>\n",
       "      <td>2020-11-03</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-12-21</td>\n",
       "      <td>Charite Campus Virchow, Berlin, 10117, Germany...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT04646525</td>\n",
       "      <td>The Relationship Between Covid-19 Infection in...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04646525</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>We aimed to find out whether the tonsils and n...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Covid19|Immune Deficiency|Tonsillitis|Tonsil H...</td>\n",
       "      <td>DIAGNOSTIC_TEST: Physical examination</td>\n",
       "      <td>The primary outcome of our study was the evalu...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2020/480</td>\n",
       "      <td>2020-10-01</td>\n",
       "      <td>2021-02-01</td>\n",
       "      <td>2021-02-01</td>\n",
       "      <td>2020-11-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020-11-30</td>\n",
       "      <td>Selcuk University, Konya, Selcuklu, 42100, Turkey</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT04333225</td>\n",
       "      <td>Hydroxychloroquine in the Prevention of COVID-...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04333225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>In order to assess the efficacy of hydroxychlo...</td>\n",
       "      <td>YES</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>DRUG: Hydroxychloroquine</td>\n",
       "      <td>Number of Participants Infected With COVID-19 ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>020-132</td>\n",
       "      <td>2020-04-03</td>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>2020-04-03</td>\n",
       "      <td>2021-08-02</td>\n",
       "      <td>2021-08-20</td>\n",
       "      <td>Baylor University Medical Center, Dallas, Texa...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT04996225</td>\n",
       "      <td>Effect of Aerobics and Balancing Exercises on ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04996225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The recently emerged coronavirus named Severe ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Corona Virus Infection</td>\n",
       "      <td>OTHER: Aerobics exercises, Balance exercises</td>\n",
       "      <td>SPSS for Windows, version 22 (SPSS Inc., Chica...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>A,B E COVID 19</td>\n",
       "      <td>2021-08-01</td>\n",
       "      <td>2022-10-25</td>\n",
       "      <td>2023-02-10</td>\n",
       "      <td>2021-08-09</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-02-22</td>\n",
       "      <td>Ahmed.Assem, Sohag, 82951, Egypt</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT04858425</td>\n",
       "      <td>Safety and Efficacy of Niclosamide in Patients...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04858425</td>\n",
       "      <td>RESERVOIR</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This is a 2-part, 2-arm, Phase 2 , multicentre...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Covid19</td>\n",
       "      <td>DRUG: Niclosamide|DRUG: Placebo</td>\n",
       "      <td>SAEs, Serious adverse event (SAE) coded by Sys...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>AZ-NICL-COV-1</td>\n",
       "      <td>2021-04-30</td>\n",
       "      <td>2022-06-04</td>\n",
       "      <td>2023-05</td>\n",
       "      <td>2021-04-26</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-04-06</td>\n",
       "      <td>Central Alabama Research, Birmingham, Alabama,...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT04614025  Open-label Multicenter Study to Evaluate the E...   \n",
       "1  NCT04646525  The Relationship Between Covid-19 Infection in...   \n",
       "2  NCT04333225  Hydroxychloroquine in the Prevention of COVID-...   \n",
       "3  NCT04996225  Effect of Aerobics and Balancing Exercises on ...   \n",
       "4  NCT04858425  Safety and Efficacy of Niclosamide in Patients...   \n",
       "\n",
       "                                      Study URL    Acronym  \\\n",
       "0  https://clinicaltrials.gov/study/NCT04614025        NaN   \n",
       "1  https://clinicaltrials.gov/study/NCT04646525        NaN   \n",
       "2  https://clinicaltrials.gov/study/NCT04333225        NaN   \n",
       "3  https://clinicaltrials.gov/study/NCT04996225        NaN   \n",
       "4  https://clinicaltrials.gov/study/NCT04858425  RESERVOIR   \n",
       "\n",
       "            Study Status                                      Brief Summary  \\\n",
       "0  ACTIVE_NOT_RECRUITING  This clinical trial will examine if a new trea...   \n",
       "1                UNKNOWN  We aimed to find out whether the tonsils and n...   \n",
       "2              COMPLETED  In order to assess the efficacy of hydroxychlo...   \n",
       "3              COMPLETED  The recently emerged coronavirus named Severe ...   \n",
       "4  ACTIVE_NOT_RECRUITING  This is a 2-part, 2-arm, Phase 2 , multicentre...   \n",
       "\n",
       "  Study Results                                         Conditions  \\\n",
       "0            NO                                         COVID|ARDS   \n",
       "1            NO  Covid19|Immune Deficiency|Tonsillitis|Tonsil H...   \n",
       "2           YES                                           COVID-19   \n",
       "3            NO                             Corona Virus Infection   \n",
       "4            NO                                            Covid19   \n",
       "\n",
       "                                  Interventions  \\\n",
       "0                           BIOLOGICAL: PLX-PAD   \n",
       "1         DIAGNOSTIC_TEST: Physical examination   \n",
       "2                      DRUG: Hydroxychloroquine   \n",
       "3  OTHER: Aerobics exercises, Balance exercises   \n",
       "4               DRUG: Niclosamide|DRUG: Placebo   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0            Number of ventilator-free days, 28 days  ...   \n",
       "1  The primary outcome of our study was the evalu...  ...   \n",
       "2  Number of Participants Infected With COVID-19 ...  ...   \n",
       "3  SPSS for Windows, version 22 (SPSS Inc., Chica...  ...   \n",
       "4  SAEs, Serious adverse event (SAE) coded by Sys...  ...   \n",
       "\n",
       "                                        Study Design       Other IDs  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...      PLX-COV-03   \n",
       "1          Observational Model: |Time Perspective: p        2020/480   \n",
       "2  Allocation: NON_RANDOMIZED|Intervention Model:...         020-132   \n",
       "3  Allocation: RANDOMIZED|Intervention Model: PAR...  A,B E COVID 19   \n",
       "4  Allocation: RANDOMIZED|Intervention Model: PAR...   AZ-NICL-COV-1   \n",
       "\n",
       "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "0  2020-10-19              2021-08-04         2023-01   2020-11-03   \n",
       "1  2020-10-01              2021-02-01      2021-02-01   2020-11-30   \n",
       "2  2020-04-03              2020-06-30      2020-06-30   2020-04-03   \n",
       "3  2021-08-01              2022-10-25      2023-02-10   2021-08-09   \n",
       "4  2021-04-30              2022-06-04         2023-05   2021-04-26   \n",
       "\n",
       "  Results First Posted  Last Update Posted  \\\n",
       "0                  NaN          2022-12-21   \n",
       "1                  NaN          2020-11-30   \n",
       "2           2021-08-02          2021-08-20   \n",
       "3                  NaN          2023-02-22   \n",
       "4                  NaN          2023-04-06   \n",
       "\n",
       "                                           Locations  \\\n",
       "0  Charite Campus Virchow, Berlin, 10117, Germany...   \n",
       "1  Selcuk University, Konya, Selcuklu, 42100, Turkey   \n",
       "2  Baylor University Medical Center, Dallas, Texa...   \n",
       "3                   Ahmed.Assem, Sohag, 82951, Egypt   \n",
       "4  Central Alabama Research, Birmingham, Alabama,...   \n",
       "\n",
       "                            Study Documents  \n",
       "0                                       NaN  \n",
       "1                                       NaN  \n",
       "2  Study Protocol|Statistical Analysis Plan  \n",
       "3                                       NaN  \n",
       "4                                       NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 309,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# loading the covid dataset\n",
    "cov = pd.read_csv(\"Covid 19-studies.csv\")\n",
    "cov.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 310,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00914225</td>\n",
       "      <td>Effect of Bednets and a Water Purification Dev...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00914225</td>\n",
       "      <td>ITN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>In many areas of the world most severely affec...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HIV Infections|Human Immunodeficiency Virus|Ma...</td>\n",
       "      <td>OTHER: Bednets and Water Purification</td>\n",
       "      <td>To determine the effect of LLIN and a simple m...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>35464-B|SSC#1554</td>\n",
       "      <td>2009-09</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2009-06-04</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2015-05-29</td>\n",
       "      <td>Kisii Provincial Hospital, Kisii, Kenya|Kisumu...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02167425</td>\n",
       "      <td>Study of Integrating Antiretroviral Therapy Wi...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02167425</td>\n",
       "      <td>IMAT</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>To improve ART initiation among people who inj...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HIV|Opioid Dependence</td>\n",
       "      <td>OTHER: IMAT</td>\n",
       "      <td>Time to CD4 Screening, Number of days between ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>IMAT-01|R34DA037787</td>\n",
       "      <td>2015-02</td>\n",
       "      <td>2017-03</td>\n",
       "      <td>2017-03</td>\n",
       "      <td>2014-06-19</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2015-11-23</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT01423825</td>\n",
       "      <td>Evaluating the Safety and Immune Response to a...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01423825</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is an extension of the HVTN 073/SAAVI 102...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HIV Infections</td>\n",
       "      <td>BIOLOGICAL: Sub C gp140 Vaccine|BIOLOGICAL: MF...</td>\n",
       "      <td>Safety data, including signs and symptoms of l...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>HVTN 073E/SAAVI 102|11824</td>\n",
       "      <td>2011-08</td>\n",
       "      <td>2013-07</td>\n",
       "      <td>2013-07</td>\n",
       "      <td>2011-08-26</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-14</td>\n",
       "      <td>Brigham and Women's Hospital Vaccine CRS (BWH ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT02098525</td>\n",
       "      <td>Clinical Outcomes of Cryptococcal Meningitis A...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02098525</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Cryptococcal meningitis is one of the most com...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cryptococcal Meningitis|HIV/AIDS</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Long-term survival rate of CM, To describe lon...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>HIVCM-01</td>\n",
       "      <td>2013-11</td>\n",
       "      <td>2013-12</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2014-03-28</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2014-03-28</td>\n",
       "      <td>Division of Infectious Diseases, Department of...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT04515225</td>\n",
       "      <td>COVID-19 Prevalence in HIV-infected Patients</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04515225</td>\n",
       "      <td>SeCoVIHA</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>North-east area of France was hit in February ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HIV Infections</td>\n",
       "      <td>OTHER: Blood Sample</td>\n",
       "      <td>Seroprevalence of SARS-CoV-2, SARS-CoV-2 antib...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>7947</td>\n",
       "      <td>2020-11-04</td>\n",
       "      <td>2022-05-03</td>\n",
       "      <td>2022-05-03</td>\n",
       "      <td>2020-08-17</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-08-10</td>\n",
       "      <td>H√¥pitaux Universitaires de Strasbourg, Strasbo...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00914225  Effect of Bednets and a Water Purification Dev...   \n",
       "1  NCT02167425  Study of Integrating Antiretroviral Therapy Wi...   \n",
       "2  NCT01423825  Evaluating the Safety and Immune Response to a...   \n",
       "3  NCT02098525  Clinical Outcomes of Cryptococcal Meningitis A...   \n",
       "4  NCT04515225       COVID-19 Prevalence in HIV-infected Patients   \n",
       "\n",
       "                                      Study URL   Acronym Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00914225       ITN    COMPLETED   \n",
       "1  https://clinicaltrials.gov/study/NCT02167425      IMAT      UNKNOWN   \n",
       "2  https://clinicaltrials.gov/study/NCT01423825       NaN    COMPLETED   \n",
       "3  https://clinicaltrials.gov/study/NCT02098525       NaN    COMPLETED   \n",
       "4  https://clinicaltrials.gov/study/NCT04515225  SeCoVIHA      UNKNOWN   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  In many areas of the world most severely affec...            NO   \n",
       "1  To improve ART initiation among people who inj...            NO   \n",
       "2  This is an extension of the HVTN 073/SAAVI 102...            NO   \n",
       "3  Cryptococcal meningitis is one of the most com...            NO   \n",
       "4  North-east area of France was hit in February ...            NO   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  HIV Infections|Human Immunodeficiency Virus|Ma...   \n",
       "1                              HIV|Opioid Dependence   \n",
       "2                                     HIV Infections   \n",
       "3                   Cryptococcal Meningitis|HIV/AIDS   \n",
       "4                                     HIV Infections   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0              OTHER: Bednets and Water Purification   \n",
       "1                                        OTHER: IMAT   \n",
       "2  BIOLOGICAL: Sub C gp140 Vaccine|BIOLOGICAL: MF...   \n",
       "3                                                NaN   \n",
       "4                                OTHER: Blood Sample   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  To determine the effect of LLIN and a simple m...  ...   \n",
       "1  Time to CD4 Screening, Number of days between ...  ...   \n",
       "2  Safety data, including signs and symptoms of l...  ...   \n",
       "3  Long-term survival rate of CM, To describe lon...  ...   \n",
       "4  Seroprevalence of SARS-CoV-2, SARS-CoV-2 antib...  ...   \n",
       "\n",
       "                                        Study Design  \\\n",
       "0          Observational Model: |Time Perspective: p   \n",
       "1          Observational Model: |Time Perspective: p   \n",
       "2  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3          Observational Model: |Time Perspective: p   \n",
       "4          Observational Model: |Time Perspective: p   \n",
       "\n",
       "                   Other IDs  Start Date Primary Completion Date  \\\n",
       "0           35464-B|SSC#1554     2009-09                 2011-12   \n",
       "1        IMAT-01|R34DA037787     2015-02                 2017-03   \n",
       "2  HVTN 073E/SAAVI 102|11824     2011-08                 2013-07   \n",
       "3                   HIVCM-01     2013-11                 2013-12   \n",
       "4                       7947  2020-11-04              2022-05-03   \n",
       "\n",
       "  Completion Date First Posted Results First Posted  Last Update Posted  \\\n",
       "0         2011-12   2009-06-04                  NaN          2015-05-29   \n",
       "1         2017-03   2014-06-19                  NaN          2015-11-23   \n",
       "2         2013-07   2011-08-26                  NaN          2021-10-14   \n",
       "3             NaN   2014-03-28                  NaN          2014-03-28   \n",
       "4      2022-05-03   2020-08-17                  NaN          2021-08-10   \n",
       "\n",
       "                                           Locations Study Documents  \n",
       "0  Kisii Provincial Hospital, Kisii, Kenya|Kisumu...             NaN  \n",
       "1                                                NaN             NaN  \n",
       "2  Brigham and Women's Hospital Vaccine CRS (BWH ...             NaN  \n",
       "3  Division of Infectious Diseases, Department of...             NaN  \n",
       "4  H√¥pitaux Universitaires de Strasbourg, Strasbo...             NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 310,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# loading the HIV data set\n",
    "hiv = pd.read_csv(\"HIV-studies.csv\")\n",
    "hiv.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 311,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01976325</td>\n",
       "      <td>Evaluating the Ottawa Malaria Decision Aid</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01976325</td>\n",
       "      <td>OMDA</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>BRIEF SUMMARY\\n\\nCanadians often visit areas w...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>OTHER: Ottawa Malaria Decision Aid</td>\n",
       "      <td>Travellers' Knowledge Score, The traveller's k...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2010462-01H</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2015-11</td>\n",
       "      <td>2015-11</td>\n",
       "      <td>2013-11-05</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2015-04-16</td>\n",
       "      <td>National Capital Region Occupational Health Cl...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00914225</td>\n",
       "      <td>Effect of Bednets and a Water Purification Dev...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00914225</td>\n",
       "      <td>ITN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>In many areas of the world most severely affec...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HIV Infections|Human Immunodeficiency Virus|Ma...</td>\n",
       "      <td>OTHER: Bednets and Water Purification</td>\n",
       "      <td>To determine the effect of LLIN and a simple m...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>35464-B|SSC#1554</td>\n",
       "      <td>2009-09</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2009-06-04</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2015-05-29</td>\n",
       "      <td>Kisii Provincial Hospital, Kisii, Kenya|Kisumu...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT05605925</td>\n",
       "      <td>Ivermectin-artemisinin Combination Therapy for...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05605925</td>\n",
       "      <td>IVIME</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>Malaria remains a leading cause of morbidity a...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>DRUG: Artemether/lumefantrine|DRUG: Ivermectin</td>\n",
       "      <td>Malaria transmission rates in a household, Mal...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>MAKSHSREC-2021-237</td>\n",
       "      <td>2022-08-04</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-11-04</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-11-04</td>\n",
       "      <td>ST. Paul's Health Center, Kasese, Uganda</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01464125</td>\n",
       "      <td>Fosmidomycin and Azithromycin for Acute Uncomp...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01464125</td>\n",
       "      <td>JP011</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The aim of this study is to evaluate the role ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>DRUG: Fosmidomycin|DRUG: Azithromycin</td>\n",
       "      <td>day 28 cure rate of &gt;95%, Efficacy of fosmidom...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>JP011</td>\n",
       "      <td>2008-11</td>\n",
       "      <td>2009-10</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2011-11-03</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2011-11-03</td>\n",
       "      <td>Mahidol University, Bangkok, 10400, Thailand</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT02557425</td>\n",
       "      <td>Prophylaxis Against Malaria to Enhance Child D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02557425</td>\n",
       "      <td>PROTECT</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Each year, \\~85.3 million pregnant women are a...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Neurobehavioral Manifestations</td>\n",
       "      <td>OTHER: No intervention in PROTECT</td>\n",
       "      <td>Z-scores for Overall cognitive ability, 12 mon...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>1506994146</td>\n",
       "      <td>2015-10</td>\n",
       "      <td>2021-08-05</td>\n",
       "      <td>2021-08-05</td>\n",
       "      <td>2015-09-23</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-08-25</td>\n",
       "      <td>Tororo District Hospital, Tororo, Uganda</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT01976325         Evaluating the Ottawa Malaria Decision Aid   \n",
       "1  NCT00914225  Effect of Bednets and a Water Purification Dev...   \n",
       "2  NCT05605925  Ivermectin-artemisinin Combination Therapy for...   \n",
       "3  NCT01464125  Fosmidomycin and Azithromycin for Acute Uncomp...   \n",
       "4  NCT02557425  Prophylaxis Against Malaria to Enhance Child D...   \n",
       "\n",
       "                                      Study URL  Acronym Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT01976325     OMDA      UNKNOWN   \n",
       "1  https://clinicaltrials.gov/study/NCT00914225      ITN    COMPLETED   \n",
       "2  https://clinicaltrials.gov/study/NCT05605925    IVIME   RECRUITING   \n",
       "3  https://clinicaltrials.gov/study/NCT01464125    JP011      UNKNOWN   \n",
       "4  https://clinicaltrials.gov/study/NCT02557425  PROTECT    COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  BRIEF SUMMARY\\n\\nCanadians often visit areas w...            NO   \n",
       "1  In many areas of the world most severely affec...            NO   \n",
       "2  Malaria remains a leading cause of morbidity a...            NO   \n",
       "3  The aim of this study is to evaluate the role ...            NO   \n",
       "4  Each year, \\~85.3 million pregnant women are a...            NO   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                            Malaria   \n",
       "1  HIV Infections|Human Immunodeficiency Virus|Ma...   \n",
       "2                                            Malaria   \n",
       "3                                            Malaria   \n",
       "4                     Neurobehavioral Manifestations   \n",
       "\n",
       "                                    Interventions  \\\n",
       "0              OTHER: Ottawa Malaria Decision Aid   \n",
       "1           OTHER: Bednets and Water Purification   \n",
       "2  DRUG: Artemether/lumefantrine|DRUG: Ivermectin   \n",
       "3           DRUG: Fosmidomycin|DRUG: Azithromycin   \n",
       "4               OTHER: No intervention in PROTECT   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  Travellers' Knowledge Score, The traveller's k...  ...   \n",
       "1  To determine the effect of LLIN and a simple m...  ...   \n",
       "2  Malaria transmission rates in a household, Mal...  ...   \n",
       "3  day 28 cure rate of >95%, Efficacy of fosmidom...  ...   \n",
       "4  Z-scores for Overall cognitive ability, 12 mon...  ...   \n",
       "\n",
       "                                        Study Design           Other IDs  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...         2010462-01H   \n",
       "1          Observational Model: |Time Perspective: p    35464-B|SSC#1554   \n",
       "2  Allocation: RANDOMIZED|Intervention Model: PAR...  MAKSHSREC-2021-237   \n",
       "3  Allocation: NON_RANDOMIZED|Intervention Model:...               JP011   \n",
       "4          Observational Model: |Time Perspective: p          1506994146   \n",
       "\n",
       "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "0     2014-01                 2015-11         2015-11   2013-11-05   \n",
       "1     2009-09                 2011-12         2011-12   2009-06-04   \n",
       "2  2022-08-04              2022-12-31      2022-12-31   2022-11-04   \n",
       "3     2008-11                 2009-10         2011-12   2011-11-03   \n",
       "4     2015-10              2021-08-05      2021-08-05   2015-09-23   \n",
       "\n",
       "  Results First Posted  Last Update Posted  \\\n",
       "0                  NaN          2015-04-16   \n",
       "1                  NaN          2015-05-29   \n",
       "2                  NaN          2022-11-04   \n",
       "3                  NaN          2011-11-03   \n",
       "4                  NaN          2021-08-25   \n",
       "\n",
       "                                           Locations Study Documents  \n",
       "0  National Capital Region Occupational Health Cl...             NaN  \n",
       "1  Kisii Provincial Hospital, Kisii, Kenya|Kisumu...             NaN  \n",
       "2           ST. Paul's Health Center, Kasese, Uganda             NaN  \n",
       "3       Mahidol University, Bangkok, 10400, Thailand             NaN  \n",
       "4           Tororo District Hospital, Tororo, Uganda             NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 311,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# loading the malaria data set\n",
    "mal = pd.read_csv(\"malaria.csv\")\n",
    "mal.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 312,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02708225</td>\n",
       "      <td>The Influence of Medical Clowns on the Perform...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02708225</td>\n",
       "      <td>clowns</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>Medical clowns are known to assist in relaxing...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Asthma|Pneumonia</td>\n",
       "      <td>BEHAVIORAL: medical clown</td>\n",
       "      <td>length of experium (seconds), length of experi...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>0026-15</td>\n",
       "      <td>2016-03</td>\n",
       "      <td>2016-10</td>\n",
       "      <td>2017-10</td>\n",
       "      <td>2016-03-15</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2016-03-15</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03962725</td>\n",
       "      <td>Avoiding Neuromuscular Blockers to Reduce Comp...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03962725</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The goal of this study to evaluate whether eli...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Respiratory Failure|Respiratory Infection|Aspi...</td>\n",
       "      <td>DRUG: Neuromuscular Blocking Agents|DRUG: Anes...</td>\n",
       "      <td>Number of participants who either had postoper...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2019P000260</td>\n",
       "      <td>2019-08-07</td>\n",
       "      <td>2022-12-19</td>\n",
       "      <td>2022-12-19</td>\n",
       "      <td>2019-05-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-02-02</td>\n",
       "      <td>Massachusetts General Hospital, Boston, Massac...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT04646525</td>\n",
       "      <td>The Relationship Between Covid-19 Infection in...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04646525</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>We aimed to find out whether the tonsils and n...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Covid19|Immune Deficiency|Tonsillitis|Tonsil H...</td>\n",
       "      <td>DIAGNOSTIC_TEST: Physical examination</td>\n",
       "      <td>The primary outcome of our study was the evalu...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2020/480</td>\n",
       "      <td>2020-10-01</td>\n",
       "      <td>2021-02-01</td>\n",
       "      <td>2021-02-01</td>\n",
       "      <td>2020-11-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020-11-30</td>\n",
       "      <td>Selcuk University, Konya, Selcuklu, 42100, Turkey</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT04333225</td>\n",
       "      <td>Hydroxychloroquine in the Prevention of COVID-...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04333225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>In order to assess the efficacy of hydroxychlo...</td>\n",
       "      <td>YES</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>DRUG: Hydroxychloroquine</td>\n",
       "      <td>Number of Participants Infected With COVID-19 ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>020-132</td>\n",
       "      <td>2020-04-03</td>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>2020-04-03</td>\n",
       "      <td>2021-08-02</td>\n",
       "      <td>2021-08-20</td>\n",
       "      <td>Baylor University Medical Center, Dallas, Texa...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT04858425</td>\n",
       "      <td>Safety and Efficacy of Niclosamide in Patients...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04858425</td>\n",
       "      <td>RESERVOIR</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This is a 2-part, 2-arm, Phase 2 , multicentre...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Covid19</td>\n",
       "      <td>DRUG: Niclosamide|DRUG: Placebo</td>\n",
       "      <td>SAEs, Serious adverse event (SAE) coded by Sys...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>AZ-NICL-COV-1</td>\n",
       "      <td>2021-04-30</td>\n",
       "      <td>2022-06-04</td>\n",
       "      <td>2023-05</td>\n",
       "      <td>2021-04-26</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-04-06</td>\n",
       "      <td>Central Alabama Research, Birmingham, Alabama,...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT02708225  The Influence of Medical Clowns on the Perform...   \n",
       "1  NCT03962725  Avoiding Neuromuscular Blockers to Reduce Comp...   \n",
       "2  NCT04646525  The Relationship Between Covid-19 Infection in...   \n",
       "3  NCT04333225  Hydroxychloroquine in the Prevention of COVID-...   \n",
       "4  NCT04858425  Safety and Efficacy of Niclosamide in Patients...   \n",
       "\n",
       "                                      Study URL    Acronym  \\\n",
       "0  https://clinicaltrials.gov/study/NCT02708225     clowns   \n",
       "1  https://clinicaltrials.gov/study/NCT03962725        NaN   \n",
       "2  https://clinicaltrials.gov/study/NCT04646525        NaN   \n",
       "3  https://clinicaltrials.gov/study/NCT04333225        NaN   \n",
       "4  https://clinicaltrials.gov/study/NCT04858425  RESERVOIR   \n",
       "\n",
       "            Study Status                                      Brief Summary  \\\n",
       "0                UNKNOWN  Medical clowns are known to assist in relaxing...   \n",
       "1             TERMINATED  The goal of this study to evaluate whether eli...   \n",
       "2                UNKNOWN  We aimed to find out whether the tonsils and n...   \n",
       "3              COMPLETED  In order to assess the efficacy of hydroxychlo...   \n",
       "4  ACTIVE_NOT_RECRUITING  This is a 2-part, 2-arm, Phase 2 , multicentre...   \n",
       "\n",
       "  Study Results                                         Conditions  \\\n",
       "0            NO                                   Asthma|Pneumonia   \n",
       "1            NO  Respiratory Failure|Respiratory Infection|Aspi...   \n",
       "2            NO  Covid19|Immune Deficiency|Tonsillitis|Tonsil H...   \n",
       "3           YES                                           COVID-19   \n",
       "4            NO                                            Covid19   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                          BEHAVIORAL: medical clown   \n",
       "1  DRUG: Neuromuscular Blocking Agents|DRUG: Anes...   \n",
       "2              DIAGNOSTIC_TEST: Physical examination   \n",
       "3                           DRUG: Hydroxychloroquine   \n",
       "4                    DRUG: Niclosamide|DRUG: Placebo   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  length of experium (seconds), length of experi...  ...   \n",
       "1  Number of participants who either had postoper...  ...   \n",
       "2  The primary outcome of our study was the evalu...  ...   \n",
       "3  Number of Participants Infected With COVID-19 ...  ...   \n",
       "4  SAEs, Serious adverse event (SAE) coded by Sys...  ...   \n",
       "\n",
       "                                        Study Design      Other IDs  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...        0026-15   \n",
       "1  Allocation: RANDOMIZED|Intervention Model: PAR...    2019P000260   \n",
       "2          Observational Model: |Time Perspective: p       2020/480   \n",
       "3  Allocation: NON_RANDOMIZED|Intervention Model:...        020-132   \n",
       "4  Allocation: RANDOMIZED|Intervention Model: PAR...  AZ-NICL-COV-1   \n",
       "\n",
       "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "0     2016-03                 2016-10         2017-10   2016-03-15   \n",
       "1  2019-08-07              2022-12-19      2022-12-19   2019-05-24   \n",
       "2  2020-10-01              2021-02-01      2021-02-01   2020-11-30   \n",
       "3  2020-04-03              2020-06-30      2020-06-30   2020-04-03   \n",
       "4  2021-04-30              2022-06-04         2023-05   2021-04-26   \n",
       "\n",
       "  Results First Posted  Last Update Posted  \\\n",
       "0                  NaN          2016-03-15   \n",
       "1                  NaN          2023-02-02   \n",
       "2                  NaN          2020-11-30   \n",
       "3           2021-08-02          2021-08-20   \n",
       "4                  NaN          2023-04-06   \n",
       "\n",
       "                                           Locations  \\\n",
       "0                                                NaN   \n",
       "1  Massachusetts General Hospital, Boston, Massac...   \n",
       "2  Selcuk University, Konya, Selcuklu, 42100, Turkey   \n",
       "3  Baylor University Medical Center, Dallas, Texa...   \n",
       "4  Central Alabama Research, Birmingham, Alabama,...   \n",
       "\n",
       "                            Study Documents  \n",
       "0                                       NaN  \n",
       "1                                       NaN  \n",
       "2                                       NaN  \n",
       "3  Study Protocol|Statistical Analysis Plan  \n",
       "4                                       NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 312,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# loading the pneumonia dataset\n",
    "pn = pd.read_csv(\"Pneumonia-studies.csv\")\n",
    "pn.head()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 313,
   "metadata": {},
   "outputs": [],
   "source": [
    "# creating a unique column for each of the columns\n",
    "heart['category'] = \"heart\"\n",
    "pn[\"category\"] = \"pneumonia\"\n",
    "mal[\"category\"] = \"malaria\"\n",
    "hiv[\"category\"] = \"Hiv\"\n",
    "cov[\"category\"] = \"Covid\"\n",
    "can[\"category\"] = \"cancer\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 314,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>category</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>PROACT</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>...</td>\n",
       "      <td>2005-01|G050208</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2006-02-14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>...</td>\n",
       "      <td>A4070417|2U54MD007600-31</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-04-30</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2018-02-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03176225</td>\n",
       "      <td>Evaluate Safety and Effectiveness of XenoSure ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03176225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The purpose of this clinical trial is to colle...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Diseases</td>\n",
       "      <td>PROCEDURE: Open heart surgery to address the h...</td>\n",
       "      <td>Leakage rate at 6 month post-procedure measure...</td>\n",
       "      <td>...</td>\n",
       "      <td>P15077-1</td>\n",
       "      <td>2017-08-15</td>\n",
       "      <td>2025-11-15</td>\n",
       "      <td>2026-02-15</td>\n",
       "      <td>2017-06-05</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-03-10</td>\n",
       "      <td>Chinese PLA General Hospital, Beijing, Beijing...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00199225</td>\n",
       "      <td>Evaluation of Possible Effects on the QT/ QTc ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00199225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This phase I trial will evaluate the effects o...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Human Experimentation (Human Volunteers)</td>\n",
       "      <td>DRUG: Rupatadine|DRUG: moxifloxacin|PROCEDURE:...</td>\n",
       "      <td>To assess whether administration of a repeated...</td>\n",
       "      <td>...</td>\n",
       "      <td>IC012RUP/1/04</td>\n",
       "      <td>2005-02</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2005-07</td>\n",
       "      <td>2005-09-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2005-12-15</td>\n",
       "      <td>Centre de Investigaci√≥ de Medicaments-Intitut ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT05724225</td>\n",
       "      <td>\"Atriogenic Tricuspid Selected, Omics Profile,...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05724225</td>\n",
       "      <td>ATOMIC</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The aim of our study is to investigate the mol...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Tricuspid Valve Insufficiency</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Protein expression, Evaluation of the protein ...</td>\n",
       "      <td>...</td>\n",
       "      <td>4424</td>\n",
       "      <td>2021-10-06</td>\n",
       "      <td>2022-11-07</td>\n",
       "      <td>2023-12-29</td>\n",
       "      <td>2023-02-13</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-02-15</td>\n",
       "      <td>Istituto Auxologico Italiano IRCSS Ospedale Sa...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 31 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "2  NCT03176225  Evaluate Safety and Effectiveness of XenoSure ...   \n",
       "3  NCT00199225  Evaluation of Possible Effects on the QT/ QTc ...   \n",
       "4  NCT05724225  \"Atriogenic Tricuspid Selected, Omics Profile,...   \n",
       "\n",
       "                                      Study URL Acronym  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  PROACT   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325     NaN   \n",
       "2  https://clinicaltrials.gov/study/NCT03176225     NaN   \n",
       "3  https://clinicaltrials.gov/study/NCT00199225     NaN   \n",
       "4  https://clinicaltrials.gov/study/NCT05724225  ATOMIC   \n",
       "\n",
       "            Study Status                                      Brief Summary  \\\n",
       "0  ACTIVE_NOT_RECRUITING  Various patient groups with the On-X Valve can...   \n",
       "1  ACTIVE_NOT_RECRUITING  Clopidogrel is a prescription medicine used to...   \n",
       "2             RECRUITING  The purpose of this clinical trial is to colle...   \n",
       "3              COMPLETED  This phase I trial will evaluate the effects o...   \n",
       "4  ACTIVE_NOT_RECRUITING  The aim of our study is to investigate the mol...   \n",
       "\n",
       "  Study Results                                         Conditions  \\\n",
       "0            NO                                Heart Valve Disease   \n",
       "1            NO  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "2            NO                                     Heart Diseases   \n",
       "3            NO           Human Experimentation (Human Volunteers)   \n",
       "4            NO                      Tricuspid Valve Insufficiency   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "2  PROCEDURE: Open heart surgery to address the h...   \n",
       "3  DRUG: Rupatadine|DRUG: moxifloxacin|PROCEDURE:...   \n",
       "4                                                NaN   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...  ...   \n",
       "1  Major adverse cardiovascular events (MACE) red...  ...   \n",
       "2  Leakage rate at 6 month post-procedure measure...  ...   \n",
       "3  To assess whether administration of a repeated...  ...   \n",
       "4  Protein expression, Evaluation of the protein ...  ...   \n",
       "\n",
       "                  Other IDs  Start Date Primary Completion Date  \\\n",
       "0           2005-01|G050208  2006-06-06              2022-12-31   \n",
       "1  A4070417|2U54MD007600-31  2020-09-01              2023-04-30   \n",
       "2                  P15077-1  2017-08-15              2025-11-15   \n",
       "3             IC012RUP/1/04     2005-02                     NaN   \n",
       "4                      4424  2021-10-06              2022-11-07   \n",
       "\n",
       "  Completion Date First Posted Results First Posted Last Update Posted  \\\n",
       "0      2022-12-31   2006-02-14                  NaN         2022-09-14   \n",
       "1      2023-12-30   2018-02-01                  NaN         2023-05-30   \n",
       "2      2026-02-15   2017-06-05                  NaN         2023-03-10   \n",
       "3         2005-07   2005-09-20                  NaN         2005-12-15   \n",
       "4      2023-12-29   2023-02-13                  NaN         2023-02-15   \n",
       "\n",
       "                                           Locations Study Documents category  \n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...             NaN    heart  \n",
       "1  University Hospital at Carolina, Carolina, 009...             NaN    heart  \n",
       "2  Chinese PLA General Hospital, Beijing, Beijing...             NaN    heart  \n",
       "3  Centre de Investigaci√≥ de Medicaments-Intitut ...             NaN    heart  \n",
       "4  Istituto Auxologico Italiano IRCSS Ospedale Sa...             NaN    heart  \n",
       "\n",
       "[5 rows x 31 columns]"
      ]
     },
     "execution_count": 314,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "heart.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 315,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>category</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>PROACT</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>...</td>\n",
       "      <td>2005-01|G050208</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2006-02-14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>...</td>\n",
       "      <td>A4070417|2U54MD007600-31</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-04-30</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2018-02-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03176225</td>\n",
       "      <td>Evaluate Safety and Effectiveness of XenoSure ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03176225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The purpose of this clinical trial is to colle...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Diseases</td>\n",
       "      <td>PROCEDURE: Open heart surgery to address the h...</td>\n",
       "      <td>Leakage rate at 6 month post-procedure measure...</td>\n",
       "      <td>...</td>\n",
       "      <td>P15077-1</td>\n",
       "      <td>2017-08-15</td>\n",
       "      <td>2025-11-15</td>\n",
       "      <td>2026-02-15</td>\n",
       "      <td>2017-06-05</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-03-10</td>\n",
       "      <td>Chinese PLA General Hospital, Beijing, Beijing...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00199225</td>\n",
       "      <td>Evaluation of Possible Effects on the QT/ QTc ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00199225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This phase I trial will evaluate the effects o...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Human Experimentation (Human Volunteers)</td>\n",
       "      <td>DRUG: Rupatadine|DRUG: moxifloxacin|PROCEDURE:...</td>\n",
       "      <td>To assess whether administration of a repeated...</td>\n",
       "      <td>...</td>\n",
       "      <td>IC012RUP/1/04</td>\n",
       "      <td>2005-02</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2005-07</td>\n",
       "      <td>2005-09-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2005-12-15</td>\n",
       "      <td>Centre de Investigaci√≥ de Medicaments-Intitut ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT05724225</td>\n",
       "      <td>\"Atriogenic Tricuspid Selected, Omics Profile,...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05724225</td>\n",
       "      <td>ATOMIC</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The aim of our study is to investigate the mol...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Tricuspid Valve Insufficiency</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Protein expression, Evaluation of the protein ...</td>\n",
       "      <td>...</td>\n",
       "      <td>4424</td>\n",
       "      <td>2021-10-06</td>\n",
       "      <td>2022-11-07</td>\n",
       "      <td>2023-12-29</td>\n",
       "      <td>2023-02-13</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-02-15</td>\n",
       "      <td>Istituto Auxologico Italiano IRCSS Ospedale Sa...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 31 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "2  NCT03176225  Evaluate Safety and Effectiveness of XenoSure ...   \n",
       "3  NCT00199225  Evaluation of Possible Effects on the QT/ QTc ...   \n",
       "4  NCT05724225  \"Atriogenic Tricuspid Selected, Omics Profile,...   \n",
       "\n",
       "                                      Study URL Acronym  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  PROACT   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325     NaN   \n",
       "2  https://clinicaltrials.gov/study/NCT03176225     NaN   \n",
       "3  https://clinicaltrials.gov/study/NCT00199225     NaN   \n",
       "4  https://clinicaltrials.gov/study/NCT05724225  ATOMIC   \n",
       "\n",
       "            Study Status                                      Brief Summary  \\\n",
       "0  ACTIVE_NOT_RECRUITING  Various patient groups with the On-X Valve can...   \n",
       "1  ACTIVE_NOT_RECRUITING  Clopidogrel is a prescription medicine used to...   \n",
       "2             RECRUITING  The purpose of this clinical trial is to colle...   \n",
       "3              COMPLETED  This phase I trial will evaluate the effects o...   \n",
       "4  ACTIVE_NOT_RECRUITING  The aim of our study is to investigate the mol...   \n",
       "\n",
       "  Study Results                                         Conditions  \\\n",
       "0            NO                                Heart Valve Disease   \n",
       "1            NO  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "2            NO                                     Heart Diseases   \n",
       "3            NO           Human Experimentation (Human Volunteers)   \n",
       "4            NO                      Tricuspid Valve Insufficiency   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "2  PROCEDURE: Open heart surgery to address the h...   \n",
       "3  DRUG: Rupatadine|DRUG: moxifloxacin|PROCEDURE:...   \n",
       "4                                                NaN   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...  ...   \n",
       "1  Major adverse cardiovascular events (MACE) red...  ...   \n",
       "2  Leakage rate at 6 month post-procedure measure...  ...   \n",
       "3  To assess whether administration of a repeated...  ...   \n",
       "4  Protein expression, Evaluation of the protein ...  ...   \n",
       "\n",
       "                  Other IDs  Start Date Primary Completion Date  \\\n",
       "0           2005-01|G050208  2006-06-06              2022-12-31   \n",
       "1  A4070417|2U54MD007600-31  2020-09-01              2023-04-30   \n",
       "2                  P15077-1  2017-08-15              2025-11-15   \n",
       "3             IC012RUP/1/04     2005-02                     NaN   \n",
       "4                      4424  2021-10-06              2022-11-07   \n",
       "\n",
       "  Completion Date First Posted Results First Posted Last Update Posted  \\\n",
       "0      2022-12-31   2006-02-14                  NaN         2022-09-14   \n",
       "1      2023-12-30   2018-02-01                  NaN         2023-05-30   \n",
       "2      2026-02-15   2017-06-05                  NaN         2023-03-10   \n",
       "3         2005-07   2005-09-20                  NaN         2005-12-15   \n",
       "4      2023-12-29   2023-02-13                  NaN         2023-02-15   \n",
       "\n",
       "                                           Locations Study Documents category  \n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...             NaN    heart  \n",
       "1  University Hospital at Carolina, Carolina, 009...             NaN    heart  \n",
       "2  Chinese PLA General Hospital, Beijing, Beijing...             NaN    heart  \n",
       "3  Centre de Investigaci√≥ de Medicaments-Intitut ...             NaN    heart  \n",
       "4  Istituto Auxologico Italiano IRCSS Ospedale Sa...             NaN    heart  \n",
       "\n",
       "[5 rows x 31 columns]"
      ]
     },
     "execution_count": 315,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# merging the whole datasets into one df\n",
    "dfs = [heart,pn,can,hiv,cov,mal]\n",
    "df = pd.concat(dfs, ignore_index=True, sort=False)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 316,
   "metadata": {},
   "outputs": [],
   "source": [
    "# This is a function that enables us to  understand our data more better\n",
    "def understanding(df):\n",
    "    \"\"\"This is a function that enables us to understand the data \"\"\"\n",
    "    # data shape\n",
    "    print(f\"Our data consists of {df.shape[1]} columns and {df.shape[0]} rows\")\n",
    "\n",
    "    # understanding the data types\n",
    "    data_types = df.dtypes\n",
    "    print(\"Data Types:\")\n",
    "    print(data_types)\n",
    "\n",
    "    \n",
    "\n",
    "# checking the  aspects of data quality\n",
    "def quality (df):\n",
    "    \"\"\"This is a function that checks for the aspects of data quality\"\"\"\n",
    "    #checking for the missing values\n",
    "    missing = (df.isna().sum()/len(df))*100\n",
    "    missing = missing.sort_values(ascending=False)\n",
    "    print(\"Percentage of missing values:\")\n",
    "    print(missing)\n",
    "\n",
    "    # checking for duplicate values\n",
    "    dups = df.duplicated().sum()\n",
    "    print(\"duplicates:\")\n",
    "    print(dups)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 317,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Our data consists of 31 columns and 161863 rows\n",
      "Data Types:\n",
      "NCT Number                     object\n",
      "Study Title                    object\n",
      "Study URL                      object\n",
      "Acronym                        object\n",
      "Study Status                   object\n",
      "Brief Summary                  object\n",
      "Study Results                  object\n",
      "Conditions                     object\n",
      "Interventions                  object\n",
      "Primary Outcome Measures       object\n",
      "Secondary Outcome Measures     object\n",
      "Other Outcome Measures         object\n",
      "Sponsor                        object\n",
      "Collaborators                  object\n",
      "Sex                            object\n",
      "Age                            object\n",
      "Phases                         object\n",
      "Enrollment                    float64\n",
      "Funder Type                    object\n",
      "Study Type                     object\n",
      "Study Design                   object\n",
      "Other IDs                      object\n",
      "Start Date                     object\n",
      "Primary Completion Date        object\n",
      "Completion Date                object\n",
      "First Posted                   object\n",
      "Results First Posted           object\n",
      "Last Update Posted             object\n",
      "Locations                      object\n",
      "Study Documents                object\n",
      "category                       object\n",
      "dtype: object\n"
     ]
    }
   ],
   "source": [
    "# calling the function to understand the data\n",
    "understanding(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 318,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Enrollment</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>1.583940e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>9.374003e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>7.689174e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>0.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>3.000000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>7.600000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>2.340000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>1.888141e+08</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         Enrollment\n",
       "count  1.583940e+05\n",
       "mean   9.374003e+03\n",
       "std    7.689174e+05\n",
       "min    0.000000e+00\n",
       "25%    3.000000e+01\n",
       "50%    7.600000e+01\n",
       "75%    2.340000e+02\n",
       "max    1.888141e+08"
      ]
     },
     "execution_count": 318,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# understanding the summary statitics\n",
    "df.describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 319,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Percentage of missing values:\n",
      "Study Documents               93.469786\n",
      "Other Outcome Measures        91.902411\n",
      "Results First Posted          87.759401\n",
      "Acronym                       70.016619\n",
      "Collaborators                 62.425014\n",
      "Phases                        49.716118\n",
      "Secondary Outcome Measures    26.064017\n",
      "Interventions                 10.659014\n",
      "Locations                      8.792003\n",
      "Primary Completion Date        5.149416\n",
      "Primary Outcome Measures       5.057981\n",
      "Completion Date                4.524814\n",
      "Enrollment                     2.143170\n",
      "Start Date                     1.455552\n",
      "Study Design                   0.308285\n",
      "Sex                            0.101938\n",
      "Other IDs                      0.012974\n",
      "Conditions                     0.003707\n",
      "First Posted                   0.000000\n",
      "Last Update Posted             0.000000\n",
      "NCT Number                     0.000000\n",
      "Age                            0.000000\n",
      "Study Type                     0.000000\n",
      "Funder Type                    0.000000\n",
      "Study Title                    0.000000\n",
      "Sponsor                        0.000000\n",
      "Study Results                  0.000000\n",
      "Brief Summary                  0.000000\n",
      "Study Status                   0.000000\n",
      "Study URL                      0.000000\n",
      "category                       0.000000\n",
      "dtype: float64\n",
      "duplicates:\n",
      "0\n"
     ]
    }
   ],
   "source": [
    "#  checking the data quality\n",
    "quality(df)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Data Preparation"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Data Cleaning "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 320,
   "metadata": {},
   "outputs": [],
   "source": [
    "# columns with more than 50% that will be dropped\n",
    "cols = [\"Study Documents\",\"Other Outcome Measures\",\"Results First Posted\",\"Acronym\",\"Collaborators\",\"Phases\"]\n",
    "\n",
    "\n",
    "# dropping columns that have missing values of more than 50%\n",
    "df.drop(cols,axis=1,inplace=True)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 321,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Percentage of missing values:\n",
      "Secondary Outcome Measures    26.064017\n",
      "Interventions                 10.659014\n",
      "Locations                      8.792003\n",
      "Primary Completion Date        5.149416\n",
      "Primary Outcome Measures       5.057981\n",
      "Completion Date                4.524814\n",
      "Enrollment                     2.143170\n",
      "Start Date                     1.455552\n",
      "Study Design                   0.308285\n",
      "Sex                            0.101938\n",
      "Other IDs                      0.012974\n",
      "Conditions                     0.003707\n",
      "NCT Number                     0.000000\n",
      "Last Update Posted             0.000000\n",
      "First Posted                   0.000000\n",
      "Age                            0.000000\n",
      "Study Type                     0.000000\n",
      "Funder Type                    0.000000\n",
      "Study Title                    0.000000\n",
      "Sponsor                        0.000000\n",
      "Study Results                  0.000000\n",
      "Brief Summary                  0.000000\n",
      "Study Status                   0.000000\n",
      "Study URL                      0.000000\n",
      "category                       0.000000\n",
      "dtype: float64\n",
      "duplicates:\n",
      "0\n"
     ]
    }
   ],
   "source": [
    "quality(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 322,
   "metadata": {},
   "outputs": [],
   "source": [
    "# dropping rows that contain missing values\n",
    "df.dropna(axis=0,inplace = True)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 323,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Percentage of missing values:\n",
      "NCT Number                    0.0\n",
      "Enrollment                    0.0\n",
      "Locations                     0.0\n",
      "Last Update Posted            0.0\n",
      "First Posted                  0.0\n",
      "Completion Date               0.0\n",
      "Primary Completion Date       0.0\n",
      "Start Date                    0.0\n",
      "Other IDs                     0.0\n",
      "Study Design                  0.0\n",
      "Study Type                    0.0\n",
      "Funder Type                   0.0\n",
      "Age                           0.0\n",
      "Study Title                   0.0\n",
      "Sex                           0.0\n",
      "Sponsor                       0.0\n",
      "Secondary Outcome Measures    0.0\n",
      "Primary Outcome Measures      0.0\n",
      "Interventions                 0.0\n",
      "Conditions                    0.0\n",
      "Study Results                 0.0\n",
      "Brief Summary                 0.0\n",
      "Study Status                  0.0\n",
      "Study URL                     0.0\n",
      "category                      0.0\n",
      "dtype: float64\n",
      "duplicates:\n",
      "0\n"
     ]
    }
   ],
   "source": [
    "# checking for missing values\n",
    "quality(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 324,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2005-01|G050208</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2006-02-14</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>A4070417|2U54MD007600-31</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-04-30</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2018-02-01</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>15-002</td>\n",
       "      <td>2015-06-03</td>\n",
       "      <td>2022-04-30</td>\n",
       "      <td>2022-04-30</td>\n",
       "      <td>2019-05-07</td>\n",
       "      <td>2022-05-25</td>\n",
       "      <td>Division of Cardiology, Pulmonary Disease and ...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>14338</td>\n",
       "      <td>2021-08-03</td>\n",
       "      <td>2022-12-29</td>\n",
       "      <td>2022-12-29</td>\n",
       "      <td>2019-07-25</td>\n",
       "      <td>2023-08-21</td>\n",
       "      <td>Oxford Heart Centre, Oxford, OX39DU, United Ki...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>scP-01-005</td>\n",
       "      <td>2020-11-12</td>\n",
       "      <td>2021-06-24</td>\n",
       "      <td>2021-06-24</td>\n",
       "      <td>2018-03-08</td>\n",
       "      <td>2023-02-24</td>\n",
       "      <td>Olive View - UCLA Medical Center, Sylmar, Cali...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 25 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ...      Study Type  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ...  INTERVENTIONAL   \n",
       "1  number of patients with treatment-related card...  ...  INTERVENTIONAL   \n",
       "5  reduction of the left ventricular global longi...  ...  INTERVENTIONAL   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ...  INTERVENTIONAL   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ...  INTERVENTIONAL   \n",
       "\n",
       "                                        Study Design  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "5  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "7  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "8  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "\n",
       "                  Other IDs  Start Date Primary Completion Date  \\\n",
       "0           2005-01|G050208  2006-06-06              2022-12-31   \n",
       "1  A4070417|2U54MD007600-31  2020-09-01              2023-04-30   \n",
       "5                    15-002  2015-06-03              2022-04-30   \n",
       "7                     14338  2021-08-03              2022-12-29   \n",
       "8                scP-01-005  2020-11-12              2021-06-24   \n",
       "\n",
       "  Completion Date First Posted Last Update Posted  \\\n",
       "0      2022-12-31   2006-02-14         2022-09-14   \n",
       "1      2023-12-30   2018-02-01         2023-05-30   \n",
       "5      2022-04-30   2019-05-07         2022-05-25   \n",
       "7      2022-12-29   2019-07-25         2023-08-21   \n",
       "8      2021-06-24   2018-03-08         2023-02-24   \n",
       "\n",
       "                                           Locations category  \n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...    heart  \n",
       "1  University Hospital at Carolina, Carolina, 009...    heart  \n",
       "5  Division of Cardiology, Pulmonary Disease and ...    heart  \n",
       "7  Oxford Heart Centre, Oxford, OX39DU, United Ki...    heart  \n",
       "8  Olive View - UCLA Medical Center, Sylmar, Cali...    heart  \n",
       "\n",
       "[5 rows x 25 columns]"
      ]
     },
     "execution_count": 324,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 325,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Age</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>1200.0</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>150.0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>69.0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>2015-06-03</td>\n",
       "      <td>2022-04-30</td>\n",
       "      <td>2022-05-25</td>\n",
       "      <td>Division of Cardiology, Pulmonary Disease and ...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>2.0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>2021-08-03</td>\n",
       "      <td>2022-12-29</td>\n",
       "      <td>2023-08-21</td>\n",
       "      <td>Oxford Heart Centre, Oxford, OX39DU, United Ki...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>27.0</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2020-11-12</td>\n",
       "      <td>2021-06-24</td>\n",
       "      <td>2023-02-24</td>\n",
       "      <td>Olive View - UCLA Medical Center, Sylmar, Cali...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ...                 Age  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ...  ADULT, OLDER_ADULT   \n",
       "1  number of patients with treatment-related card...  ...  ADULT, OLDER_ADULT   \n",
       "5  reduction of the left ventricular global longi...  ...  ADULT, OLDER_ADULT   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ...  ADULT, OLDER_ADULT   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ...  ADULT, OLDER_ADULT   \n",
       "\n",
       "  Enrollment Funder Type      Study Type  \\\n",
       "0     1200.0    INDUSTRY  INTERVENTIONAL   \n",
       "1      150.0       OTHER  INTERVENTIONAL   \n",
       "5       69.0       OTHER  INTERVENTIONAL   \n",
       "7        2.0       OTHER  INTERVENTIONAL   \n",
       "8       27.0    INDUSTRY  INTERVENTIONAL   \n",
       "\n",
       "                                        Study Design  Start Date  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...  2006-06-06   \n",
       "1  Allocation: NON_RANDOMIZED|Intervention Model:...  2020-09-01   \n",
       "5  Allocation: NA|Intervention Model: SINGLE_GROU...  2015-06-03   \n",
       "7  Allocation: NA|Intervention Model: SINGLE_GROU...  2021-08-03   \n",
       "8  Allocation: NON_RANDOMIZED|Intervention Model:...  2020-11-12   \n",
       "\n",
       "  Completion Date Last Update Posted  \\\n",
       "0      2022-12-31         2022-09-14   \n",
       "1      2023-12-30         2023-05-30   \n",
       "5      2022-04-30         2022-05-25   \n",
       "7      2022-12-29         2023-08-21   \n",
       "8      2021-06-24         2023-02-24   \n",
       "\n",
       "                                           Locations category  \n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...    heart  \n",
       "1  University Hospital at Carolina, Carolina, 009...    heart  \n",
       "5  Division of Cardiology, Pulmonary Disease and ...    heart  \n",
       "7  Oxford Heart Centre, Oxford, OX39DU, United Ki...    heart  \n",
       "8  Olive View - UCLA Medical Center, Sylmar, Cali...    heart  \n",
       "\n",
       "[5 rows x 22 columns]"
      ]
     },
     "execution_count": 325,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# dropping columns that are unnecessary columns\n",
    "drop_list = [\"Other IDs\",\"Primary Completion Date\",\"First Posted\"]\n",
    "df = df.drop(drop_list,axis=1)\n",
    "df.head()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 326,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['NCT Number', 'Study Title', 'Study URL', 'Study Status',\n",
       "       'Brief Summary', 'Study Results', 'Conditions', 'Interventions',\n",
       "       'Primary Outcome Measures', 'Secondary Outcome Measures', 'Sponsor',\n",
       "       'Sex', 'Age', 'Enrollment', 'Funder Type', 'Study Type', 'Study Design',\n",
       "       'Start Date', 'Completion Date', 'Last Update Posted', 'Locations',\n",
       "       'category'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 326,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 327,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Specify the format for each date column\n",
    "date_format_start = \"%Y-%m-%d\"\n",
    "date_format_completion = \"%Y-%m-%d\"\n",
    "date_format_update = \"%Y-%m-%d\"\n",
    "\n",
    "# Convert the date columns to datetime using the specified formats\n",
    "df[\"Start Date\"] = pd.to_datetime(df[\"Start Date\"], format=\"ISO8601\")\n",
    "df[\"Completion Date\"] = pd.to_datetime(df[\"Completion Date\"], format=\"ISO8601\")\n",
    "df[\"Last Update Posted\"] = pd.to_datetime(df[\"Last Update Posted\"], format=\"ISO8601\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 328,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number                            object\n",
       "Study Title                           object\n",
       "Study URL                             object\n",
       "Study Status                          object\n",
       "Brief Summary                         object\n",
       "Study Results                         object\n",
       "Conditions                            object\n",
       "Interventions                         object\n",
       "Primary Outcome Measures              object\n",
       "Secondary Outcome Measures            object\n",
       "Sponsor                               object\n",
       "Sex                                   object\n",
       "Age                                   object\n",
       "Enrollment                           float64\n",
       "Funder Type                           object\n",
       "Study Type                            object\n",
       "Study Design                          object\n",
       "Start Date                    datetime64[ns]\n",
       "Completion Date               datetime64[ns]\n",
       "Last Update Posted            datetime64[ns]\n",
       "Locations                             object\n",
       "category                              object\n",
       "dtype: object"
      ]
     },
     "execution_count": 328,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.dtypes"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Feature Engineering"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 329,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "      <th>start_year</th>\n",
       "      <th>completion_year</th>\n",
       "      <th>last_year_posted</th>\n",
       "      <th>duration</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2006</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>16</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2023</td>\n",
       "      <td>2023</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>2015-06-03</td>\n",
       "      <td>2022-04-30</td>\n",
       "      <td>2022-05-25</td>\n",
       "      <td>Division of Cardiology, Pulmonary Disease and ...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2015</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>2021-08-03</td>\n",
       "      <td>2022-12-29</td>\n",
       "      <td>2023-08-21</td>\n",
       "      <td>Oxford Heart Centre, Oxford, OX39DU, United Ki...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2021</td>\n",
       "      <td>2022</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2020-11-12</td>\n",
       "      <td>2021-06-24</td>\n",
       "      <td>2023-02-24</td>\n",
       "      <td>Olive View - UCLA Medical Center, Sylmar, Cali...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2021</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 26 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ...  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ...   \n",
       "1  number of patients with treatment-related card...  ...   \n",
       "5  reduction of the left ventricular global longi...  ...   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ...   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ...   \n",
       "\n",
       "                                        Study Design Start Date  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR... 2006-06-06   \n",
       "1  Allocation: NON_RANDOMIZED|Intervention Model:... 2020-09-01   \n",
       "5  Allocation: NA|Intervention Model: SINGLE_GROU... 2015-06-03   \n",
       "7  Allocation: NA|Intervention Model: SINGLE_GROU... 2021-08-03   \n",
       "8  Allocation: NON_RANDOMIZED|Intervention Model:... 2020-11-12   \n",
       "\n",
       "  Completion Date  Last Update Posted  \\\n",
       "0      2022-12-31          2022-09-14   \n",
       "1      2023-12-30          2023-05-30   \n",
       "5      2022-04-30          2022-05-25   \n",
       "7      2022-12-29          2023-08-21   \n",
       "8      2021-06-24          2023-02-24   \n",
       "\n",
       "                                           Locations category start_year  \\\n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...    heart       2006   \n",
       "1  University Hospital at Carolina, Carolina, 009...    heart       2020   \n",
       "5  Division of Cardiology, Pulmonary Disease and ...    heart       2015   \n",
       "7  Oxford Heart Centre, Oxford, OX39DU, United Ki...    heart       2021   \n",
       "8  Olive View - UCLA Medical Center, Sylmar, Cali...    heart       2020   \n",
       "\n",
       "  completion_year last_year_posted duration  \n",
       "0            2022             2022       16  \n",
       "1            2023             2023        3  \n",
       "5            2022             2022        7  \n",
       "7            2022             2023        1  \n",
       "8            2021             2023        1  \n",
       "\n",
       "[5 rows x 26 columns]"
      ]
     },
     "execution_count": 329,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# creating years  from start,completion and last posted dates\n",
    "df[\"start_year\"]= df[\"Start Date\"].dt.year\n",
    "df[\"completion_year\"] = df[\"Completion Date\"].dt.year\n",
    "df[\"last_year_posted\"] = df[\"Last Update Posted\"].dt.year\n",
    "df[\"duration\"] = df[\"completion_year\"] - df[\"start_year\"]\n",
    "\n",
    "\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 330,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Design\n",
       "Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT                                                                                22461\n",
       "Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT                                                                            13571\n",
       "Observational Model: |Time Perspective: p                                                                                                                               12776\n",
       "Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT                                                                         3784\n",
       "Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT                                                                     3527\n",
       "                                                                                                                                                                        ...  \n",
       "Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose:                                        1\n",
       "Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: DEVICE_FEASIBILITY                 1\n",
       "Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: |Primary Purpose: SUPPORTIVE_CARE                                                                                  1\n",
       "Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER                                              1\n",
       "Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC        1\n",
       "Name: count, Length: 830, dtype: int64"
      ]
     },
     "execution_count": 330,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# understanding the study design column\n",
    "df[\"Study Design\"].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 331,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Primary Purpose\n",
       "TREATMENT     61264\n",
       "PREVENTION     7839\n",
       "SUPPORTIVE     4729\n",
       "DIAGNOSTIC     4404\n",
       "OTHER          2554\n",
       "HEALTH         1546\n",
       "BASIC          1268\n",
       "SCREENING       890\n",
       "DEVICE          175\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 331,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#splitting the data design  to get the primary purpose of the study\n",
    "# Extract \"Primary Purpose\" using regular expressions\n",
    "df['Primary Purpose'] = df['Study Design'].str.extract(r'Primary Purpose: ([A-Z]+)')\n",
    "df[\"Primary Purpose\"].value_counts()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 332,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number                            object\n",
       "Study Title                           object\n",
       "Study URL                             object\n",
       "Study Status                          object\n",
       "Brief Summary                         object\n",
       "Study Results                         object\n",
       "Conditions                            object\n",
       "Interventions                         object\n",
       "Primary Outcome Measures              object\n",
       "Secondary Outcome Measures            object\n",
       "Sponsor                               object\n",
       "Sex                                   object\n",
       "Age                                   object\n",
       "Enrollment                           float64\n",
       "Funder Type                           object\n",
       "Study Type                            object\n",
       "Study Design                          object\n",
       "Start Date                    datetime64[ns]\n",
       "Completion Date               datetime64[ns]\n",
       "Last Update Posted            datetime64[ns]\n",
       "Locations                             object\n",
       "category                              object\n",
       "start_year                             int32\n",
       "completion_year                        int32\n",
       "last_year_posted                       int32\n",
       "duration                               int32\n",
       "Primary Purpose                       object\n",
       "dtype: object"
      ]
     },
     "execution_count": 332,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.dtypes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 333,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "      <th>start_year</th>\n",
       "      <th>completion_year</th>\n",
       "      <th>last_year_posted</th>\n",
       "      <th>duration</th>\n",
       "      <th>Primary Purpose</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>2020-11-12</td>\n",
       "      <td>2021-06-24</td>\n",
       "      <td>2023-02-24</td>\n",
       "      <td>Olive View - UCLA Medical Center, Sylmar, Cali...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2021</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>NCT02920125</td>\n",
       "      <td>Study the Result of Ayurvedic SUVED &amp; Reimmuge...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02920125</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>To evaluate the benefits of Ayurvedic SUVED \\&amp;...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Coronary Artery Disease|Cerebro Vascular Disea...</td>\n",
       "      <td>DRUG: SUVED|COMBINATION_PRODUCT: REIMMUGEN|OTH...</td>\n",
       "      <td>changes in IMT as a indicator of atheroscleros...</td>\n",
       "      <td>Assessing the development/risk of ischaemic ev...</td>\n",
       "      <td>...</td>\n",
       "      <td>2016-01-01</td>\n",
       "      <td>2017-09-01</td>\n",
       "      <td>2017-09-26</td>\n",
       "      <td>Smt Kashibai Navle Medical College and General...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2016</td>\n",
       "      <td>2017</td>\n",
       "      <td>2017</td>\n",
       "      <td>1</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>941</th>\n",
       "      <td>NCT03137212</td>\n",
       "      <td>Safety and Efficacy of Percutaneous Coronary I...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03137212</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>Patients with acute ST-segment elevation myoca...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Acute ST Segment Elevation Myocardial Infarction</td>\n",
       "      <td>COMBINATION_PRODUCT: thrombolysis and PCI of A...</td>\n",
       "      <td>Post-PCIÔºàpercutaneous coronary interventionÔºâ m...</td>\n",
       "      <td>Major Adverse Cardiovascular Events ÔºàMACEÔºâ, De...</td>\n",
       "      <td>...</td>\n",
       "      <td>2017-04-17</td>\n",
       "      <td>2020-03-31</td>\n",
       "      <td>2017-05-02</td>\n",
       "      <td>The second hospital of Jilin university, Chang...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2017</td>\n",
       "      <td>2020</td>\n",
       "      <td>2017</td>\n",
       "      <td>3</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2159</th>\n",
       "      <td>NCT04146766</td>\n",
       "      <td>Effectiveness of eHealth on the Self-managemen...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04146766</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This article uses the smart medical case manag...</td>\n",
       "      <td>NO</td>\n",
       "      <td>eHealth|Coronary Artery Disease|Quality of Lif...</td>\n",
       "      <td>COMBINATION_PRODUCT: eHealth</td>\n",
       "      <td>physiological indicators-HDL-C(T1), HDL-C, the...</td>\n",
       "      <td>self-management-T1, use The partners in Health...</td>\n",
       "      <td>...</td>\n",
       "      <td>2019-09-18</td>\n",
       "      <td>2020-10-05</td>\n",
       "      <td>2021-03-03</td>\n",
       "      <td>TSGH, Taipei city, Taiwan</td>\n",
       "      <td>heart</td>\n",
       "      <td>2019</td>\n",
       "      <td>2020</td>\n",
       "      <td>2021</td>\n",
       "      <td>1</td>\n",
       "      <td>HEALTH</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2348</th>\n",
       "      <td>NCT00106587</td>\n",
       "      <td>Treatment of In-Stent Restenosis by Paclitaxel...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00106587</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The PACCOCATH ISR study is a randomized, doubl...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Coronary Restenosis</td>\n",
       "      <td>DEVICE: PTCA|COMBINATION_PRODUCT: paclitaxel c...</td>\n",
       "      <td>angiographic late lumen loss, angiographic lat...</td>\n",
       "      <td>binary restenosis rate, binary restenosis rate...</td>\n",
       "      <td>...</td>\n",
       "      <td>2003-12-01</td>\n",
       "      <td>2012-03-01</td>\n",
       "      <td>2023-04-27</td>\n",
       "      <td>Klinik fuer Innere Medizin III, Universitaetsk...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2003</td>\n",
       "      <td>2012</td>\n",
       "      <td>2023</td>\n",
       "      <td>9</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160652</th>\n",
       "      <td>NCT04167566</td>\n",
       "      <td>Impact of Scaling up Mass Testing, Treatment a...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04167566</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Malaria poses a serious burden in sub-Sahara A...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria|Malaria, Asymptomatic Parasitaemia</td>\n",
       "      <td>COMBINATION_PRODUCT: Artemisinin Combination T...</td>\n",
       "      <td>The rate of asymptomatic malaria parasitaemia ...</td>\n",
       "      <td>The cost benefit analysis of the scaling up MT...</td>\n",
       "      <td>...</td>\n",
       "      <td>2017-07-01</td>\n",
       "      <td>2019-07-30</td>\n",
       "      <td>2019-11-19</td>\n",
       "      <td>Noguchi Memorial Institute for Medical Researc...</td>\n",
       "      <td>malaria</td>\n",
       "      <td>2017</td>\n",
       "      <td>2019</td>\n",
       "      <td>2019</td>\n",
       "      <td>2</td>\n",
       "      <td>SCREENING</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160887</th>\n",
       "      <td>NCT05330273</td>\n",
       "      <td>Drug-drug Interaction Study of Ganaplacide and...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05330273</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study assessed the effect of multiple dos...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>DRUG: Ganaplacide|COMBINATION_PRODUCT: Lumefan...</td>\n",
       "      <td>Observed maximum plasma concentration (Cmax) f...</td>\n",
       "      <td>Observed maximum plasma concentration (Cmax) f...</td>\n",
       "      <td>...</td>\n",
       "      <td>2022-04-28</td>\n",
       "      <td>2022-11-22</td>\n",
       "      <td>2023-01-12</td>\n",
       "      <td>Novartis Investigative Site, Belfast, Northern...</td>\n",
       "      <td>malaria</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>2023</td>\n",
       "      <td>0</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161011</th>\n",
       "      <td>NCT05874271</td>\n",
       "      <td>Short Course Primaquine for the Radical Cure o...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05874271</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>Significant gains have been made in reducing t...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Vivax Malaria|G6PD Deficiency</td>\n",
       "      <td>COMBINATION_PRODUCT: Revised case management p...</td>\n",
       "      <td>Proportion of patients experiencing at least o...</td>\n",
       "      <td>The proportion of patients with any AESI durin...</td>\n",
       "      <td>...</td>\n",
       "      <td>2023-07-10</td>\n",
       "      <td>2025-07-31</td>\n",
       "      <td>2023-07-11</td>\n",
       "      <td>Napapar Health Centre, Kokopo, East New Britai...</td>\n",
       "      <td>malaria</td>\n",
       "      <td>2023</td>\n",
       "      <td>2025</td>\n",
       "      <td>2023</td>\n",
       "      <td>2</td>\n",
       "      <td>OTHER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161167</th>\n",
       "      <td>NCT02610400</td>\n",
       "      <td>Evaluation of Reactive Focal Mass Drug Adminis...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02610400</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is a cluster randomised controlled trial ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>COMBINATION_PRODUCT: RACD|COMBINATION_PRODUCT:...</td>\n",
       "      <td>Incidence, Incidence of confirmed, passively i...</td>\n",
       "      <td>All-age infection prevalence, The investigator...</td>\n",
       "      <td>...</td>\n",
       "      <td>2016-02-01</td>\n",
       "      <td>2017-12-01</td>\n",
       "      <td>2020-07-17</td>\n",
       "      <td>University of Namibia Multidisciplinary Resear...</td>\n",
       "      <td>malaria</td>\n",
       "      <td>2016</td>\n",
       "      <td>2017</td>\n",
       "      <td>2020</td>\n",
       "      <td>1</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161693</th>\n",
       "      <td>NCT05879224</td>\n",
       "      <td>Short Course Primaquine for the Radical Cure o...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05879224</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>The proportion of malaria that is the Plasmodi...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Vivax Malaria|G6PD Deficiency</td>\n",
       "      <td>COMBINATION_PRODUCT: Revised case management p...</td>\n",
       "      <td>Proportion of patients experiencing at least o...</td>\n",
       "      <td>The proportion of patients with any AESI durin...</td>\n",
       "      <td>...</td>\n",
       "      <td>2023-07-01</td>\n",
       "      <td>2025-07-31</td>\n",
       "      <td>2023-06-22</td>\n",
       "      <td>Puskesmas Hanura, Hanura, Lampung, Indonesia|P...</td>\n",
       "      <td>malaria</td>\n",
       "      <td>2023</td>\n",
       "      <td>2025</td>\n",
       "      <td>2023</td>\n",
       "      <td>2</td>\n",
       "      <td>OTHER</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>658 rows √ó 27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         NCT Number                                        Study Title  \\\n",
       "8       NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "74      NCT02920125  Study the Result of Ayurvedic SUVED & Reimmuge...   \n",
       "941     NCT03137212  Safety and Efficacy of Percutaneous Coronary I...   \n",
       "2159    NCT04146766  Effectiveness of eHealth on the Self-managemen...   \n",
       "2348    NCT00106587  Treatment of In-Stent Restenosis by Paclitaxel...   \n",
       "...             ...                                                ...   \n",
       "160652  NCT04167566  Impact of Scaling up Mass Testing, Treatment a...   \n",
       "160887  NCT05330273  Drug-drug Interaction Study of Ganaplacide and...   \n",
       "161011  NCT05874271  Short Course Primaquine for the Radical Cure o...   \n",
       "161167  NCT02610400  Evaluation of Reactive Focal Mass Drug Adminis...   \n",
       "161693  NCT05879224  Short Course Primaquine for the Radical Cure o...   \n",
       "\n",
       "                                           Study URL        Study Status  \\\n",
       "8       https://clinicaltrials.gov/study/NCT03458325           COMPLETED   \n",
       "74      https://clinicaltrials.gov/study/NCT02920125           COMPLETED   \n",
       "941     https://clinicaltrials.gov/study/NCT03137212             UNKNOWN   \n",
       "2159    https://clinicaltrials.gov/study/NCT04146766           COMPLETED   \n",
       "2348    https://clinicaltrials.gov/study/NCT00106587           COMPLETED   \n",
       "...                                              ...                 ...   \n",
       "160652  https://clinicaltrials.gov/study/NCT04167566           COMPLETED   \n",
       "160887  https://clinicaltrials.gov/study/NCT05330273           COMPLETED   \n",
       "161011  https://clinicaltrials.gov/study/NCT05874271          RECRUITING   \n",
       "161167  https://clinicaltrials.gov/study/NCT02610400           COMPLETED   \n",
       "161693  https://clinicaltrials.gov/study/NCT05879224  NOT_YET_RECRUITING   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "8       The study is to evaluate the safe admission av...           YES   \n",
       "74      To evaluate the benefits of Ayurvedic SUVED \\&...            NO   \n",
       "941     Patients with acute ST-segment elevation myoca...            NO   \n",
       "2159    This article uses the smart medical case manag...            NO   \n",
       "2348    The PACCOCATH ISR study is a randomized, doubl...            NO   \n",
       "...                                                   ...           ...   \n",
       "160652  Malaria poses a serious burden in sub-Sahara A...            NO   \n",
       "160887  This study assessed the effect of multiple dos...            NO   \n",
       "161011  Significant gains have been made in reducing t...            NO   \n",
       "161167  This is a cluster randomised controlled trial ...            NO   \n",
       "161693  The proportion of malaria that is the Plasmodi...            NO   \n",
       "\n",
       "                                               Conditions  \\\n",
       "8                                           Heart Failure   \n",
       "74      Coronary Artery Disease|Cerebro Vascular Disea...   \n",
       "941      Acute ST Segment Elevation Myocardial Infarction   \n",
       "2159    eHealth|Coronary Artery Disease|Quality of Lif...   \n",
       "2348                                  Coronary Restenosis   \n",
       "...                                                   ...   \n",
       "160652         Malaria|Malaria, Asymptomatic Parasitaemia   \n",
       "160887                                            Malaria   \n",
       "161011                      Vivax Malaria|G6PD Deficiency   \n",
       "161167                                            Malaria   \n",
       "161693                      Vivax Malaria|G6PD Deficiency   \n",
       "\n",
       "                                            Interventions  \\\n",
       "8                   COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "74      DRUG: SUVED|COMBINATION_PRODUCT: REIMMUGEN|OTH...   \n",
       "941     COMBINATION_PRODUCT: thrombolysis and PCI of A...   \n",
       "2159                         COMBINATION_PRODUCT: eHealth   \n",
       "2348    DEVICE: PTCA|COMBINATION_PRODUCT: paclitaxel c...   \n",
       "...                                                   ...   \n",
       "160652  COMBINATION_PRODUCT: Artemisinin Combination T...   \n",
       "160887  DRUG: Ganaplacide|COMBINATION_PRODUCT: Lumefan...   \n",
       "161011  COMBINATION_PRODUCT: Revised case management p...   \n",
       "161167  COMBINATION_PRODUCT: RACD|COMBINATION_PRODUCT:...   \n",
       "161693  COMBINATION_PRODUCT: Revised case management p...   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "8       Healthcare Utilization Costs, The difference i...   \n",
       "74      changes in IMT as a indicator of atheroscleros...   \n",
       "941     Post-PCIÔºàpercutaneous coronary interventionÔºâ m...   \n",
       "2159    physiological indicators-HDL-C(T1), HDL-C, the...   \n",
       "2348    angiographic late lumen loss, angiographic lat...   \n",
       "...                                                   ...   \n",
       "160652  The rate of asymptomatic malaria parasitaemia ...   \n",
       "160887  Observed maximum plasma concentration (Cmax) f...   \n",
       "161011  Proportion of patients experiencing at least o...   \n",
       "161167  Incidence, Incidence of confirmed, passively i...   \n",
       "161693  Proportion of patients experiencing at least o...   \n",
       "\n",
       "                               Secondary Outcome Measures  ... Start Date  \\\n",
       "8       Heart-Failure Related Hospital Admissions, The...  ... 2020-11-12   \n",
       "74      Assessing the development/risk of ischaemic ev...  ... 2016-01-01   \n",
       "941     Major Adverse Cardiovascular Events ÔºàMACEÔºâ, De...  ... 2017-04-17   \n",
       "2159    self-management-T1, use The partners in Health...  ... 2019-09-18   \n",
       "2348    binary restenosis rate, binary restenosis rate...  ... 2003-12-01   \n",
       "...                                                   ...  ...        ...   \n",
       "160652  The cost benefit analysis of the scaling up MT...  ... 2017-07-01   \n",
       "160887  Observed maximum plasma concentration (Cmax) f...  ... 2022-04-28   \n",
       "161011  The proportion of patients with any AESI durin...  ... 2023-07-10   \n",
       "161167  All-age infection prevalence, The investigator...  ... 2016-02-01   \n",
       "161693  The proportion of patients with any AESI durin...  ... 2023-07-01   \n",
       "\n",
       "       Completion Date Last Update Posted  \\\n",
       "8           2021-06-24         2023-02-24   \n",
       "74          2017-09-01         2017-09-26   \n",
       "941         2020-03-31         2017-05-02   \n",
       "2159        2020-10-05         2021-03-03   \n",
       "2348        2012-03-01         2023-04-27   \n",
       "...                ...                ...   \n",
       "160652      2019-07-30         2019-11-19   \n",
       "160887      2022-11-22         2023-01-12   \n",
       "161011      2025-07-31         2023-07-11   \n",
       "161167      2017-12-01         2020-07-17   \n",
       "161693      2025-07-31         2023-06-22   \n",
       "\n",
       "                                                Locations category start_year  \\\n",
       "8       Olive View - UCLA Medical Center, Sylmar, Cali...    heart       2020   \n",
       "74      Smt Kashibai Navle Medical College and General...    heart       2016   \n",
       "941     The second hospital of Jilin university, Chang...    heart       2017   \n",
       "2159                            TSGH, Taipei city, Taiwan    heart       2019   \n",
       "2348    Klinik fuer Innere Medizin III, Universitaetsk...    heart       2003   \n",
       "...                                                   ...      ...        ...   \n",
       "160652  Noguchi Memorial Institute for Medical Researc...  malaria       2017   \n",
       "160887  Novartis Investigative Site, Belfast, Northern...  malaria       2022   \n",
       "161011  Napapar Health Centre, Kokopo, East New Britai...  malaria       2023   \n",
       "161167  University of Namibia Multidisciplinary Resear...  malaria       2016   \n",
       "161693  Puskesmas Hanura, Hanura, Lampung, Indonesia|P...  malaria       2023   \n",
       "\n",
       "       completion_year last_year_posted duration Primary Purpose  \n",
       "8                 2021             2023        1       TREATMENT  \n",
       "74                2017             2017        1       TREATMENT  \n",
       "941               2020             2017        3       TREATMENT  \n",
       "2159              2020             2021        1          HEALTH  \n",
       "2348              2012             2023        9       TREATMENT  \n",
       "...                ...              ...      ...             ...  \n",
       "160652            2019             2019        2       SCREENING  \n",
       "160887            2022             2023        0       TREATMENT  \n",
       "161011            2025             2023        2           OTHER  \n",
       "161167            2017             2020        1       TREATMENT  \n",
       "161693            2025             2023        2           OTHER  \n",
       "\n",
       "[658 rows x 27 columns]"
      ]
     },
     "execution_count": 333,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# understanding interventions columns\n",
    "def check (name):\n",
    "    \"\"\"Checking for each type of interventipns\"\"\"\n",
    "    int_df = df[df[\"Interventions\"].str.contains(name)==True]\n",
    "    return int_df\n",
    "\n",
    "\n",
    "check(\"COMBINATIO\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 334,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "      <th>start_year</th>\n",
       "      <th>completion_year</th>\n",
       "      <th>last_year_posted</th>\n",
       "      <th>duration</th>\n",
       "      <th>Primary Purpose</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2006</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>16</td>\n",
       "      <td>PREVENTION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2023</td>\n",
       "      <td>2023</td>\n",
       "      <td>3</td>\n",
       "      <td>BASIC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>2015-06-03</td>\n",
       "      <td>2022-04-30</td>\n",
       "      <td>2022-05-25</td>\n",
       "      <td>Division of Cardiology, Pulmonary Disease and ...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2015</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>7</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>2021-08-03</td>\n",
       "      <td>2022-12-29</td>\n",
       "      <td>2023-08-21</td>\n",
       "      <td>Oxford Heart Centre, Oxford, OX39DU, United Ki...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2021</td>\n",
       "      <td>2022</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>OTHER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>2020-11-12</td>\n",
       "      <td>2021-06-24</td>\n",
       "      <td>2023-02-24</td>\n",
       "      <td>Olive View - UCLA Medical Center, Sylmar, Cali...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2021</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ... Start Date  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ... 2006-06-06   \n",
       "1  number of patients with treatment-related card...  ... 2020-09-01   \n",
       "5  reduction of the left ventricular global longi...  ... 2015-06-03   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ... 2021-08-03   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ... 2020-11-12   \n",
       "\n",
       "  Completion Date Last Update Posted  \\\n",
       "0      2022-12-31         2022-09-14   \n",
       "1      2023-12-30         2023-05-30   \n",
       "5      2022-04-30         2022-05-25   \n",
       "7      2022-12-29         2023-08-21   \n",
       "8      2021-06-24         2023-02-24   \n",
       "\n",
       "                                           Locations category start_year  \\\n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...    heart       2006   \n",
       "1  University Hospital at Carolina, Carolina, 009...    heart       2020   \n",
       "5  Division of Cardiology, Pulmonary Disease and ...    heart       2015   \n",
       "7  Oxford Heart Centre, Oxford, OX39DU, United Ki...    heart       2021   \n",
       "8  Olive View - UCLA Medical Center, Sylmar, Cali...    heart       2020   \n",
       "\n",
       "  completion_year last_year_posted duration Primary Purpose  \n",
       "0            2022             2022       16      PREVENTION  \n",
       "1            2023             2023        3           BASIC  \n",
       "5            2022             2022        7      DIAGNOSTIC  \n",
       "7            2022             2023        1           OTHER  \n",
       "8            2021             2023        1       TREATMENT  \n",
       "\n",
       "[5 rows x 27 columns]"
      ]
     },
     "execution_count": 334,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 335,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "      <th>start_year</th>\n",
       "      <th>completion_year</th>\n",
       "      <th>last_year_posted</th>\n",
       "      <th>duration</th>\n",
       "      <th>Primary Purpose</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2006</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>16</td>\n",
       "      <td>PREVENTION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2023</td>\n",
       "      <td>2023</td>\n",
       "      <td>3</td>\n",
       "      <td>BASIC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>2015-06-03</td>\n",
       "      <td>2022-04-30</td>\n",
       "      <td>2022-05-25</td>\n",
       "      <td>Division of Cardiology, Pulmonary Disease and ...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2015</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>7</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>2021-08-03</td>\n",
       "      <td>2022-12-29</td>\n",
       "      <td>2023-08-21</td>\n",
       "      <td>Oxford Heart Centre, Oxford, OX39DU, United Ki...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2021</td>\n",
       "      <td>2022</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>OTHER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>2020-11-12</td>\n",
       "      <td>2021-06-24</td>\n",
       "      <td>2023-02-24</td>\n",
       "      <td>Olive View - UCLA Medical Center, Sylmar, Cali...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2021</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ... Start Date  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ... 2006-06-06   \n",
       "1  number of patients with treatment-related card...  ... 2020-09-01   \n",
       "5  reduction of the left ventricular global longi...  ... 2015-06-03   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ... 2021-08-03   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ... 2020-11-12   \n",
       "\n",
       "  Completion Date Last Update Posted  \\\n",
       "0      2022-12-31         2022-09-14   \n",
       "1      2023-12-30         2023-05-30   \n",
       "5      2022-04-30         2022-05-25   \n",
       "7      2022-12-29         2023-08-21   \n",
       "8      2021-06-24         2023-02-24   \n",
       "\n",
       "                                           Locations category start_year  \\\n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...    heart       2006   \n",
       "1  University Hospital at Carolina, Carolina, 009...    heart       2020   \n",
       "5  Division of Cardiology, Pulmonary Disease and ...    heart       2015   \n",
       "7  Oxford Heart Centre, Oxford, OX39DU, United Ki...    heart       2021   \n",
       "8  Olive View - UCLA Medical Center, Sylmar, Cali...    heart       2020   \n",
       "\n",
       "  completion_year last_year_posted duration Primary Purpose  \n",
       "0            2022             2022       16      PREVENTION  \n",
       "1            2023             2023        3           BASIC  \n",
       "5            2022             2022        7      DIAGNOSTIC  \n",
       "7            2022             2023        1           OTHER  \n",
       "8            2021             2023        1       TREATMENT  \n",
       "\n",
       "[5 rows x 27 columns]"
      ]
     },
     "execution_count": 335,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 336,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "      <th>start_year</th>\n",
       "      <th>completion_year</th>\n",
       "      <th>last_year_posted</th>\n",
       "      <th>duration</th>\n",
       "      <th>Primary Purpose</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2006</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>16</td>\n",
       "      <td>PREVENTION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2023</td>\n",
       "      <td>2023</td>\n",
       "      <td>3</td>\n",
       "      <td>BASIC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>2015-06-03</td>\n",
       "      <td>2022-04-30</td>\n",
       "      <td>2022-05-25</td>\n",
       "      <td>Division of Cardiology, Pulmonary Disease and ...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2015</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>7</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>2021-08-03</td>\n",
       "      <td>2022-12-29</td>\n",
       "      <td>2023-08-21</td>\n",
       "      <td>Oxford Heart Centre, Oxford, OX39DU, United Ki...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2021</td>\n",
       "      <td>2022</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>OTHER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>2020-11-12</td>\n",
       "      <td>2021-06-24</td>\n",
       "      <td>2023-02-24</td>\n",
       "      <td>Olive View - UCLA Medical Center, Sylmar, Cali...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2021</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ... Start Date  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ... 2006-06-06   \n",
       "1  number of patients with treatment-related card...  ... 2020-09-01   \n",
       "5  reduction of the left ventricular global longi...  ... 2015-06-03   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ... 2021-08-03   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ... 2020-11-12   \n",
       "\n",
       "  Completion Date Last Update Posted  \\\n",
       "0      2022-12-31         2022-09-14   \n",
       "1      2023-12-30         2023-05-30   \n",
       "5      2022-04-30         2022-05-25   \n",
       "7      2022-12-29         2023-08-21   \n",
       "8      2021-06-24         2023-02-24   \n",
       "\n",
       "                                           Locations category start_year  \\\n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...    heart       2006   \n",
       "1  University Hospital at Carolina, Carolina, 009...    heart       2020   \n",
       "5  Division of Cardiology, Pulmonary Disease and ...    heart       2015   \n",
       "7  Oxford Heart Centre, Oxford, OX39DU, United Ki...    heart       2021   \n",
       "8  Olive View - UCLA Medical Center, Sylmar, Cali...    heart       2020   \n",
       "\n",
       "  completion_year last_year_posted duration Primary Purpose  \n",
       "0            2022             2022       16      PREVENTION  \n",
       "1            2023             2023        3           BASIC  \n",
       "5            2022             2022        7      DIAGNOSTIC  \n",
       "7            2022             2023        1           OTHER  \n",
       "8            2021             2023        1       TREATMENT  \n",
       "\n",
       "[5 rows x 27 columns]"
      ]
     },
     "execution_count": 336,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 337,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "      <th>start_year</th>\n",
       "      <th>completion_year</th>\n",
       "      <th>last_year_posted</th>\n",
       "      <th>duration</th>\n",
       "      <th>Primary Purpose</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2006</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>16</td>\n",
       "      <td>PREVENTION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2023</td>\n",
       "      <td>2023</td>\n",
       "      <td>3</td>\n",
       "      <td>BASIC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>2015-06-03</td>\n",
       "      <td>2022-04-30</td>\n",
       "      <td>2022-05-25</td>\n",
       "      <td>Division of Cardiology, Pulmonary Disease and ...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2015</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>7</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>2021-08-03</td>\n",
       "      <td>2022-12-29</td>\n",
       "      <td>2023-08-21</td>\n",
       "      <td>Oxford Heart Centre, Oxford, OX39DU, United Ki...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2021</td>\n",
       "      <td>2022</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>OTHER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>2020-11-12</td>\n",
       "      <td>2021-06-24</td>\n",
       "      <td>2023-02-24</td>\n",
       "      <td>Olive View - UCLA Medical Center, Sylmar, Cali...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2021</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ... Start Date  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ... 2006-06-06   \n",
       "1  number of patients with treatment-related card...  ... 2020-09-01   \n",
       "5  reduction of the left ventricular global longi...  ... 2015-06-03   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ... 2021-08-03   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ... 2020-11-12   \n",
       "\n",
       "  Completion Date Last Update Posted  \\\n",
       "0      2022-12-31         2022-09-14   \n",
       "1      2023-12-30         2023-05-30   \n",
       "5      2022-04-30         2022-05-25   \n",
       "7      2022-12-29         2023-08-21   \n",
       "8      2021-06-24         2023-02-24   \n",
       "\n",
       "                                           Locations category start_year  \\\n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...    heart       2006   \n",
       "1  University Hospital at Carolina, Carolina, 009...    heart       2020   \n",
       "5  Division of Cardiology, Pulmonary Disease and ...    heart       2015   \n",
       "7  Oxford Heart Centre, Oxford, OX39DU, United Ki...    heart       2021   \n",
       "8  Olive View - UCLA Medical Center, Sylmar, Cali...    heart       2020   \n",
       "\n",
       "  completion_year last_year_posted duration Primary Purpose  \n",
       "0            2022             2022       16      PREVENTION  \n",
       "1            2023             2023        3           BASIC  \n",
       "5            2022             2022        7      DIAGNOSTIC  \n",
       "7            2022             2023        1           OTHER  \n",
       "8            2021             2023        1       TREATMENT  \n",
       "\n",
       "[5 rows x 27 columns]"
      ]
     },
     "execution_count": 337,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 338,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pycountry\n",
    "\n",
    "# Function to get country from location text\n",
    "def extract_country(location_text):\n",
    "    for country in pycountry.countries:\n",
    "        if country.name in location_text:\n",
    "            return country.name\n",
    "\n",
    "    if \"Taiwan\" in location_text:\n",
    "        return \"Taiwan\"\n",
    "    \n",
    "    elif \"Czech\" in location_text:\n",
    "        return \"Czech Republic\"\n",
    "    \n",
    "    elif \"Tanzania\" in location_text:\n",
    "        return \"Tanzania\"\n",
    "    \n",
    "    elif \"Vietnam\" in location_text:\n",
    "        return \"Vietnam\"\n",
    "    \n",
    "    elif \"Swaziland\" in location_text:\n",
    "        return \"Swaziland\"\n",
    "    \n",
    "    elif \"C√¥te D'Ivoire\" in location_text:\n",
    "        return \"C√¥te D'Ivoire\"\n",
    "    \n",
    "    elif \"Venezuela\" in location_text:\n",
    "        return \"Venezuela\"\n",
    "    \n",
    "    elif \"Bolivia\" in location_text:\n",
    "        return \"Bolivia\"\n",
    "    \n",
    "    elif \"Palestinian\" in location_text:\n",
    "        return \"Palestine\"\n",
    "    \n",
    "    elif \"Macedonia\"  in location_text:\n",
    "        return \"Macedonia\"\n",
    "     # Return \"Unknown\" if no country is found\n",
    "    return \"Kosovo\"\n",
    "\n",
    "# Assuming you have a DataFrame named 'df' with a 'Locations' column\n",
    "df['country'] = df['Locations'].apply(extract_country)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 339,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0                 Canada\n",
      "1            Puerto Rico\n",
      "5                Germany\n",
      "7         United Kingdom\n",
      "8                  India\n",
      "               ...      \n",
      "161856             Niger\n",
      "161857      Burkina Faso\n",
      "161859             Kenya\n",
      "161860             India\n",
      "161861             Benin\n",
      "Name: country, Length: 98065, dtype: object\n"
     ]
    }
   ],
   "source": [
    "# checking if the countries have been created\n",
    "print(df[\"country\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 340,
   "metadata": {},
   "outputs": [],
   "source": [
    "count = df[\"country\"].value_counts()\n",
    "\n",
    "country = pd.DataFrame(count)\n",
    "\n",
    "pd.set_option(\"display.max_rows\",500)\n",
    "#country.head(160)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 341,
   "metadata": {},
   "outputs": [],
   "source": [
    "df[\"description\"]=df[\"Interventions\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 342,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "      <th>start_year</th>\n",
       "      <th>completion_year</th>\n",
       "      <th>last_year_posted</th>\n",
       "      <th>duration</th>\n",
       "      <th>Primary Purpose</th>\n",
       "      <th>country</th>\n",
       "      <th>description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2006</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>16</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>Canada</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2023</td>\n",
       "      <td>2023</td>\n",
       "      <td>3</td>\n",
       "      <td>BASIC</td>\n",
       "      <td>Puerto Rico</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>2022-05-25</td>\n",
       "      <td>Division of Cardiology, Pulmonary Disease and ...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2015</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>7</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>Germany</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>2023-08-21</td>\n",
       "      <td>Oxford Heart Centre, Oxford, OX39DU, United Ki...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2021</td>\n",
       "      <td>2022</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>2023-02-24</td>\n",
       "      <td>Olive View - UCLA Medical Center, Sylmar, Cali...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2021</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>India</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 29 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ... Last Update Posted  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ...         2022-09-14   \n",
       "1  number of patients with treatment-related card...  ...         2023-05-30   \n",
       "5  reduction of the left ventricular global longi...  ...         2022-05-25   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ...         2023-08-21   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ...         2023-02-24   \n",
       "\n",
       "                                           Locations category  start_year  \\\n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...    heart        2006   \n",
       "1  University Hospital at Carolina, Carolina, 009...    heart        2020   \n",
       "5  Division of Cardiology, Pulmonary Disease and ...    heart        2015   \n",
       "7  Oxford Heart Centre, Oxford, OX39DU, United Ki...    heart        2021   \n",
       "8  Olive View - UCLA Medical Center, Sylmar, Cali...    heart        2020   \n",
       "\n",
       "  completion_year last_year_posted duration Primary Purpose         country  \\\n",
       "0            2022             2022       16      PREVENTION          Canada   \n",
       "1            2023             2023        3           BASIC     Puerto Rico   \n",
       "5            2022             2022        7      DIAGNOSTIC         Germany   \n",
       "7            2022             2023        1           OTHER  United Kingdom   \n",
       "8            2021             2023        1       TREATMENT           India   \n",
       "\n",
       "                                         description  \n",
       "0  DEVICE: On-X valve using reduced anticoagulati...  \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...  \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...  \n",
       "7                                      DEVICE: PICSO  \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor  \n",
       "\n",
       "[5 rows x 29 columns]"
      ]
     },
     "execution_count": 342,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 343,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "interven_summary\n",
       "'DRUG'                                                     39352\n",
       "'OTHER'                                                    10089\n",
       "'DEVICE'                                                    7097\n",
       "'PROCEDURE'                                                 6087\n",
       "'BEHAVIORAL'                                                5788\n",
       "'BIOLOGICAL'                                                5302\n",
       "'DIAGNOSTIC_TEST'                                           2981\n",
       "'DRUG', 'OTHER'                                             2317\n",
       "'DRUG', 'BIOLOGICAL'                                        2088\n",
       "'RADIATION'                                                 1901\n",
       "'PROCEDURE', 'DRUG'                                         1656\n",
       "'DRUG', 'RADIATION'                                         1623\n",
       "'DIETARY_SUPPLEMENT'                                         903\n",
       "'OTHER', 'BIOLOGICAL'                                        715\n",
       "'OTHER', 'BEHAVIORAL'                                        577\n",
       "'PROCEDURE', 'OTHER'                                         504\n",
       "'PROCEDURE', 'DRUG', 'RADIATION'                             441\n",
       "'PROCEDURE', 'DEVICE'                                        402\n",
       "'COMBINATION_PRODUCT'                                        398\n",
       "'OTHER', 'DRUG'                                              369\n",
       "'DEVICE', 'OTHER'                                            366\n",
       "'DRUG', 'DEVICE'                                             356\n",
       "'DRUG', 'BIOLOGICAL', 'OTHER'                                331\n",
       "'DEVICE', 'DRUG'                                             314\n",
       "'GENETIC'                                                    293\n",
       "'PROCEDURE', 'DRUG', 'BIOLOGICAL'                            292\n",
       "'PROCEDURE', 'DRUG', 'OTHER'                                 262\n",
       "'OTHER', 'DIETARY_SUPPLEMENT'                                227\n",
       "'DRUG', 'DIETARY_SUPPLEMENT'                                 207\n",
       "'PROCEDURE', 'RADIATION'                                     203\n",
       "'DRUG', 'BEHAVIORAL'                                         178\n",
       "'DRUG', 'RADIATION', 'BIOLOGICAL'                            177\n",
       "'PROCEDURE', 'BIOLOGICAL'                                    175\n",
       "'OTHER', 'RADIATION'                                         138\n",
       "'PROCEDURE', 'DRUG', 'RADIATION', 'BIOLOGICAL'               137\n",
       "'DIAGNOSTIC_TEST', 'OTHER'                                   134\n",
       "'DRUG', 'RADIATION', 'OTHER'                                 126\n",
       "'PROCEDURE', 'DRUG', 'RADIATION', 'OTHER'                    114\n",
       "'COMBINATION_PRODUCT', 'DRUG'                                104\n",
       "'PROCEDURE', 'DRUG', 'BIOLOGICAL', 'OTHER'                    96\n",
       "'DEVICE', 'BEHAVIORAL'                                        92\n",
       "'DIAGNOSTIC_TEST', 'DRUG'                                     91\n",
       "'OTHER', 'BIOLOGICAL', 'DRUG'                                 85\n",
       "'OTHER', 'DEVICE'                                             80\n",
       "'PROCEDURE', 'OTHER', 'RADIATION'                             76\n",
       "'PROCEDURE', 'DRUG', 'RADIATION', 'OTHER', 'BIOLOGICAL'       72\n",
       "'RADIATION', 'BIOLOGICAL'                                     63\n",
       "'PROCEDURE', 'OTHER', 'BIOLOGICAL'                            63\n",
       "'DEVICE', 'BIOLOGICAL'                                        58\n",
       "'PROCEDURE', 'BEHAVIORAL'                                     54\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 343,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# extracting the intervention column\n",
    "def extract2(text):\n",
    "    \"\"\"extracts the intervention summary from the invervention column\"\"\"\n",
    "    pattern_re = r\"\\w+:\"\n",
    "    new_text = []\n",
    "    text_list = re.findall(pattern_re,text)\n",
    "    new_text = [x.replace(\":\",\"\") for x in text_list]\n",
    "    new_text = list(set(new_text))\n",
    "    new_text = str(new_text)\n",
    "    to_remove = [\":\",\"[\",\"]\",\"\"]\n",
    "    for each in to_remove:\n",
    "        if new_text != \"\":\n",
    "            new_text=new_text.replace(each,\"\")\n",
    "        else:\n",
    "            new_text == None\n",
    "    return new_text\n",
    "\n",
    "\n",
    "## Applying the function\n",
    "df[\"interven_summary\"] = df[\"Interventions\"].apply(lambda x:extract2((x))if x !=None else None )\n",
    "\n",
    "df[\"interven_summary\"].value_counts().head(50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 344,
   "metadata": {},
   "outputs": [],
   "source": [
    "df['interven_summary'] = df['interven_summary'].str.replace(\"'\", '')\n",
    "\n",
    "# Split values by comma and create separate rows\n",
    "#df = df.assign(Interventions=df['interven_summary'].str.split(', ')).explode('interven_summary')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 345,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "interven_summary\n",
       "DRUG                39352\n",
       "OTHER               10089\n",
       "DEVICE               7097\n",
       "PROCEDURE            6087\n",
       "BEHAVIORAL           5788\n",
       "BIOLOGICAL           5302\n",
       "DIAGNOSTIC_TEST      2981\n",
       "DRUG, OTHER          2317\n",
       "DRUG, BIOLOGICAL     2088\n",
       "RADIATION            1901\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 345,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"interven_summary\"].value_counts()[:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 347,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "      <th>start_year</th>\n",
       "      <th>completion_year</th>\n",
       "      <th>last_year_posted</th>\n",
       "      <th>duration</th>\n",
       "      <th>Primary Purpose</th>\n",
       "      <th>country</th>\n",
       "      <th>description</th>\n",
       "      <th>interven_summary</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2006</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>16</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>Canada</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>DEVICE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2023</td>\n",
       "      <td>2023</td>\n",
       "      <td>3</td>\n",
       "      <td>BASIC</td>\n",
       "      <td>Puerto Rico</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>DIAGNOSTIC_TEST, GENETIC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>Division of Cardiology, Pulmonary Disease and ...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2015</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>7</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>Germany</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>DIAGNOSTIC_TEST</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>Oxford Heart Centre, Oxford, OX39DU, United Ki...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2021</td>\n",
       "      <td>2022</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>DEVICE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>Olive View - UCLA Medical Center, Sylmar, Cali...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2021</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>India</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>COMBINATION_PRODUCT</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ...  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ...   \n",
       "1  number of patients with treatment-related card...  ...   \n",
       "5  reduction of the left ventricular global longi...  ...   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ...   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ...   \n",
       "\n",
       "                                           Locations category start_year  \\\n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...    heart       2006   \n",
       "1  University Hospital at Carolina, Carolina, 009...    heart       2020   \n",
       "5  Division of Cardiology, Pulmonary Disease and ...    heart       2015   \n",
       "7  Oxford Heart Centre, Oxford, OX39DU, United Ki...    heart       2021   \n",
       "8  Olive View - UCLA Medical Center, Sylmar, Cali...    heart       2020   \n",
       "\n",
       "   completion_year last_year_posted duration Primary Purpose         country  \\\n",
       "0             2022             2022       16      PREVENTION          Canada   \n",
       "1             2023             2023        3           BASIC     Puerto Rico   \n",
       "5             2022             2022        7      DIAGNOSTIC         Germany   \n",
       "7             2022             2023        1           OTHER  United Kingdom   \n",
       "8             2021             2023        1       TREATMENT           India   \n",
       "\n",
       "                                         description          interven_summary  \n",
       "0  DEVICE: On-X valve using reduced anticoagulati...                    DEVICE  \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...  DIAGNOSTIC_TEST, GENETIC  \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...           DIAGNOSTIC_TEST  \n",
       "7                                      DEVICE: PICSO                    DEVICE  \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor       COMBINATION_PRODUCT  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 347,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 348,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "def remove_values(row):\n",
    "    interventions = row['interven_summary'].split('|')\n",
    "    description = row['Interventions']\n",
    "\n",
    "    for intervention in interventions:\n",
    "        if intervention and intervention in description:\n",
    "            description = re.sub(re.escape(intervention), '', description)\n",
    "\n",
    "    return description\n",
    "\n",
    "# Apply the function to the DataFrame\n",
    "df['type'] = df.apply(remove_values, axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 349,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>category</th>\n",
       "      <th>start_year</th>\n",
       "      <th>completion_year</th>\n",
       "      <th>last_year_posted</th>\n",
       "      <th>duration</th>\n",
       "      <th>Primary Purpose</th>\n",
       "      <th>country</th>\n",
       "      <th>description</th>\n",
       "      <th>interven_summary</th>\n",
       "      <th>type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2006</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>16</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>Canada</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>: On-X valve using reduced anticoagulation|: O...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2023</td>\n",
       "      <td>2023</td>\n",
       "      <td>3</td>\n",
       "      <td>BASIC</td>\n",
       "      <td>Puerto Rico</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>DIAGNOSTIC_TEST, GENETIC</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2015</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>7</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>Germany</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>DIAGNOSTIC_TEST</td>\n",
       "      <td>: Cardiac MRI and echocardiography, laboratory...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2021</td>\n",
       "      <td>2022</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>: PICSO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2021</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>India</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>COMBINATION_PRODUCT</td>\n",
       "      <td>: Furoscix Infusor</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 31 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ... category start_year  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ...    heart       2006   \n",
       "1  number of patients with treatment-related card...  ...    heart       2020   \n",
       "5  reduction of the left ventricular global longi...  ...    heart       2015   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ...    heart       2021   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ...    heart       2020   \n",
       "\n",
       "  completion_year  last_year_posted duration Primary Purpose         country  \\\n",
       "0            2022              2022       16      PREVENTION          Canada   \n",
       "1            2023              2023        3           BASIC     Puerto Rico   \n",
       "5            2022              2022        7      DIAGNOSTIC         Germany   \n",
       "7            2022              2023        1           OTHER  United Kingdom   \n",
       "8            2021              2023        1       TREATMENT           India   \n",
       "\n",
       "                                         description  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "           interven_summary                                               type  \n",
       "0                    DEVICE  : On-X valve using reduced anticoagulation|: O...  \n",
       "1  DIAGNOSTIC_TEST, GENETIC  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...  \n",
       "5           DIAGNOSTIC_TEST  : Cardiac MRI and echocardiography, laboratory...  \n",
       "7                    DEVICE                                            : PICSO  \n",
       "8       COMBINATION_PRODUCT                                 : Furoscix Infusor  \n",
       "\n",
       "[5 rows x 31 columns]"
      ]
     },
     "execution_count": 349,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 350,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>category</th>\n",
       "      <th>start_year</th>\n",
       "      <th>completion_year</th>\n",
       "      <th>last_year_posted</th>\n",
       "      <th>duration</th>\n",
       "      <th>Primary Purpose</th>\n",
       "      <th>country</th>\n",
       "      <th>description</th>\n",
       "      <th>interven_summary</th>\n",
       "      <th>type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2006</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>16</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>Canada</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>: On-X valve using reduced anticoagulation|: O...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2023</td>\n",
       "      <td>2023</td>\n",
       "      <td>3</td>\n",
       "      <td>BASIC</td>\n",
       "      <td>Puerto Rico</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>DIAGNOSTIC_TEST, GENETIC</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2015</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>7</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>Germany</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>DIAGNOSTIC_TEST</td>\n",
       "      <td>: Cardiac MRI and echocardiography, laboratory...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2021</td>\n",
       "      <td>2022</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>: PICSO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2021</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>India</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>COMBINATION_PRODUCT</td>\n",
       "      <td>: Furoscix Infusor</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 31 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ... category start_year  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ...    heart       2006   \n",
       "1  number of patients with treatment-related card...  ...    heart       2020   \n",
       "5  reduction of the left ventricular global longi...  ...    heart       2015   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ...    heart       2021   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ...    heart       2020   \n",
       "\n",
       "  completion_year  last_year_posted duration Primary Purpose         country  \\\n",
       "0            2022              2022       16      PREVENTION          Canada   \n",
       "1            2023              2023        3           BASIC     Puerto Rico   \n",
       "5            2022              2022        7      DIAGNOSTIC         Germany   \n",
       "7            2022              2023        1           OTHER  United Kingdom   \n",
       "8            2021              2023        1       TREATMENT           India   \n",
       "\n",
       "                                         description  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "           interven_summary                                               type  \n",
       "0                    DEVICE  : On-X valve using reduced anticoagulation|: O...  \n",
       "1  DIAGNOSTIC_TEST, GENETIC  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...  \n",
       "5           DIAGNOSTIC_TEST  : Cardiac MRI and echocardiography, laboratory...  \n",
       "7                    DEVICE                                            : PICSO  \n",
       "8       COMBINATION_PRODUCT                                 : Furoscix Infusor  \n",
       "\n",
       "[5 rows x 31 columns]"
      ]
     },
     "execution_count": 350,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 351,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number                            object\n",
       "Study Title                           object\n",
       "Study URL                             object\n",
       "Study Status                          object\n",
       "Brief Summary                         object\n",
       "Study Results                         object\n",
       "Conditions                            object\n",
       "Interventions                         object\n",
       "Primary Outcome Measures              object\n",
       "Secondary Outcome Measures            object\n",
       "Sponsor                               object\n",
       "Sex                                   object\n",
       "Age                                   object\n",
       "Enrollment                           float64\n",
       "Funder Type                           object\n",
       "Study Type                            object\n",
       "Study Design                          object\n",
       "Start Date                    datetime64[ns]\n",
       "Completion Date               datetime64[ns]\n",
       "Last Update Posted            datetime64[ns]\n",
       "Locations                             object\n",
       "category                              object\n",
       "start_year                             int32\n",
       "completion_year                        int32\n",
       "last_year_posted                       int32\n",
       "duration                               int32\n",
       "Primary Purpose                       object\n",
       "country                               object\n",
       "description                           object\n",
       "interven_summary                      object\n",
       "type                                  object\n",
       "dtype: object"
      ]
     },
     "execution_count": 351,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.dtypes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 352,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>category</th>\n",
       "      <th>start_year</th>\n",
       "      <th>completion_year</th>\n",
       "      <th>last_year_posted</th>\n",
       "      <th>duration</th>\n",
       "      <th>Primary Purpose</th>\n",
       "      <th>country</th>\n",
       "      <th>description</th>\n",
       "      <th>interven_summary</th>\n",
       "      <th>type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2006</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>16</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>Canada</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>: On-X valve using reduced anticoagulation|: O...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2023</td>\n",
       "      <td>2023</td>\n",
       "      <td>3</td>\n",
       "      <td>BASIC</td>\n",
       "      <td>Puerto Rico</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>DIAGNOSTIC_TEST, GENETIC</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2015</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>7</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>Germany</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>DIAGNOSTIC_TEST</td>\n",
       "      <td>: Cardiac MRI and echocardiography, laboratory...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2021</td>\n",
       "      <td>2022</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>: PICSO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2021</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>India</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>COMBINATION_PRODUCT</td>\n",
       "      <td>: Furoscix Infusor</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 31 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ... category start_year  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ...    heart       2006   \n",
       "1  number of patients with treatment-related card...  ...    heart       2020   \n",
       "5  reduction of the left ventricular global longi...  ...    heart       2015   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ...    heart       2021   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ...    heart       2020   \n",
       "\n",
       "  completion_year  last_year_posted duration Primary Purpose         country  \\\n",
       "0            2022              2022       16      PREVENTION          Canada   \n",
       "1            2023              2023        3           BASIC     Puerto Rico   \n",
       "5            2022              2022        7      DIAGNOSTIC         Germany   \n",
       "7            2022              2023        1           OTHER  United Kingdom   \n",
       "8            2021              2023        1       TREATMENT           India   \n",
       "\n",
       "                                         description  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "           interven_summary                                               type  \n",
       "0                    DEVICE  : On-X valve using reduced anticoagulation|: O...  \n",
       "1  DIAGNOSTIC_TEST, GENETIC  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...  \n",
       "5           DIAGNOSTIC_TEST  : Cardiac MRI and echocardiography, laboratory...  \n",
       "7                    DEVICE                                            : PICSO  \n",
       "8       COMBINATION_PRODUCT                                 : Furoscix Infusor  \n",
       "\n",
       "[5 rows x 31 columns]"
      ]
     },
     "execution_count": 352,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 353,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number                            object\n",
       "Study Title                           object\n",
       "Study URL                             object\n",
       "Study Status                          object\n",
       "Brief Summary                         object\n",
       "Study Results                         object\n",
       "Conditions                            object\n",
       "Interventions                         object\n",
       "Primary Outcome Measures              object\n",
       "Secondary Outcome Measures            object\n",
       "Sponsor                               object\n",
       "Sex                                   object\n",
       "Age                                   object\n",
       "Enrollment                           float64\n",
       "Funder Type                           object\n",
       "Study Type                            object\n",
       "Study Design                          object\n",
       "Start Date                    datetime64[ns]\n",
       "Completion Date               datetime64[ns]\n",
       "Last Update Posted            datetime64[ns]\n",
       "Locations                             object\n",
       "category                              object\n",
       "start_year                             int32\n",
       "completion_year                        int32\n",
       "last_year_posted                       int32\n",
       "duration                               int32\n",
       "Primary Purpose                       object\n",
       "country                               object\n",
       "description                           object\n",
       "interven_summary                      object\n",
       "type                                  object\n",
       "dtype: object"
      ]
     },
     "execution_count": 353,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.dtypes"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Exploratoraty data Analysis"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Univariate Analysis\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 354,
   "metadata": {},
   "outputs": [],
   "source": [
    "def count_plot(data,column,limit= 15):\n",
    "    \"\"\"A function that plots a countplot using seaborn\"\"\"\n",
    "    # Get the top 'limit' unique values in the specified column\n",
    "    top_values = data[column].value_counts().index[:limit]\n",
    "    plt.figure(figsize=(16, 8))\n",
    "    sns.countplot(x=column, data=data, palette='Blues',saturation=2)\n",
    "    plt.title(f'{column} Distribution',fontsize = 20,loc=\"left\")\n",
    "    #plt.ylabel('Count')\n",
    "    plt.xticks(rotation=90)  # Rotate x-axis labels for better visibility if needed\n",
    "    plt.show()\n",
    "    \n",
    "def hoz_plot(data, column, limit=15):\n",
    "    \"\"\"A function that plots an horizontal bar graph using seaborn\"\"\"\n",
    "    top_val = data[column].value_counts().index[:limit]\n",
    "    plt.figure(figsize=(16, 8))\n",
    "    sns.barplot(x=data[column].value_counts().head(limit), y=top_val)\n",
    "    plt.title(f'{column} Distribution', fontsize=20, loc=\"left\")\n",
    "    plt.show()\n",
    "\n",
    "    \n",
    "def pie_chart(data, column):\n",
    "    \"\"\"A function that plots a pie chart\"\"\"\n",
    "    value_counts = data[column].value_counts()\n",
    "    labels = value_counts.index\n",
    "    sizes = value_counts.values\n",
    "    explode = [0] * len(labels)\n",
    "    \n",
    "    # Set the explode value for a specific slice (e.g., the first slice)\n",
    "    explode[0] = 0.1  # Adjust this value to control the explosion\n",
    "    plt.figure(figsize=(16, 8))\n",
    "    plt.pie(sizes, labels=labels, autopct='%1.1f%%', startangle=140,explode=explode)\n",
    "    plt.title(f'{column} Distribution', fontsize=20,loc=\"left\")\n",
    "    plt.axis('equal')  # Equal aspect ratio ensures that pie is drawn as a circle.\n",
    "    plt.show()\n",
    "\n",
    "\n",
    "def line_chart(data,column):\n",
    "    \"\"\"A function that plots a line chart\"\"\"\n",
    "    plt.figure(figsize=(16,8))\n",
    "    year_count = data.groupby(df[column]).count()\n",
    "    plt.plot(year_count.index,year_count,marker=\".\")\n",
    "    plt.title(\"Clinical trials over the years\")\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 355,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "line_chart(df,\"start_year\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "ta"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 356,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAABYoAAALJCAYAAAAagxfNAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjguMCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy81sbWrAAAACXBIWXMAAA9hAAAPYQGoP6dpAACTWklEQVR4nOzdeVRV9f7/8dcBDgiiggpycACczSFNy7G0tMzUzAm1HCC1UhssTW+aiXXVHOpahmlpjqXhlDlUDjmbF7pqzmOSISDiLIIe4Pz+8Of5SggCgkfdz8darHX23p/9+bz35uxF69XHzzbZbDabAAAAAAAAAACG5eToAgAAAAAAAAAAjkVQDAAAAAAAAAAGR1AMAAAAAAAAAAZHUAwAAAAAAAAABkdQDAAAAAAAAAAGR1AMAAAAAAAAAAZHUAwAAAAAAAAABkdQDAAAAAAAAAAGR1AMAAAAAAAAAAZHUAzggWEymWQymRQWFuboUnJk1qxZ9pqjo6MzHW/WrJlMJpOaNWt212u7E2FhYfbrAgAAAAAA9wcXRxcAwHg2bNigJ598MtN+Z2dnFS1aVMWKFVPZsmVVt25dNWnSRG3btpWrq6sDKgUAAAAAADAGZhQD96n7bfZsTqSlpencuXOKjo7W5s2bNWnSJHXq1EllypTRv//9b6Wmpjqkrvt1Zm9+ut3sZwAAAAAAcH8jKAbgUP369dOePXvsP7/99ptWrVqljz/+WE8//bRMJpNOnz6tESNGqHHjxjp9+nSWfdlsNtlstvsmPA8JCbHXHBgY6Ohy8k1YWJj9ugAAAAAAwP2BpScAOJSvr69q1KiRaX+rVq00dOhQ7d+/X927d9fOnTsVGRmp9u3b69dff2UpCgAAAAAAgHzEjGIA97SHHnpIW7duVZ06dSRJW7duVXh4uIOrAgAAAAAAeLAQFOO+tHXrVvXp00dVqlRR0aJF5erqqjJlyqhNmzYKDw/X+fPnszx3+fLl9nVv3dzcVKJECTVs2FAff/yxLl++nOV5YWFh9jVas7NhwwZ7uw0bNmQ6/s/1bk+ePKl33nlHFStWlLu7u0qUKKGWLVvqp59+umX/gYGBGWoYNWqUfbwbPyEhIVnWk56erm+++UZPPvmkSpUqJScnJ4WEhGj37t32dh9//HG21yhJkydPtrePjIy8bfs74e7urrlz59qve+LEibJarZna3W7d5vPnz2v06NFq2LChvL29ZTab5ePjo4ceekjt27fXl19+qVOnTtnbh4SEyGQyaePGjZKkjRs3ZrrX/1wy4p81/Prrr+rcubPKli0rs9mcoX1u1/09dOiQXnnlFQUFBalQoUKyWCwKDg7W9u3bszzndt/H7Gq/+fzQ0FD7vqCgoEz34ea+c/qsREdH6+2331b16tVVpEgReXh4qFKlSnr11Ve1Z8+eXNUaFRWlbt262Z/r0qVLq0ePHjpw4EC2/QAAAAAAgOtYegL3leTkZPXu3Vvz58/PdOzkyZM6efKkVq5cqdOnT2cKC1NSUvTiiy9q6dKlGfafPXtW27dv1/bt2zV58mStXLlStWvXLsCr+D9bt27VCy+8oMTExAx1rl69WqtXr9aECRM0ePDgfBsvJSVFLVu21Nq1azMdq1Wrlh599FFFRUVp9uzZ+te//pVtXzNnzpQkVa9eXY899li+1ZiV6tWr6+mnn9bq1asVGxurqKgoNWrUKMfnHzhwQC1atFBsbGyG/YmJiUpMTNSBAwf0ww8/KC0tTa+//nq+1Dx8+HCNGTMmX/r66aef1LlzZyUlJdn3xcfHa+HChVq8eLE++eQTDRw4MF/GuhvmzJmjV155RVevXs2w/+jRozp69KhmzJihjz76SO+9995t+5oyZYreeuutDC87jI2N1bx587RkyRL99NNPeuKJJ/L9GgAAAAAAeJAQFOO+kZ6ernbt2mnNmjWSpEqVKql///6qV6+ePDw8FBcXp23btikiIuKW5/fq1cseEj/88MMaNGiQqlWrprNnz2rBggWaNWuWYmNj1bx5c+3evVulS5cu0OuJi4vTCy+8ICcnJ3388cdq0qSJXF1dtWXLFn344Yc6f/683nvvPbVq1UrVq1e3n7d69Wpdu3ZNNWvWlHT9ZXD9+/fP0Le3t/ctxxw6dKh2796t559/XiEhIQoICNCpU6d08eJFSVKfPn0UFRWlgwcP6rffflPDhg1v2c8ff/yhnTt3SpJefvnlO74XOdWiRQutXr1akrR58+ZcBcU9evRQbGyszGaz+vbtq1atWsnPz0/p6emKiYnR9u3bM/1PhNGjR2vw4MEKDQ3V77//rnr16tkD8huyWit5yZIl2rNnj2rWrKm3335bNWrUUHJysnbt2pW7i9b10PPFF1+Ui4uLxowZY5+Nvn79eo0bN04XL17U22+/rcDAQL3wwgu57j87jz76qPbs2aNly5bp/ffflyT98ssv8vf3z9AuKCgox32uXLnS/iI/T09PDRo0SC1atJCLi4u2bdumsWPHKjExUcOGDZOXl5f69euXZV+//PKLIiMjVbNmTb311luqWbOmkpOTtXTpUn322We6cuWKevTooSNHjrCuNQAAAAAA2bEB94nPPvvMJskmyda+fXtbSkrKLdulpaXZYmJiMuxbsWKF/dzmzZvbrl69mum8r776yt4mODg40/GRI0faj2dn/fr19nbr16/PdLxp06b24wEBAZlqtdlsts2bN9tMJpNNku3NN9+85Tg3+hg5cmSO65Fke//997Nse/HiRVvhwoVtkmx9+/bNst2bb75pk2Qzm822hISEbMe/XU23q/9ma9eutZ/38ssvZzqeVZ/Hjh2zH5s8eXKW/aenp9vOnj2baf+N31nTpk1vW+PN97p58+ZZfk9tNptt5syZ9rbHjx/PclxJtmLFitn279+fqc3evXttRYsWtUmylS5d2nbt2rUMx2/3fbxV7bf6ndyu1ptl96xcu3bN5u/vb5Nk8/T0tO3cuTNTm+joaJvFYrFJsnl4eNhOnz6dZa2SbM8999wtn+l///vf9jZLlizJtmYAAAAAAIyONYpxX0hPT9eECRMkSWXKlNGcOXPk5uZ2y7ZOTk6ZZgPfePmZ2WzWzJkzbzmzsG/fvmrRooWk67NB4+Li8vMSbmny5Mm3nLncpEkT1a9fX9L1mbP5pXLlylmu3ytJRYoUUXBwsCTp+++/V3JycqY2165d07fffitJatOmjXx8fPKtvtspUaKE/fO5c+dyfF58fLz9c3ZLEJhMpixnY+eWk5OTpk+fnuX3NLdGjBihatWqZdpfvXp1DR8+XNL15VeWLVuWL+MVlKVLl9qX/3j//fdvucxLQECA/Xm/cuVKplncNytUqFCWz/Sbb75p35+fzxEAAAAAAA8igmLcF3bt2qWYmBhJ1wNdT0/PHJ+bmppqfxnZM888o7Jly2bZtm/fvvZzbvfirzvl5eWl1q1bZ3m8bt26kqQ///wz38bs0qWLnJ2ds23Tp08fSdLFixe1ePHiTMeXL1+uM2fOSLq7y05IyvB7v3TpUo7Ps1gs9s+zZs3Kz5Ky1Lhx40wvussrk8mkXr16ZXk8NDTU/uK4W60/fS+5UZ/JZMr2+9O5c2cVK1Yswzm38vTTT8vX1/eWx4oUKaJKlSpJyt/nCAAAAACABxFBMe4LN9bDlaTHH388V+f++eefunLliiTZZ+lm5ebje/fuzdU4uVWpUiU5OWX9CBYvXlxS7gLR26lVq9Zt2zRq1EgPPfSQJN1yJueNfRaLRa1atcq32nLi5ntRtGjRHJ8XFBRk/9785z//UfXq1fXBBx/o119/tX838ltO7nVOBQUFqWTJklke9/HxsYfSe/bsybdxC8KN5yooKCjb2eiurq6qU6dOhnNupWrVqtmOVxDPEQAAAAAADyKCYtwXEhMT7Z9vnh2aE2fPnrV/zmrm4Q1+fn63PK8geHh4ZHv8Roicnp6eb2PmdFmF3r17S7r+srTo6Gj7/ri4OP3888+SpJ49e952dnJ+u/l7cCMAzKn58+fbX863f/9+ffTRR2revLm8vLz0xBNPaOrUqUpJScm3WvNrCQvp9t9bSSpVqpSkgv/e3qkb9eXkmm48j9ldU06fo7S0tJyWCAAAAACAIREUw1Bu/PN8o8ppsNuzZ0+5urrKZrNp9uzZ9v1z5syxB253e9kJKePM8ipVquTq3NKlS2vbtm1au3at+vfvr+rVq8tkMslqtWrz5s3q16+fatSoocOHD+dLrfkZoj+I39sH8ZoAAAAAALifERTjvnDzP7vP7Uvmbp55eurUqWzb3vzSs3/OWL15mYjsZvkmJSXlqr57UcmSJdWuXTtJ0uzZs2Wz2ST93/q+jRs3VuXKle96XWvWrLF/btKkSZ76aN68ucLDw7V3716dPn1aCxYs0FNPPSVJOnbsmLp06ZIvtean231vb25zr39vb9SXk2u68TzmdvY4AAAAAADIPYJi3BceeeQR++dNmzbl6tzy5cvb/3n6f//732zbRkZG2j/XqFEjw7EiRYrYP587dy7LPvJrRqqj3Xip3fHjx7VhwwZt27ZNBw8elOSY2cR79+7VunXrJElly5ZVvXr17rjPEiVKqEuXLlq3bp2ef/55SddfnHjkyJEM7Rw9+/X48eP2FwjeyunTp+1LhBTU9za/7sGN+o4fP67Tp09n2c5qtdpnkP/zmgAAAAAAQP4jKMZ94eGHH1bZsmUlSdOnT9fly5dzfK6Li4uaNm0q6fqM1JiYmCzbTp8+3X5Os2bNMhwLCgqyf/7999+z7GPBggU5ru1OFCpUSJJ09erVAum/RYsWCggIkHT9BXY3XmLn6emp4ODgAhkzK8nJyerZs6d9ZvPgwYPl4uKSr2M0b97c/vnmtZClgr/Xt2Oz2TRnzpwsj8+aNct+b1q0aJHh2I2X3EnZf2/nz5+fbQ037oF0Z/fhRn02m+2WL0u8YdGiRbpw4UKGcwAAAAAAQMEhKMZ9wcnJSe+++64kKSYmRj179tS1a9du2TY9PV2xsbEZ9g0YMECSdO3aNfXu3VtWqzXTed98841Wr14tSerQoUOml+Y1atTIHk7+5z//sQdzN5swYUKGWckF6UZ9x44dK5D+nZyc7DOHFy9erO+//16S1LlzZ3l6ehbImLeyf/9+NWnSxD67tGnTpurXr1+u+ti1a5d27dqV5XGbzaa1a9dKuj5z9uZwVfq/e/3nn3/e8vd+N3z00Uc6dOhQpv0HDhzQ6NGjJV2v88aSITd4e3urVq1akq4H/rd6MdyWLVv02WefZTv+zc/DnXznXnjhBfn7+0uSRo8erT179mRq8/fff2vw4MGSrr+sLjQ0NM/jAQAAAACAnMnfKXlAARowYICWL1+uNWvWaOnSpapZs6b69++vevXqycPDQ/Hx8dq+fbvmz5+vF198UWFhYfZzW7durc6dO2vhwoVavXq1GjRooHfeeUdVq1bVuXPntGDBAn3zzTeSrq+H+umnn2Ya39fXV507d9b8+fP1yy+/6Pnnn9eAAQNUqlQpnThxQnPnztXixYvVqFEjbdu2rcDvR6NGjXT8+HH9+OOPmjZtmho3bmyf9Vm0aFH5+vre8Rgvv/yyRo0apStXrmTYl58SEhK0d+9e+3ZSUpLOnTun3bt3a926dVqzZo09nG3QoIEWLVoks9mcqzF27dql0NBQPfroo2rbtq0eeeQR+fn5yWq16vjx45o5c6Z9/ePnn3/+lv+TYObMmUpISNA777yj7t27q1ixYpIks9lsn3ldUCpWrKjTp0+rQYMGGjp0qH22+4YNG/Txxx/bZ95OnjxZrq6umc4fMGCAXn31VZ06dUqPP/64RowYoSpVqujs2bNauXKlpkyZonr16mX7va1Tp44KFSqklJQUjRgxwn7dN9ZALl26tNzd3W97La6urvrqq6/Utm1bXbx4UY0bN9a7776r5s2by9nZWdu2bdPHH3+shIQESdLEiRMzrFEOAAAAAAAKiA24jyQlJdk6depkk5Ttz8iRIzOdm5ycbGvfvn225/n7+9t27tyZ5fjx8fG2SpUqZXl+165dbWvXrrVvr1+/PlMfTZs2tUmyNW3aNNtrHTlypL2fW9m5c6fNzc3tlnX06tXL3m79+vXZ1nM7rVq1sp9fuXLlXJ9/KzfXlJMfHx8f2+jRo21WqzXbfrP6/c+cOTNH4zRq1MiWmJiYqd9Lly7Zypcvf8tzAgICclTDrdxc1/HjxzMdv/m7smLFCpuHh8cta3BycrJNnDgxy3HS0tJsL7zwQpbXXbNmTVtcXNxtax8yZEiWfdz83brdd9dms9lmzZqV5fdXks3Z2dk2ZsyYLM/P6X3O6fMGAAAAAIDRsfQE7iseHh5auHChfv31V/Xo0UNBQUFyd3eXq6urypYtq7Zt22ratGkaNGhQpnMLFSqkJUuW6Mcff1SHDh3k7+8vV1dXeXt7q379+ho7dqwOHTqk2rVrZzl+qVKl9N///ldDhw5VpUqV5ObmpuLFi+uJJ57QvHnzNH/+fDk7OxfgHfg/tWvX1m+//aZu3bqpXLlycnNzK5BxevToYf9c0EsAODk5qVixYipXrpwef/xxDRw4UIsXL1ZMTIyGDRuW53WJu3XrplWrVuntt99WkyZNFBQUJA8PD7m6uqpMmTJ6/vnn9e2332rz5s0qUaJEpvM9PT21bds2vfXWW6pWrZr95Yh3U+vWrfX7778rNDRUAQEBcnV1la+vrzp27KgtW7bc8jt/g5OTkxYtWqTw8HA9+uijKly4sAoXLqxatWpp9OjR+u9//ys/P7/b1vDxxx/r66+/1uOPP67ixYvf0Xe9V69eOnjwoP2eFi5cWO7u7qpQoYL69u2rnTt36r333stz/wAAAAAAIHdMNpuDFtwEcF8YPny4xowZI2dnZ/3999+ZlmUAAAAAAADA/Y8ZxQCylJaWpjlz5kiSWrVqRUgMAAAAAADwgCIoBpClb7/9VjExMZKk1157zcHVAAAAAAAAoKCw9ASADI4ePSqr1arff/9dAwcO1NmzZ/Xwww9r586dMplMji4PAAAAAAAABYCgGEAG/wyDzWazNm7cqIYNGzqoIgAAAAAAABQ0lp4AcEve3t5q3ry5NmzYQEgMAAAAAADwgHNxdAEA7i38IwMAAAAAAADjYUYxAAAAAAAAABgcQTEAAAAAAAAAGBxLT+C+cO7cOaWmpjq6DMBQfHx8dPr0aUeXARgSzx/gGDx7gOPw/AGOwbNnDC4uLvL29r59u7tQC3DHUlNTZbVaHV0GYBgmk0nS9WePdauBu4vnD3AMnj3AcXj+AMfg2cM/sfQEAAAAAAAAABicycb/MsB9YP/wN5QcfczRZQAAAAAAAOABYZkw3dEl3BVms1k+Pj63bceMYgAAAAAAAAAwOIJiAAAAAAAAADA4gmIAAAAAAAAAMDiCYgAAAAAAAAAwOIJiAAAAAAAAADA4gmIAAAAAAAAAMDiCYgAAAAAAAAAwOIJiAAAAAAAAADA4gmIAAAAAAAAAMDiCYgAAAAAAAAAwOILiAjBgwACtXLmyQPoODg5WZGRkgfQNAAAAAAAAwJgIiv+/sLAwzZo1K9P+DRs2KCQkJFd9jR07Vi1atLBv381w9+LFi/r666/Vr18/vfjii+rbt69Gjx6tgwcP3nE9BRmAAwAAAAAAAHAcF0cX8CAqWrSow8b+5JNPlJqaqgEDBqhUqVK6cOGC9uzZo8uXLzusJgAAAAAAAAD3NoLiXAoPD1dSUpKqVq2qFStWKDU1VY0aNVJISIhcXK7fzgEDBui5555T69atNWDAAEnSxIkTJUk+Pj4KDw+XJEVFRWnRokWKiYmRt7e3mjZtqg4dOsjZ2VmSFBcXp6lTp+ro0aPy9fVVaGhotrUlJSXpwIEDCgsL00MPPWQfr2LFivY2WdUTHx+vOXPm6MiRI0pJSVGZMmXUrVs31apVS9L1GdenT5/W7NmzNXv2bElSRESEJOngwYP67rvvdOzYMRUtWlSPPvqoXnzxRRUqVEiS9Msvv2jlypU6c+aMPDw8VLVqVQ0aNOhOfg0AAAAAAAAA8hFBcR7s27dP3t7eGjlypOLj4zVp0iQFBgZmWG7ihrFjx6pPnz7q37+/ateuLSen66t9HDhwQF988YVCQ0NVrVo1nTp1StOmTZMkde7cWenp6Zo4caK8vLw0evRoXblyxR7QZqVQoUIqVKiQIiMjValSJZnN5hzXk5KSojp16qhr164ym83auHGjxo0bp88++0wlS5bU4MGD9e6776p58+YZrjM+Pl6jR49W165d1a9fP128eFHffPONvvnmG/Xv31/Hjh3TzJkz9frrr6tKlSq6fPmyDhw4kOU1WK1WWa1W+7bJZJK7u3u21w0AAAAAAADgzhAU54Gnp6d69+4tJycnlS5dWnXq1NHevXtvGRTfWIbCw8NDXl5e9v2LFi3SCy+8oGbNmkmSSpUqpS5duujbb79V586dtWfPHsXGxmr48OEqXry4JKlbt24aM2ZMlnU5Ozurf//+mjZtmtasWaPy5curWrVqaty4sQICArKtJzAwUIGBgfbtrl27KioqSr///rueffZZeXp6ysnJSe7u7hnO++GHH/T444+rdevWkiSLxaLQ0FCNHDlSffr0UWJiotzc3FS3bl25u7vLx8dHQUFBWV7D0qVLtWjRIvt2UFCQxo0bl2V7AAAAAAAAAHeOoDgPypQpY5+JK0ne3t46ceJErvqIjo7WwYMHtWTJEvu+9PR0Wa1WXb16VSdPnlSJEiXsIbEkVa5c+bb9NmjQQI888ogOHjyow4cPa9euXfrxxx/12muv2UPpW0lJSVFERIR27typc+fOKS0tTdeuXVNiYmK24/3111/666+/tHnz5gz7bTabEhISVKtWLfn4+Oj1119X7dq1Vbt2bT322GNyc3O7ZX/t27dXmzZt7Nsmk+m21wwAAAAAAADgzhAU/3/u7u66cuVKpv1JSUny8PDIsO/GGsI3mEwm2Wy2XI2XkpKi4OBg1a9fP9OxWy0ZkRuurq6qVauWatWqpU6dOmnq1KmKiIjINiieM2eO9uzZox49esjPz0+urq72F+Pd7jpatGih5557LtOxkiVLysXFRePGjdO+ffu0e/duRUREaOHChRo7dqwKFy6c6Ryz2XzH1w8AAAAAAAAgdwiK/z9/f3/t3r070/7jx4/LYrHcUd/Ozs5KT0/PsK98+fKKjY2Vn5/fLc8pXbq0zpw5o3Pnzsnb21uSdPjw4TyNX6ZMGUVFRWVbz6FDh9S0aVM99thjkq4HwKdPn87QxsXFJdN5QUFBOnnyZJbXcWO8m4Pr0NBQ7d2795YhOQAAAAAAAIC7z+n2TYzhmWeeUWxsrL755hv99ddfio2N1YoVK7R161a1bdv2jvr29fXV3r17df78eV2+fFmS1LFjR23atEkLFy7U33//rZiYGG3dulULFiyQJNWsWVMWi0Xh4eGKjo7WgQMH7MeycunSJY0aNUqbNm3SX3/9pYSEBP32229atmyZ6tWrl209FotFkZGRio6OVnR0tD777LNMs6R9fHx04MABnT17VhcvXpQktWvXTocOHdKMGTMUHR2tuLg4RUVFacaMGZKk//3vf1q1apWio6N1+vRpbdq0Senp6fL397+jewoAAAAAAAAg/zCj+P8rVaqURo0apQULFuijjz5SamqqSpcurbffflu1a9e+o7579OihOXPmaN26dSpevLjCw8NVu3ZtDR06VIsXL9ayZcvk7Oys0qVL66mnnpIkOTk5afDgwZo6daqGDRsmHx8fhYaGZvsyu0KFCqlSpUpauXKlTp06pbS0NJUoUULNmzdXhw4dsq2nZ8+e+vLLL/X++++rSJEiateunZKTkzP0HxwcrK+//lpvvPGGrFarIiIiFBAQoLCwMC1YsEAffPCBbDab/Pz81LBhQ0lS4cKFFRkZqYULF8pqtcpiseitt95S2bJl7+ieAgAAAAAAAMg/JltuF9cFHGD/8DeUHH3M0WUAAAAAAADgAWGZMN3RJdwVZrNZPj4+t23H0hMAAAAAAAAAYHAExQAAAAAAAABgcATFAAAAAAAAAGBwBMUAAAAAAAAAYHAExQAAAAAAAABgcATFAAAAAAAAAGBwBMUAAAAAAAAAYHAExQAAAAAAAABgcATFAAAAAAAAAGBwBMUAAAAAAAAAYHAmm81mc3QRwO2cPn1aVqvV0WUAhmEymWSxWBQXFyf+TAB3F88f4Bg8e4Dj8PwBjsGzZxxms1k+Pj63bceMYgAAAAAAAAAwOIJiAAAAAAAAADA4gmIAAAAAAAAAMDiCYgAAAAAAAAAwOIJiAAAAAAAAADA4gmIAAAAAAAAAMDiCYgAAAAAAAAAwOBdHFwDkxOlJHyo5+pijywAMJdbRBQAGxvN3f7JMmO7oEgAAAIA8Y0YxAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABgcQTEkScHBwYqMjMzy+L59+xQcHKykpKS7WBUAAAAAAACAu8HF0QXg7jh//ryWLFmiHTt26OzZsypWrJgCAgLUunVr1axZ87bnV6lSRV999ZU8PDzuQrUAAAAAAAAA7iaCYgNISEjQiBEjVLhwYXXv3l3lypVTWlqa/vjjD82YMUOTJk26bR8uLi7y8vIq8FoBAAAAAAAA3H0ExQYwY8YMmUwmjRkzRoUKFbLvL1u2rJ588kn79qVLlzRhwgT98ccfKl68uHr27Kl69epJur70xKhRozRz5kwVLlxYGzZs0KxZszRw4EDNnj1biYmJqlq1qvr37y9vb29J0tGjRzV//nxFR0crNTVVgYGB6tWrl8qXL393bwAAAAAAAACAbLFG8QPu8uXL2rVrl1q2bJkhJL6hcOHC9s+LFi1Sw4YNNXHiRNWpU0eff/65Ll++nGXfV69e1fLly/X6669r1KhRSkxM1Ny5c+3HU1JS1LRpU3344YcaPXq0LBaLxo4dq+Tk5Cz7tFqtunLliv0nu7YAAAAAAAAA8gczih9w8fHxstlsKl269G3bNm3aVE2aNJEkdevWTT/99JOOHj2q2rVr37J9Wlqa+vbtKz8/P0nSs88+q0WLFtmP16hRI0P7V155RaGhodq/f7/q1q17yz6XLl2aoY+goCCNGzfutrUDAAAAAAAAyDuC4geczWbLcduAgAD750KFCsnd3V0XLlzIsr2bm5s9JJYkb29vXbx40b59/vx5LViwQPv379eFCxeUnp6ua9euKTExMcs+27dvrzZt2ti3TSZTjusHAAAAAAAAkDcExQ84i8Uik8mkkydP3rats7Nzhm2TyZRt0PzP9lLGYDo8PFyXL19WSEiIfHx8ZDabNXz4cKWmpmbZp9lsltlsvm2tAAAAAAAAAPIPaxQ/4Dw9PfXwww/rl19+UUpKSqbjSUlJBTb2oUOH1KpVKz3yyCMqW7asXFxcdOnSpQIbDwAAAAAAAEDeEBQbQO/evZWenq5hw4Zp+/btiouLU0xMjFatWqX333+/wMa1WCzatGmTYmJidOTIEU2ePFmurq4FNh4AAAAAAACAvGHpCQMoVaqUxo0bpyVLlmju3Lk6d+6cihYtqvLly6tPnz4FNu5rr72mr776SkOHDlXJkiXVrVs3zZ07t8DGAwAAAAAAAJA3Jltu3nYGOMj+4W8oOfqYo8sAAADIkmXCdEeXgDtgMplksVgUFxeXqxdCA7hzPH+AY/DsGYfZbJaPj89t27H0BAAAAAAAAAAYHEExAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYnIujCwBywmfgB7JarY4uAzAMk8kki8WiuLg42Ww2R5cDGArPHwAAAABHYEYxAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABici6MLAHLi9KQPlRx9zNFlAIYSW8D9WyZML+ARAAAAAABATjGjGAAAAAAAAAAMjqAYAAAAAAAAAAyOoBgAAAAAAAAADI6gGAAAAAAAAAAMjqAYAAAAAAAAAAyOoBgAAAAAAAAADI6gGAAAAAAAAAAMjqAYAAAAAAAAAAyOoBgAAAAAAAAADI6gGAAAAAAAAAAMjqAYAAAAAAAAAAzOxdEFIH+Eh4dr48aNmfZ//vnn8vPzc0BFAAAAAAAAAO4XBMUPkNq1a6t///4Z9hUtWjTDdmpqqlxc+LUDAAAAAAAA+D8khg8QFxcXeXl5ZdgXFhamsmXLytnZWZs3b1a5cuU0cuRIrVixQuvXr1dCQoI8PT1Vt25dde/eXYUKFZIkbdiwQbNmzdLAgQM1e/ZsJSYmqmrVqurfv7+8vb3t/f/6669asWKF4uPj5enpqfr166t3796SpKSkJM2dO1dRUVFKTU1V+fLl1atXLwUGBt6tWwIAAAAAAAAgBwiKDWDjxo165pln9NFHH9n3mUwmhYaGytfXVwkJCZo+fbrmzZunPn362NtcvXpVy5cv1+uvvy6TyaTJkydr7ty5evPNNyVJq1ev1uzZs/XSSy+pdu3aunLlig4dOmQ//9NPP5Wrq6uGDRsmDw8PrVmzRh999JE+++wzeXp63rJWq9Uqq9WaoU53d/f8viUAAAAAAAAAbkJQ/ADZsWOHevToYd+uU6eOJMlisah79+4Z2rZu3dr+2dfXV127dtXXX3+dIShOS0tT37597WscP/vss1q0aJH9+OLFi9W2bVs999xz9n0VK1aUJB08eFBHjx7V9OnTZTabJUk9e/ZUVFSUtm/frhYtWtzyGpYuXZphjKCgII0bNy53NwIAAAAAAABArhAUP0CqV6+uvn372rfd3Nz02WefKSgoKFPb3bt364cfftDJkyeVnJystLQ0Wa1WXb16VW5ubvbzb34Rnre3ty5evChJunDhgs6dO6caNWrcspbo6GilpKTo5ZdfzrD/2rVrio+Pz/Ia2rdvrzZt2ti3TSZTDq4cAAAAAAAAwJ0gKH6A/DPYveHGusM3JCQkaNy4cXr66afVtWtXeXp66uDBg5o6dapSU1PtQbGzs3Omvmw2myTJ1dU121pSUlLk7e2tsLCwTMc8PDyyPM9sNttnIAMAAAAAAAC4OwiKDejPP/9Uenq6evbsKScnJ0nSb7/9lqs+3N3d5ePjo717995yVnH58uV1/vx5OTk5ydfXN1/qBgAAAAAAAFAwnBxdAO4+Pz8/paWl6eeff9apU6e0adMmrVmzJtf9dO7cWcuXL9eqVasUFxenP//8Uz/99JMkqWbNmqpcubImTJigP/74QwkJCTp06JDmz5+vY8eO5fclAQAAAAAAALgDzCg2oMDAQPXs2VPLli3Td999p2rVqunFF1/UF198kat+mjVrJqvVqpUrV2ru3LkqWrSo6tevL+n62sLvvfee5s+frylTpujixYvy8vJStWrVVKxYsYK4LAAAAAAAAAB5ZLLdWHQWuIftH/6GkqOZiQw8SCwTpju6BOCeZDKZZLFYFBcXJ/4zDbh7ePYAx+H5AxyDZ884zGazfHx8btuOpScAAAAAAAAAwOAIigEAAAAAAADA4AiKAQAAAAAAAMDgCIoBAAAAAAAAwOAIigEAAAAAAADA4AiKAQAAAAAAAMDgCIoBAAAAAAAAwOAIigEAAAAAAADA4AiKAQAAAAAAAMDgCIoBAAAAAAAAwOBcHF0AkBM+Az+Q1Wp1dBmAYZhMJlksFsXFxclmszm6HAAAAAAAUMCYUQwAAAAAAAAABkdQDAAAAAAAAAAGR1AMAAAAAAAAAAZHUAwAAAAAAAAABkdQDAAAAAAAAAAGR1AMAAAAAAAAAAZHUAwAAAAAAAAABufi6AKAnDg96UMlRx9zdBmAocT+Y9syYbpD6gAAAAAAAAWPGcUAAAAAAAAAYHAExQAAAAAAAABgcATFAAAAAAAAAGBwBMUAAAAAAAAAYHAExQAAAAAAAABgcATFAAAAAAAAAGBwBMUAAAAAAAAAYHAExQAAAAAAAABgcATFAAAAAAAAAGBwBMUAAAAAAAAAYHAExQAAAAAAAABgcATFyDfBwcGKjIx0dBkAAAAAAAAAcsnF0QUgd86fP68lS5Zox44dOnv2rIoVK6aAgAC1bt1aNWvWdHR5AAAAAAAAAO5DBMX3kYSEBI0YMUKFCxdW9+7dVa5cOaWlpemPP/7QjBkzNGnSJEeXCAAAAAAAAOA+RFB8H5kxY4ZMJpPGjBmjQoUK2feXLVtWTz75pCRpxYoVWr9+vRISEuTp6am6deuqe/fu9vYbNmzQrFmzNHDgQM2ePVuJiYmqWrWq+vfvL29vb0nS0aNHNX/+fEVHRys1NVWBgYHq1auXypcvbx8zLi5OU6dO1dGjR+Xr66vQ0NBM9c6bN09RUVE6c+aMvLy81KRJE3Xq1EkuLll/7axWq6xWq33bZDLJ3d39zm4cAAAAAAAAgGwRFN8nLl++rF27dqlr164ZQuIbChcuLOl6sBoaGipfX18lJCRo+vTpmjdvnvr06WNve/XqVS1fvlyvv/66TCaTJk+erLlz5+rNN9+UJKWkpKhp06Z6+eWXZbPZtGLFCo0dO1aff/653N3dlZ6erokTJ8rLy0ujR4/WlStXNHv27Ew1ubu72wPoEydOaNq0aXJ3d1e7du2yvM6lS5dq0aJF9u2goCCNGzcuz/cNAAAAAAAAwO0RFN8n4uPjZbPZVLp06WzbtW7d2v7Z19dXXbt21ddff50hKE5LS1Pfvn3l5+cnSXr22WczhLM1atTI0Ocrr7yi0NBQ7d+/X3Xr1tWePXsUGxur4cOHq3jx4pKkbt26acyYMRnO69ixY4ZaYmNjtW3btmyD4vbt26tNmzb2bZPJlO31AgAAAAAAALhzBMX3CZvNlqN2u3fv1g8//KCTJ08qOTlZaWlpslqtunr1qtzc3CRJbm5u9pBYkry9vXXx4kX79vnz57VgwQLt379fFy5cUHp6uq5du6bExERJ0smTJ1WiRAl7SCxJlStXzlTLtm3b9NNPPyk+Pl4pKSlKT0+/7TISZrNZZrM5R9cKAAAAAAAAIH8QFN8nLBaLTCaTTp48mWWbhIQEjRs3Tk8//bS6du0qT09PHTx4UFOnTlVqaqo9KHZ2ds507s1BdHh4uC5fvqyQkBD5+PjIbDZr+PDhSk1NzXG9hw8f1ueff67g4GA9/PDD8vDw0NatW7VixYpcXDUAAAAAAACAu8HJ0QUgZzw9PfXwww/rl19+UUpKSqbjSUlJ+vPPP5Wenq6ePXuqcuXK8vf317lz53I91qFDh9SqVSs98sgjKlu2rFxcXHTp0iX78dKlS+vMmTMZ+j58+HCmPnx8fNShQwdVqFBBFovFPiMZAAAAAAAAwL2FoPg+0rt3b6Wnp2vYsGHavn274uLiFBMTo1WrVun999+Xn5+f0tLS9PPPP+vUqVPatGmT1qxZk+txLBaLNm3apJiYGB05ckSTJ0+Wq6ur/XjNmjVlsVgUHh6u6OhoHThwQAsWLMjUR2JiorZu3ar4+HitWrVKkZGRd3wPAAAAAAAAAOQ/guL7SKlSpTRu3DhVr15dc+fO1aBBg/Tvf/9be/fuVZ8+fRQYGKiePXtq2bJlGjRokDZv3qwXX3wx1+O89tprSkpK0tChQ/XFF1+oVatWKlasmP24k5OTBg8erGvXrmnYsGGaOnWqunbtmqGPevXqqXXr1vrmm280ZMgQHT58OMPL7QAAAAAAAADcO0y2nL4lDXCg/cPfUHL0MUeXARiaZcJ0R5cAGILJZJLFYlFcXFyOX2YL4M7x7AGOw/MHOAbPnnGYzWb5+Pjcth0zigEAAAAAAADA4AiKAQAAAAAAAMDgCIoBAAAAAAAAwOAIigEAAAAAAADA4AiKAQAAAAAAAMDgCIoBAAAAAAAAwOAIigEAAAAAAADA4AiKAQAAAAAAAMDgCIoBAAAAAAAAwOBcHF0AkBM+Az+Q1Wp1dBmAYZhMJlksFsXFxclmszm6HAAAAAAAUMCYUQwAAAAAAAAABkdQDAAAAAAAAAAGR1AMAAAAAAAAAAZHUAwAAAAAAAAABkdQDAAAAAAAAAAGR1AMAAAAAAAAAAZHUAwAAAAAAAAABufi6AKAnDg96UMlRx9zdBm4z1kmTHd0CQAAAAAAAPckZhQDAAAAAAAAgMERFAMAAAAAAACAwREUAwAAAAAAAIDBERQDAAAAAAAAgMERFAMAAAAAAACAwREUAwAAAAAAAIDBERQDAAAAAAAAgMERFAMAAAAAAACAwREUAwAAAAAAAIDBERQDAAAAAAAAgMERFAMAAAAAAACAwREUAwAAAAAAAIDBuTi6AFx3/vx5LV26VDt27NDZs2fl4eEhPz8/Pf7442ratKnc3NwcXSIAAAAAAACABxRB8T3g1KlTGjFihAoXLqxu3bqpXLlyMpvNOnHihNauXavixYurXr16ue43NTVVLi78igEAAAAAAABkjxTxHjB9+nQ5Oztr7NixKlSokH1/qVKl9Oijj8pms0mSkpKSNHfuXEVFRSk1NVXly5dXr169FBgYKEmKiIhQVFSUnn32WS1ZskSJiYn6/vvvFRwcrL59++p///uf9u7dKx8fH/Xr109FixbV1KlTdezYMQUEBOj111+Xn5+fJCk+Pl5z5szRkSNHlJKSojJlyqhbt26qVauWvb4BAwaoefPmio+P1/bt21W4cGF17NhRLVq0kCSNGjVKZcqUUe/eve3nXLx4Ua+++qqGDRummjVrFvStBQAAAAAAAJADrFHsYJcuXdLu3bvVsmXLDCHxzUwmkyTp008/1YULFzRs2DB9/PHHCgoK0kcffaTLly/b28bHx+u///2vBg8erPHjx9v3L168WE888YTGjx8vf39/ffbZZ/rqq6/0wgsvaOzYsbLZbPrmm2/s7VNSUlSnTh2NGDFC48eP18MPP6xx48YpMTExQ20rVqxQhQoVNH78eLVs2VJff/21YmNjJUnNmzfXli1bZLVa7e03bdqk4sWLq0aNGre8VqvVqitXrth/kpOTc3lHAQAAAAAAAOQWM4odLD4+XjabTf7+/hn29+7dW9euXZMktWzZUvXq1dPRo0c1ffp0mc1mSVLPnj0VFRWl7du322fxpqam6vXXX1fRokUz9NesWTM1atRIktSuXTu9//776tixo2rXri1Jeu655zRlyhR7+8DAQPtMZUnq2rWroqKi9Pvvv+vZZ5+1769Tp45atmxp73flypXau3ev/P399dhjj2nGjBmKioqyj71x40Y1a9bMHn7/09KlS7Vo0SL7dlBQkMaNG5ezmwkAAAAAAAAgTwiK71FjxoyRzWbT559/rtTUVEVHRyslJUUvv/xyhnbXrl1TfHy8fdvHxydTSCxJAQEB9s9eXl6SpHLlytn3FStWzD6b18PDQykpKYqIiNDOnTt17tw5paWl6dq1a5lmFN/cr8lkkpeXly5evChJcnV11RNPPKH169erUaNG+vPPP3XixAkNGTIky+tu37692rRpk6FPAAAAAAAAAAWLoNjB/Pz8ZDKZ7Ms13FCqVClJ18NW6fpSEN7e3goLC8vUh4eHh/2zm5vbLcdxdnbOtO/mF93dCGRvrIc8Z84c7dmzRz169JCfn59cXV31ySefKDU19bb9pqen2z83b95c7777rs6cOaMNGzaoRo0a8vHxuWWNkmQ2m+0zpgEAAAAAAADcHQTFDlakSBHVqlVLP//8s5599tks1ykuX768zp8/LycnJ/n6+hZ4XYcOHVLTpk312GOPSboeVJ8+fTrX/ZQrV04VKlTQunXrtGXLlkwzogEAAAAAAAA4Hi+zuwf07t1baWlpeu+997Rt2zbFxMQoNjZWmzZt0smTJ+Xk5KSaNWuqcuXKmjBhgv744w8lJCTo0KFDmj9/vo4dO5bvNVksFkVGRio6OlrR0dH67LPP7LONc+upp57SDz/8IJvNZg+eAQAAAAAAANw7mFF8D/Dz89P48eO1dOlSfffddzpz5ozMZrPKlCmjtm3bqmXLljKZTHrvvfc0f/58TZkyRRcvXpSXl5eqVaumYsWK5XtNPXv21Jdffqn3339fRYoUUbt27ZScnJynvpo0aaLZs2ercePG9qU0AAAAAAAAANw7TLa8ThMFcighIUFvvPGGxo4dq/Lly+epj/3D31BydP7PnIaxWCZMd3QJ9w2TySSLxaK4uLg8/2sCAHnD8wc4Bs8e4Dg8f4Bj8OwZh9lszvadYTcwoxgFJjU1VZcvX9aCBQtUuXLlPIfEAAAAAAAAAAoWaxSjwBw6dEivvPKKjh07pr59+zq6HAAAAAAAAABZYEYxCkz16tUVERHh6DIAAAAAAAAA3AYzigEAAAAAAADA4AiKAQAAAAAAAMDgCIoBAAAAAAAAwOAIigEAAAAAAADA4AiKAQAAAAAAAMDgCIoBAAAAAAAAwOBcHF0AkBM+Az+Q1Wp1dBkAAAAAAADAA4kZxQAAAAAAAABgcATFAAAAAAAAAGBwBMUAAAAAAAAAYHAExQAAAAAAAABgcATFAAAAAAAAAGBwBMUAAAAAAAAAYHAExQAAAAAAAABgcC6OLgDIidOTPlRy9DFHl4F7kGXCdEeXAAAAAAAAcN9jRjEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYHEEx8iQiIkLvvvuufTs8PFzjx493YEUAAAAAAAAA8oqg+B5z+PBhdenSRWPHjs3Xfjds2KCQkJB87fNmoaGhGjBgQIH1DwAAAAAAAKDgEBTfY3799Ve1atVKBw4c0NmzZ+/6+KmpqXk6z8PDQ4ULF87nagAAAAAAAADcDS6OLgD/JyUlRdu2bdPHH3+s8+fPa8OGDerQoYOk6zOCZ82apVmzZtnbR0ZGauLEiYqIiJAkRUdHa/bs2Tp27JhMJpP8/Pz0yiuvKCUlRVOmTJEkBQcHS5I6deqk4OBgDRgwQE8++aTi4+MVFRWlxx57TAMGDNC8efMUFRWlM2fOyMvLS02aNFGnTp3k4nLrr0x4eLiSkpI0ZMgQSdKuXbu0ePFi/f3333JyclLlypUVEhIiPz+/grp9AAAAAAAAAPKIoPgesm3bNpUuXVr+/v56/PHHNWvWLLVv314mkylH50+ePFmBgYHq06ePnJycFB0dLWdnZ1WpUkUhISH6/vvv9dlnn0mSChUqZD9v+fLl6tSpkzp16mTf5+7urv79+8vb21snTpzQtGnT5O7urnbt2uWolpSUFLVp00YBAQFKSUnR999/r4kTJ2r8+PFycsp6IrvVapXVarVvm0wmubu752hMAAAAAAAAAHlDUHwPWb9+vR5//HFJUu3atXXlyhXt379f1atXz9H5iYmJatu2rUqXLi1Jslgs9mMeHh4ymUzy8vLKdF6NGjXUtm3bDPs6duxo/+zr66vY2Fht27Ytx0FxgwYNMmz369dPffr0UUxMjMqVK5fleUuXLtWiRYvs20FBQRo3blyOxgQAAAAAAACQNwTF94jY2FgdPXpUgwcPliQ5OzurUaNG+vXXX3McFLdu3VrTpk3T5s2bVbNmTTVo0CBHSz1UqFAh075t27bpp59+Unx8vFJSUpSenp6rmb1xcXH6/vvvdfToUV26dEnp6emSrofZ2QXF7du3V5s2bezbOZ1NDQAAAAAAACDvCIrvEb/++qvS0tL06quv2vfZbDaZzWb17t1bJpNJNpstwzlpaWkZtoODg9WkSRPt2LFDu3btUkREhAYOHKjHHnss27Hd3NwybB8+fFiff/65goOD9fDDD8vDw0Nbt27VihUrcnw948aNk4+Pj1599VV5e3vLZrNp0KBBt31ZntlsltlszvE4AAAAAAAAAO4cQfE9IC0tTRs3blTPnj1Vq1atDMcmTJigLVu2yMfHRykpKUpJSbGvLxwdHZ2pL39/f/n7+6tNmzaaNGmS1q9fr8cee0wuLi72Wb23c+jQIfn4+NhfpCddnwmcU5cuXVJsbKxeffVVVatWTZJ08ODBHJ8PAAAAAAAA4O4iKL4H/O9//1NSUpKeeuopeXh4ZDhWv359rV+/XsOHD5erq6vmz5+vVq1a6ejRo9qwYYO93bVr1zR37lw1aNBAvr6+OnPmjI4dO6b69etLkj1o3rNnjwICAuTm5pZpJvENFotFiYmJ2rp1qypUqKAdO3YoMjIyx9dTuHBhFSlSRGvXrpW3t7cSExP17bff5v7GAAAAAAAAALgrnBxdAK4vO1GzZs1MIbF0/aVwx44d05kzZ/TGG29o586dGjx4sLZs2aLOnTvb2zk5OenSpUv64osv9NZbb+k///mP6tSpo+DgYElSlSpV9PTTT2vSpEnq06ePli1blmU99erVU+vWrfXNN99oyJAhOnz4cIaX292Ok5OT3nrrLf35558aNGiQZs+erR49euTijgAAAAAAAAC4m0y2fy58C9yD9g9/Q8nRxxxdBu5BlgnTHV3CA8lkMslisSguLi7T+ugAChbPH+AYPHuA4/D8AY7Bs2ccZrNZPj4+t23HjGIAAAAAAAAAMDiCYgAAAAAAAAAwOIJiAAAAAAAAADA4gmIAAAAAAAAAMDiCYgAAAAAAAAAwOIJiAAAAAAAAADA4gmIAAAAAAAAAMDiCYgAAAAAAAAAwOIJiAAAAAAAAADA4F0cXAOSEz8APZLVaHV0GAAAAAAAA8EBiRjEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABgcQTEAAAAAAAAAGJyLowsAcuL0pA+VHH3M0WXAgSwTpju6BAAAAAAAgAcWM4oBAAAAAAAAwOAIigEAAAAAAADA4AiKAQAAAAAAAMDgCIoBAAAAAAAAwOAIigEAAAAAAADA4AiKAQAAAAAAAMDgCIoBAAAAAAAAwOAIigEAAAAAAADA4AiKAQAAAAAAAMDgCIoBAAAAAAAAwOAIigEAAAAAAADA4AiK/2HAgAFauXJlgfQdHBysyMjIO+ojLCxMs2bNyp+CsrFv3z4FBwcrKSmpwMcCAAAAAAAA4FgPRFCcVXi6YcMGhYSE5KqvsWPHqkWLFvbt/Ah3cyo8PFzjx4/PsG/79u166aWXtHz5cknS4MGD1aVLl7tSDwAAAAAAAABjcHF0AfeaokWLOroEu3Xr1mnGjBnq27evnnzySUmSp6eng6sCAAAAAAAA8KAxVFAcHh6upKQkVa1aVStWrFBqaqoaNWqkkJAQubhcvxUDBgzQc889p9atW2vAgAGSpIkTJ0qSfHx8FB4eLkmKiorSokWLFBMTI29vbzVt2lQdOnSQs7OzJCkuLk5Tp07V0aNH5evrq9DQ0FzVumzZMkVERGjgwIF67LHH7PvDwsIUGBhonyk9YMAANW/eXPHx8dq+fbsKFy6sjh07ZpgVfejQIU2fPl2xsbEqW7asOnTooIkTJ2r8+PEKDAyUJO3YsUOzZ89WYmKiKleurKZNm2aqafv27YqIiFB8fLy8vb317LPPqm3btvbjAwYM0FNPPaW4uDj997//VZEiRfTyyy+rcuXKmjp1qvbs2aNSpUqpX79+qlChQq7uBwAAAAAAAICCY6igWLq+9q63t7dGjhyp+Ph4TZo0SYGBgRmC1RvGjh2rPn36qH///qpdu7acnK6v1HHgwAF98cUXCg0NVbVq1XTq1ClNmzZNktS5c2elp6dr4sSJ8vLy0ujRo3XlyhXNnj07xzXOmzdPq1ev1r/+9S/VrFnztu1XrFihLl26qEOHDtq+fbu+/vprPfTQQ/L399eVK1c0btw41alTR2+99ZZOnz6daZmOxMREffLJJ2rZsqVatGihY8eOac6cORna/Pnnn/rPf/6jzp07q1GjRjp8+LCmT5+uIkWKqFmzZvZ2K1euVLdu3dSxY0etXLlSkydPVpUqVfTkk0+qe/fu+vbbb/XFF1/o008/lclkynQtVqtVVqvVvm0ymeTu7p7jewcAAAAAAAAg9x6INYpzw9PTU71791bp0qVVt25d1alTR3v37r1l2xvLUHh4eMjLy8u+vWjRIr3wwgtq1qyZSpUqpVq1aqlLly5au3atJGnPnj2KjY3VgAEDFBgYqIceekjdunXLUX27du3Sjz/+qCFDhuQoJJakOnXqqGXLlvLz81O7du1UtGhR+zVt2bJFJpNJr776qsqUKaM6dero+eefz3D+6tWrVapUKfXs2VP+/v56/PHHM4S/0vUwumbNmurUqZP8/f3VrFkzPfvss/rxxx8z1fL000/LYrGoU6dOSk5OVoUKFdSwYUP5+/urXbt2OnnypC5cuHDLa1m6dKlCQkLsP2FhYTm6BwAAAAAAAADyznAzisuUKWOfGSxJ3t7eOnHiRK76iI6O1sGDB7VkyRL7vvT0dFmtVl29elUnT55UiRIlVLx4cfvxypUr56jvgIAAXbx4UREREapYsaIKFSqUo3NuMJlM8vLy0sWLFyVJsbGxKleunFxdXe1tKlasmOH8kydPZtr3z3pPnjypevXqZdhXpUoVrVy5Uunp6fZ7enMtxYoVkySVK1fOvs/Ly0uSdOHCBfvnm7Vv315t2rTJcD0AAAAAAAAACtYDERS7u7vrypUrmfYnJSXJw8Mjw74bawjfYDKZZLPZcjVeSkqKgoODVb9+/UzHzGZzrvr6J29vb73zzjsaNWqURo8erWHDht126YV/XpN0Pbh2hJtruRHy3qq+rO652Wy+43sIAAAAAAAAIHceiKUn/P39dfz48Uz7jx8/LovFckd9Ozs7Zwpdy5cvr9jYWPn5+WX6cXJyUunSpXXmzBmdO3fOfs7hw4dzPKaPj4/CwsJ0/vx5jRkzRsnJyXmu39/fXydOnMiw7u+xY8cytCldunSmfUeOHMnU5tChQxn2HTp0SP7+/hlmaAMAAAAAAAC4/zwQCd8zzzyj2NhYffPNN/rrr78UGxurFStWaOvWrWrbtu0d9e3r66u9e/fq/Pnzunz5siSpY8eO2rRpkxYuXKi///5bMTEx2rp1qxYsWCBJqlmzpiwWi8LDwxUdHa0DBw7Yj+VUyZIlFRYWpgsXLthfiJcXTZo0kc1m07Rp0xQTE6Ndu3Zp+fLlGdo888wziouL09y5cxUbG6stW7Zow4YNGdq0adNGe/bs0aJFixQbG6sNGzbo559/vuP7CwAAAAAAAMDxHoiguFSpUho1apRiY2P10UcfadiwYfrtt9/09ttvq3bt2nfUd48ePbR7927169dPQ4cOlSTVrl1bQ4cO1e7du/Xee+9p+PDhWrlypUqWLClJcnJy0uDBg3Xt2jUNGzZMU6dOVdeuXXM9dokSJRQWFqZLly7lOSz28PDQ0KFD9ddff2nIkCFasGCBOnbsKEn2dYtLliypQYMGKSoqSu+++67WrFmT6eV75cuX19tvv61t27Zp0KBBioiIUHBwcKaX3gEAAAAAAAC4/5hsuV2gF/e9zZs3a8qUKZo9e3aGl9zdy/YPf0PJ0cdu3xAPLMuE6Y4uwVBMJpMsFovi4uJyvY47gDvD8wc4Bs8e4Dg8f4Bj8OwZh9lslo+Pz23bPRAvs0P2Nm7cqFKlSql48eKKjo7Wt99+q4YNG943ITEAAAAAAACAgkVQbADnz59XRESEzp8/Ly8vLzVo0CDT0hIAAAAAAAAAjIug2ADatWundu3aOboMAAAAAAAAAPeoB+JldgAAAAAAAACAvCMoBgAAAAAAAACDy3NQ/Pbbb2vJkiU6ffp0ftYDAAAAAAAAALjL8rxGcYkSJbRw4UJFRESoSpUqeuKJJ9SwYUN5eHjkZ30AAAAAAAAAgAKW56D4/fff1/nz57VlyxZt3bpVX331lb755hs98sgjeuKJJ1SnTh25uPCuPAAAAAAAAAC4191Rkuvl5aU2bdqoTZs2io2N1aZNm7R161ZFRkaqcOHCatSokR5//HFVqVIlv+oFAAAAAAAAAOQzk81ms+Vnh+fPn9fMmTO1fft2+75SpUrpueee0zPPPCMnJ96fh9w7ffq0rFaro8sADMNkMslisSguLk75/GcCwG3w/AGOwbMHOA7PH+AYPHvGYTab5ePjc9t2+bI2REpKiiIjI7V582bt3btXkvTII4+oadOmcnFx0dq1azVz5kydOHFCr7zySn4MCQAAAAAAAADIJ3kOitPT07Vr1y5t3rxZv//+u65du6by5curZ8+eaty4sYoWLWpvW69ePX333Xf65ZdfCIoBAAAAAAAA4B6T56C4b9++unz5sooXL65WrVrpiSeeUJkyZbJsHxAQoJSUlLwOBwAAAAAAAAAoIHkOih955BE98cQTqlGjhkwm023bN27cWI0bN87rcAAAAAAAAACAApKnN8tdu3ZNnp6eunr1ao5CYgAAAAAAAADAvStPQbGrq6vWrl2rCxcu5Hc9AAAAAAAAAIC7LE9BsSSVL19ef//9d37WAgAAAAAAAABwgDyvUdyrVy+NHTtWZcuWVbNmzeTs7JyfdQEZnJ70oZKjjzm6DOQzy4Tpji4BAAAAAAAAuoOgeMqUKXJyctJXX32lmTNnqnjx4nJ1dc3QxmQyacKECXdcJAAAAAAAAACg4OQ5KPb09FSRIkXk7++fn/UAAAAAAAAAAO6yPAfFYWFh+VgGAAAAAAAAAMBR8vwyu40bNyohISHL46dPn9bGjRvz2j0AAAAAAAAA4C7Jc1A8ZcoUHT58OMvjR44c0ZQpU/LaPQAAAAAAAADgLslzUHw7KSkpcnZ2LqjuAQAAAAAAAAD5JFdrFP/111+Kjo62bx84cEBpaWmZ2iUlJWnNmjWyWCx3XCAAAAAAAAAAoGDlKiiOjIzUokWL7Ntr167V2rVrb9nWw8NDr7/++p1VBwAAAAAAAAAocLkKilu0aKG6devKZrNp2LBhCg4OVp06dTK1K1SokEqVKsXSEwAAAAAAAABwH8hVUOzt7S1vb29J0siRI1W6dGkVK1asQAoDAAAAAAAAANwduQqKb/bQQw/lZx0AAAAAAAAAAAfJc1AsSbt27dKvv/6qhIQEJSUlyWazZThuMpk0efLkOyoQ94/w8HAlJSVpyJAhji4FAAAAAAAAQC7kOSj+8ccf9e2338rLy0sVKlRQuXLl8rMu3GU3h7xhYWEKDAxUSEiIo8sCAAAAAAAAcBfkOShetWqVatSooffee08uLnc0MRkAAAAAAAAA4EB5TniTkpLUoEEDQuIHTHh4uPbv36/9+/dr1apVkqQvvvhCJUuW1LRp07R3716dP39eJUuWVMuWLfXcc8/dsp+NGzdq9uzZmjZtmsxms33/+PHj5e7urjfeeOOuXA8AAAAAAACA28tzyluxYkXFxsbmZy24B4SGhiouLk5ly5ZVly5dJElFixZVenq6SpQooXfeeUdFihTRoUOH9NVXX8nLy0uNGjXK1E/Dhg01c+ZM/f7772rYsKEk6cKFC9q5c6eGDx+e5fhWq1VWq9W+bTKZ5O7uns9XCQAAAAAAAOBmeQ6Ke/furbFjx6pChQpq0qRJftYEB/Lw8JCLi4vc3Nzk5eVl3+/k5KTg4GD7tq+vrw4fPqzffvvtlkGxq6urmjRpog0bNtiD4s2bN6tkyZKqXr16luMvXbpUixYtsm8HBQVp3Lhx+XBlAAAAAAAAALKS56B40qRJSktL0+TJk/X111+rRIkScnJyytDGZDJpwoQJd1wk7g0///yz1q9fr8TERF27dk2pqakKDAzMsn3z5s313nvv6ezZsypevLg2bNigpk2bymQyZXlO+/bt1aZNG/t2dm0BAAAAAAAA5I88B8Wenp4qUqSILBZLftaDe9TWrVs1d+5c9ezZU5UrV5a7u7t+/PFHHTlyJMtzgoKCFBAQoI0bN+rhhx/W33//rX/961/ZjmM2mzOsaQwAAAAAAACg4OU5KA4LC8vHMnAvcXFxUXp6eoZ9hw4dUpUqVdSyZUv7vlOnTt22r+bNm2vlypU6e/asatWqpZIlS+Z7vQAAAAAAAADujNPtm8BofHx8dOTIESUkJOjixYtKT0+Xn5+fjh07pl27dik2NlYLFizQ0aNHb9tXkyZNdPbsWa1bt05PPvnkXageAAAAAAAAQG7leUbx/v37c9TuoYceyusQcJC2bdsqPDxc77zzjq5du6YvvvhCTz/9tKKjozVp0iSZTCY1btxYLVu21M6dO7Pty8PDQ/Xr19eOHTv06KOP3qUrAAAAAAAAAJAbJpvNZsvLiV26dMlRu++//z4v3eMB8uGHH6pMmTJ6+eWX89zH/uFvKDn6WD5WhXuBZcJ0R5eALJhMJlksFsXFxSmPfyYA5BHPH+AYPHuA4/D8AY7Bs2ccZrNZPj4+t22X5xnFI0eOzLQvPT1dCQkJWrdundLT0/XSSy/ltXs8AC5fvqz9+/dr37596tOnj6PLAQAAAAAAAJCFPAfF2S0p0axZM40cOVL79u1TjRo18joE7nNDhw7V5cuX9dJLL8nf39/R5QAAAAAAAADIQp6D4uw4OTmpUaNG+uGHH3K8RAUePOHh4Y4uAQAAAAAAAEAOOBVUx5cvX1ZSUlJBdQ8AAAAAAAAAyCd5nlGcmJh4y/1JSUk6cOCAfvzxR1WrVi3PhQEAAAAAAAAA7o48B8UDBgzI9nilSpXUt2/fvHYPAAAAAAAAALhL8hwU9+vXL9M+k8mkwoULy8/PT2XKlLmjwgAAAAAAAAAAd0eeg+JmzZrlYxkAAAAAAAAAAEfJc1B8s5iYGJ0+fVqS5OPjw2xiAAAAAAAAALiP3FFQHBUVpTlz5ighISHDfl9fX/Xq1Uv16tW7o+KAG3wGfiCr1eroMgAAAAAAAIAHUp6D4h07duiTTz6Rj4+PunXrZp9FHBMTo3Xr1mnixIn617/+pdq1a+dXrQAAAAAAAACAApDnoHjx4sUKCAjQqFGjVKhQIfv+evXq6dlnn9UHH3yghQsXEhQDAAAAAAAAwD3OKa8nnjhxQk2bNs0QEt9QqFAhNWvWTCdOnLij4gAAAAAAAAAABS/PQbHZbNbly5ezPH758mWZzea8dg8AAAAAAAAAuEvyHBTXqFFDq1at0uHDhzMdO3LkiH766SfVrFnzjooDAAAAAAAAABS8PK9R3L17dw0fPlwjRoxQxYoV5e/vL0mKjY3V0aNHVaxYMb300kv5VigAAAAAAAAAoGDkOSj29fXVxIkTtXTpUu3atUvbtm2TJPn4+Oi5557TCy+8oGLFiuVboQAAAAAAAACAgpHnoDgtLU1ms1khISG3PH7lyhWlpaXJ2dk5r0MAdqcnfajk6GOOLgP5yDJhuqNLAAAAAAAAwP+X5zWKZ86cqREjRmR5fMSIEZozZ05euwcAAAAAAAAA3CV5Dop37dql+vXrZ3m8QYMG2rlzZ167BwAAAAAAAADcJXkOis+dO6fixYtnedzb21tnz57Na/cAAAAAAAAAgLskz0Gxp6enYmNjszx+8uRJubu757V7AAAAAAAAAMBdkueguHbt2lq7dq2OHz+e6diff/6ptWvXqk6dOndUHAAAAAAAAACg4Lnk9cQuXbpo165dGjZsmOrWrauyZctKkv7++2/973//U9GiRdWlS5d8KxQAAAAAAAAAUDDyHBQXL15cH3/8sb799lv9/vvvioqKkiS5u7urSZMm6tatW7ZrGAMAAAAAAAAA7g15Doql6y+se/3112Wz2XTx4kVJUtGiRWUymfKlOAAAAAAAAABAwbujoPgGk8mkYsWK5UdXAAAAAAAAAIC7LM8vswMAAAAAAAAAPBgIigEAAAAAAADA4AiKkW8iIiL07rvvOroMAAAAAAAAALmUL2sU49538eJFff/999qxY4cuXLigwoULKzAwUB07dlTVqlXzZYznn39erVq1ype+AAAAAAAAANw9BMUG8cknnyg1NVUDBgxQqVKldOHCBe3Zs0eXL1/OtzEKFSqkQoUK5Vt/AAAAAAAAAO4OgmIDSEpK0oEDBxQWFqaHHnpIkuTj46OKFSva2wQHB6tPnz76/ffftW/fPnl7e6t79+5q0KCBvc28efMUFRWlM2fOyMvLS02aNFGnTp3k4nL9axQREaGoqChNmDBBkhQeHq6kpCRVrVpVK1asUGpqqho1aqSQkBD7OQAAAAAAAAAcjzWKDeDGTN/IyEhZrdYs233//feqX7++JkyYoCZNmmjSpEmKiYmxH3d3d1f//v316aefKiQkROvWrdPKlSuzHXvfvn06deqURo4cqQEDBmjjxo3asGFDlu2tVquuXLli/0lOTs719QIAAAAAAADIHaZ1GoCzs7P69++vadOmac2aNSpfvryqVaumxo0bKyAgwN6uQYMGat68uSSpa9eu2rNnj37++Wf16dNHktSxY0d7W19fX8XGxmrbtm1q165dlmN7enqqd+/ecnJyUunSpVWnTh3t3btXLVq0uGX7pUuXatGiRfbtoKAgjRs37o6uHwAAAAAAAED2CIoNokGDBnrkkUd08OBBHT58WLt27dKPP/6o1157Tc2aNZMkVa5cOcM5lSpV0l9//WXf3rZtm3766SfFx8crJSVF6enpcnd3z3bcMmXKyMnp/yaue3t768SJE1m2b9++vdq0aWPfNplMublMAAAAAAAAAHlAUGwgrq6uqlWrlmrVqqVOnTpp6tSpioiIsAfF2Tl8+LA+//xzBQcH6+GHH5aHh4e2bt2qFStWZHues7Nzhm2TySSbzZZle7PZLLPZnKPrAQAAAAAAAJA/WKPYwMqUKaOrV6/at48cOZLh+JEjR1S6dGlJ0qFDh+Tj46MOHTqoQoUKslgsSkxMvKv1AgAAAAAAACgYzCg2gEuXLunTTz/Vk08+qYCAALm7u+vYsWNatmyZ6tWrZ2/322+/qXz58qpataq2bNmio0ePql+/fpJkD4a3bt2qChUqaMeOHYqMjHTUJQEAAAAAAADIRwTFBlCoUCFVqlRJK1eu1KlTp5SWlqYSJUqoefPm6tChg71dcHCwtm3bphkzZsjLy0tvvfWWypQpI0mqV6+eWrdurW+++UZWq1WPPPKIOnbsqIULFzrqsgAAAAAAAADkE5MtuwVjYRjBwcEaPHiwHnvsMUeXckv7h7+h5Ohjji4D+cgyYbqjS0A2TCaTLBaL4uLisl1XHED+4/kDHINnD3Acnj/AMXj2jMNsNsvHx+e27VijGAAAAAAAAAAMjqAYAAAAAAAAAAyONYohSYqIiHB0CQAAAAAAAAAchBnFAAAAAAAAAGBwBMUAAAAAAAAAYHAExQAAAAAAAABgcATFAAAAAAAAAGBwBMUAAAAAAAAAYHAExQAAAAAAAABgcC6OLgDICZ+BH8hqtTq6DAAAAAAAAOCBxIxiAAAAAAAAADA4gmIAAAAAAAAAMDiCYgAAAAAAAAAwOIJiAAAAAAAAADA4gmIAAAAAAAAAMDiCYgAAAAAAAAAwOIJiAAAAAAAAADA4F0cXAOTE6UkfKjn6mKPLQB5YJkx3dAkAAAAAAAC4DWYUAwAAAAAAAIDBERQDAAAAAAAAgMERFAMAAAAAAACAwREUAwAAAAAAAIDBERQDAAAAAAAAgMERFAMAAAAAAACAwREUAwAAAAAAAIDBERQDAAAAAAAAgMERFAMAAAAAAACAwREUAwAAAAAAAIDBERQDAAAAAAAAgMERFCPfhIeHa/z48Y4uAwAAAAAAAEAuuTi6AOTc+fPntXTpUu3YsUNnz56Vh4eH/Pz89Pjjj6tp06Zyc3NzaH2hoaGy2WwOrQEAAAAAAABA7hEU3ydOnTqlESNGqHDhwurWrZvKlSsns9msEydOaO3atSpevLjq1atXIGOnpqbKxeX2XxUPD48CGR8AAAAAAABAwSIovk9Mnz5dzs7OGjt2rAoVKmTfX6pUKT366KP2mbxJSUmaO3euoqKilJqaqvLly6tXr14KDAy0n7N69WotX75ciYmJ8vX1VceOHfXEE0/YjwcHB6tPnz7auXOn9u7dq7Zt2yo4OFiLFy/WTz/9pGvXrqlRo0YqUqSIdu3apQkTJki6vvREUlKShgwZIknatWuXFi9erL///ltOTk6qXLmyQkJC5OfndxfuGAAAAAAAAICcIii+D1y6dEm7d+9Wt27dMoTENzOZTJKkTz/9VK6urho2bJg8PDy0Zs0affTRR/rss8/k6empyMhIzZw5UyEhIapZs6Z27NihKVOmqHjx4qpRo4a9v4ULF+rFF19USEiInJ2dtXnzZi1ZskR9+vRRlSpVtG3bNi1fvly+vr5Z1p2SkqI2bdooICBAKSkp+v777zVx4kSNHz9eTk63Xh7barXKarVmuC53d/e83DYAAAAAAAAAOURQfB+Ij4+XzWaTv79/hv29e/fWtWvXJEktW7ZUvXr1dPToUU2fPl1ms1mS1LNnT0VFRWn79u1q0aKFli9frmbNmqlly5aSJH9/fx0+fFjLly/PEBQ3btxYTz75pH37559/1lNPPWXf16lTJ/3xxx9KSUnJsu4GDRpk2O7Xr5/69OmjmJgYlStX7pbnLF26VIsWLbJvBwUFady4cbe9RwAAAAAAAADyjqD4PjZmzBjZbDZ9/vnnSk1NVXR0tFJSUvTyyy9naHft2jXFx8dLkmJiYtS8efMMx6tWrapVq1Zl2FehQoUM27GxsXrmmWcy7KtYsaL27t2bZX1xcXH6/vvvdfToUV26dEnp6emSpMTExCyD4vbt26tNmzb27RszpQEAAAAAAAAUHILi+4Cfn59MJpNiY2Mz7C9VqpQkydXVVdL1pR68vb0VFhaWqY/cvmjOzc0tb8XeZNy4cfLx8dGrr74qb29v2Ww2DRo0SKmpqVmeYzab7bOhAQAAAAAAANwdt14oFveUIkWKqFatWvr555+zXeqhfPnyOn/+vJycnOTn55fhp2jRopKkMmXK6NChQxnOO3jwoMqUKZNtDf7+/jp27FiGff/cvtmlS5cUGxurDh06qGbNmipTpoySkpJud6kAAAAAAAAAHICg+D7Ru3dvpaWl6b333tO2bdsUExOj2NhYbdq0SSdPnpSTk5Nq1qypypUra8KECfrjjz+UkJCgQ4cOaf78+fZQt23bttqwYYNWr16tuLg4rVixQpGRkWrbtm224z/77LP69ddftWHDBsXFxWnx4sX666+/slwaonDhwipSpIjWrl2r+Ph47d27V7Nnz873+wIAAAAAAADgzrH0xH3Cz89P48eP19KlS/Xdd9/pzJkzMpvNKlOmjNq2bauWLVvKZDLpvffe0/z58zVlyhRdvHhRXl5eqlatmooVKyZJeuyxxxQaGqrly5dr5syZ8vX1Vf/+/VW9evVsx3/88cd16tQpzZ07V1arVQ0bNlSzZs109OjRW7Z3cnLSW2+9pZkzZ2rQoEHy9/dXaGjoLZfFAAAAAAAAAOBYJpvNZnN0Ebg/ffTRR/Ly8tIbb7xR4GPtH/6GkqOzXuoC9y7LhOmOLgF5YDKZZLFYFBcXJ/5MAHcXzx/gGDx7gOPw/AGOwbNnHGazWT4+Prdtx9ITyJGrV69qxYoV+vvvv3Xy5ElFRERoz549atq0qaNLAwAAAAAAAHCHWHoCOWIymbRz504tWbJEVqtV/v7+GjRokGrVquXo0gAAAAAAAADcIYJi5Iirq6tGjBjh6DIAAAAAAAAAFACWngAAAAAAAAAAgyMoBgAAAAAAAACDIygGAAAAAAAAAIMjKAYAAAAAAAAAgyMoBgAAAAAAAACDIygGAAAAAAAAAINzcXQBQE74DPxAVqvV0WUAAAAAAAAADyRmFAMAAAAAAACAwREUAwAAAAAAAIDBERQDAAAAAAAAgMERFAMAAAAAAACAwREUAwAAAAAAAIDBERQDAAAAAAAAgMERFAMAAAAAAACAwbk4ugAgJ05P+lDJ0cccXQbywDJhuqNLAAAAAAAAwG0woxgAAAAAAAAADI6gGAAAAAAAAAAMjqAYAAAAAAAAAAyOoBgAAAAAAAAADI6gGAAAAAAAAAAMjqAYAAAAAAAAAAyOoBgAAAAAAAAADI6gGAAAAAAAAAAMjqAYAAAAAAAAAAyOoBgAAAAAAAAADI6gGAAAAAAAAAAMjqD4ARUREaF333032zbh4eEaP368fTssLEyzZs0q0LoiIyP1xhtvqEuXLgU+FgAAAAAAAICccXF0ATcLDw9XUlKShgwZYt+3fft2TZ48WV27dlXbtm0dWN3tRUREaNGiRZIkk8mk4sWLq3bt2nrppZfk6enp4Opub/DgwXJ2di7QMb7++ms1a9ZMrVq1kru7e4GOBQAAAAAAACBn7qmg+J/WrVunGTNmqG/fvnryySfz1EdqaqpcXO7eZZYtW1YjRoxQenq6YmJi9OWXX+rKlSt6++2371oNeVXQYXZKSoouXLighx9+WMWLFy/QsQAAAAAAAADk3D0bFC9btkwREREaOHCgHnvsMfv+1atXa/ny5UpMTJSvr686duyoJ554wn48ODhYffr00c6dO7V37161bdtWwcHBioqK0qJFixQTEyNvb281bdpUHTp0sM+gXbFihdavX6+EhAR5enqqbt266t69uwoVKpSrup2cnOTl5SVJKl68uBo2bKj169dnaLNu3TqtWLFCCQkJ8vHxUatWrdSyZUtJUkJCgl5//XW99dZb+umnn3T8+HH5+fmpd+/eeuihhyRJGzZs0KxZszIs3RAZGamJEycqIiIiw1hr1qzRkiVLdOnSJT3yyCN67bXX5OHhccvaw8LCFBgYqJCQEEmS1WrV999/r61bt+rChQsqUaKE2rdvr6eeeuqW51++fFmzZs3S//73P1mtVj300EMKDQ2VxWLRvn37NGrUKEnShx9+KEkaOXKkqlevnvObCwAAAAAAAKBA3JNB8bx587R69Wr961//Us2aNe37IyMjNXPmTIWEhKhmzZrasWOHpkyZouLFi6tGjRr2dgsXLtSLL76okJAQOTs768CBA/riiy8UGhqqatWq6dSpU5o2bZokqXPnzpKuLxURGhoqX19fJSQkaPr06Zo3b5769OmT5+tISEjQH3/8kWFG8+bNmxUREaGXX35ZQUFBOn78uKZNmyY3Nzc1a9Yswz3o1auXypQpoxUrVmjcuHH64osvVKRIkRyPHx8fr99++01Dhw7VlStXNHXqVE2fPl1vvvlmjs7/4osvdPjwYYWGhiogIEAJCQm6dOlSlu2nTJmiuLg4DRkyRO7u7vr22281duxYffrpp6pSpYomTZqkgQMHatCgQapSpcotZzBbrVZZrVb7tslkYokKAAAAAAAAoIDdc0Hxrl279Pvvv+uDDz7IEP5K0vLly9WsWTP77Ft/f38dPnxYy5cvz9C2cePGGZaq+PLLL/XCCy/Yg9hSpUqpS5cu+vbbb+1BcevWre3tfX191bVrV3399de5DopPnDihHj16KD093R549uzZ0348IiJCPXr0UP369e1jxcTEaO3atRmC4pYtW6pBgwaSpL59++qPP/7Qr7/+qnbt2uW4FqvVqtdff92+zMPLL7+ssWPHqmfPnvZZz1mJjY3Vb7/9pvfff1+1atWSdP2+ZSUuLk6///67PvroI1WpUkWS9Oabb6pfv36KiopSw4YNVaxYMUnXl7jIavylS5fa13mWpKCgII0bNy6nlwwAAAAAAAAgD+65oDggIEAXL15URESEKlasmGHph5iYGDVv3jxD+6pVq2rVqlUZ9lWoUCHDdnR0tA4ePKglS5bY990Icq9evSo3Nzft3r1bP/zwg06ePKnk5GSlpaVlOJ5T/v7+Gjp0qK5du6bNmzcrOjparVq1knR9jd5Tp05p6tSp9hnNN2r553IQlStXtn92dnZW+fLldfLkyRzXIUklS5bMsBZw5cqVZbPZFBsbe9ugODo6Wk5OTvblLm7n5MmTcnZ2VqVKlez7ihQpIn9//1zV3b59e7Vp08a+bTKZcnwuAAAAAAAAgLy554Jib29vvfPOOxo1apRGjx6tYcOG5XrpgX8GuykpKQoODrbP4r2Z2WxWQkKCxo0bp6efflpdu3aVp6enDh48qKlTpyo1NTVXQbGLi4v8/PwkSS+99JLGjh2rhQsXqmvXrkpJSZEkvfrqqxkCVen62sY5ZTKZZLPZMuxLS0vL8fk54erqmq/95ZTZbJbZbHbI2AAAAAAAAIBR5TydvIt8fHwUFham8+fPa8yYMUpOTpYklSlTRocOHcrQ9uDBgypTpky2/ZUvX16xsbHy8/PL9OPk5KQ///xT6enp6tmzpypXrix/f3+dO3cuX66lY8eOWr58uc6ePSsvLy95e3vr1KlTmerw9fXNcN6RI0fsn9PS0vTnn3+qdOnSkqSiRYsqJSXFHjxL12cA/1NiYqLOnj1r3z58+LBMJpP8/f1vW3e5cuVks9m0f//+HF1n6dKllZaWlqHuS5cuKTY29ra/HwAAAAAAAACOdU8GxdL1ZRPCwsJ04cIFjR49WleuXFHbtm21YcMGrV69WnFxcVqxYoUiIyPVtm3bbPvq2LGjNm3apIULF+rvv/9WTEyMtm7dqgULFkiS/Pz8lJaWpp9//lmnTp3Spk2btGbNmny5jsqVKysgIEBLly6VJAUHB+uHH37QqlWrFBsbqxMnTmj9+vVasWJFhvN++eUXRUZG6uTJk5oxY4aSkpLs6y5XqlRJrq6umj9/vuLj47VlyxZt2LAh09hms1nh4eGKjo7WgQMHNHPmTDVs2PC2y05I19dObtq0qb788ktFRkYqISFB+/bt07Zt227Z3mKxqF69epo2bZoOHjyo6OhoTZ48WcWLF1e9evVyd9MAAAAAAAAA3FX33NITNytRooTCwsLsy1AMHz5coaGhWr58uWbOnClfX1/1799f1atXz7af2rVra+jQoVq8eLGWLVsmZ2dnlS5dWk899ZQkKTAwUD179tSyZcv03XffqVq1anrxxRf1xRdfZOgnODhY/fv3z/DSuZxo3bq1pkyZonbt2ql58+Zyc3PTjz/+qHnz5snNzU3lypXL8DI9SXrxxRf1ww8/KDo6Wn5+fhoyZIiKFi0q6frL4N544w3NmzdP69atU40aNdS5c2d99dVXGfrw8/NT/fr1NXbsWF2+fFl169bN1cv5+vTpo/nz52vGjBm6dOmSSpYsqfbt22fZvn///po1a5Y+/vhjpaamqlq1anrvvffk4nJPf80AAAAAAAAAwzPZ/rnYLW4pISFBb731lj799FNZLJYCHef111/X+PHjFRgYWGDj3G/2D39DydHHHF0G8sAyYbqjS0AemEwmWSwWxcXFZVoTHUDB4vkDHINnD3Acnj/AMXj2jMNsNsvHx+e27e7ZpSfuNTt27FDz5s0LNCQGAAAAAAAAAEdgTYAcevbZZx1dAgAAAAAAAAAUCILie4yvr68iIiIcXQYAAAAAAAAAA2HpCQAAAAAAAAAwOIJiAAAAAAAAADA4gmIAAAAAAAAAMDiCYgAAAAAAAAAwOIJiAAAAAAAAADA4gmIAAAAAAAAAMDgXRxcA5ITPwA9ktVodXQYAAAAAAADwQGJGMQAAAAAAAAAYHEExAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABgcQTEAAAAAAAAAGBxBMQAAAAAAAAAYHEExAAAAAAAAABici6MLAHLi9KQPlRx9zNFl4P+zTJju6BIAAAAAAACQj5hRDAAAAAAAAAAGR1AMAAAAAAAAAAZHUAwAAAAAAAAABkdQDAAAAAAAAAAGR1AMAAAAAAAAAAZHUAwAAAAAAAAABkdQDAAAAAAAAAAGR1AMAAAAAAAAAAZHUAwAAAAAAAAABkdQDAAAAAAAAAAGR1D8gAsPD9f48eNzdc6AAQO0cuXKAqoIAAAAAAAAwL3GxdEFIGvh4eHauHGjfdvT01MVKlRQ9+7dFRAQUGDjjh07Vm5ubgXWPwAAAAAAAIB7C0HxPa527drq37+/JOn8+fNasGCBPv74Y3355ZcFNmbRokULrG8AAAAAAAAA9x6WnrjHubi4yMvLS15eXgoMDNQLL7ygM2fO6OLFi5KkxMREffrppwoJCVFoaKjGjx+vhISELPtLTk7W559/rh49euiVV17RihUrFBYWplmzZtnb3Lz0REJCgoKDgxUdHW0/npSUpODgYO3bt0+StG/fPgUHB2vXrl0aMmSIXnrpJY0aNUoXLlzQzp079fbbb6tXr1767LPPdPXq1fy/SQAAAAAAAADuCDOK7yMpKSnatGmT/Pz85OnpqdTUVI0ePVqVK1fWhx9+KCcnJy1ZskRjxozRxIkT5eKS+dc7e/ZsHTp0SEOGDFGxYsUUERGh48ePKzAw8I7rW7hwoV5++WW5ubnpP//5j/7zn//IbDbrzTffVEpKiiZOnKiffvpJL7zwQpZ9WK1WWa1W+7bJZJK7u/sd1wYAAAAAAAAgawTF97gdO3aoR48ekqSrV6/K29tbQ4cOlZOTk7Zs2SKbzabXXntNJpNJktS/f3+FhIRo3759evjhhzP0lZycrI0bN+qtt95SzZo17e1fffXVfKm1a9euqlq1qiTpqaee0nfffafJkyerVKlSkqT69etr37592QbFS5cu1aJFi+zbQUFBGjduXL7UBwAAAAAAAODWCIrvcdWrV1ffvn0lSZcvX9bq1as1duxYjRkzRn/99Zfi4+PVs2fPDOdYrVadOnUqU1+nTp1SWlqaKlasaN/n4eEhf3//fKn15hfsFStWTG5ubvaQWJK8vLx07NixbPto37692rRpY9++EYADAAAAAAAAKDgExfc4Nzc3+fn52bfLly+vXr16ad26dUpJSVH58uX15ptvZjovv15I5+R0fRlrm81m35eWlnbLts7OzvbPJpMpw/YN6enp2Y5nNptlNpvzUioAAAAAAACAPOJldvchJycnXbt2TUFBQYqLi1PRokXl5+eX4cfDwyPTeaVKlZKzs7OOHj1q33flyhXFxsZmOdaNwPncuXP2fTe/2A4AAAAAAADA/Y8Zxfe41NRUnT9/XtL1pSd+/vlnpaSkqG7duqpYsaKWL1+uCRMmKDg4WCVKlNDp06f13//+V+3atVOJEiUy9OXu7q6mTZtq3rx58vT0tL/M7sas4VtxdXVVpUqVtGzZMvn6+urixYtasGBBQV4yAAAAAAAAgLuMoPget2vXLr3yyiuSrge9/v7+evvtt1W9enVJ0qhRozRv3jxNnDhRKSkpKl68uGrUqCF3d/db9terVy99/fXXGjdunNzd3fX888/rzJkzcnV1zbKGfv36aerUqfrXv/4lf39/de/eXf/+97/z/2IBAAAAAAAAOITJdvPiszCclJQUvfbaa+rZs6eeeuopR5eTpf3D31BydPYvwsPdY5kw3dEloICZTCZZLBbFxcWJPxPA3cXzBzgGzx7gODx/gGPw7BmH2WyWj4/Pbdsxo9hgjh8/rpMnT6pixYq6cuWKFi1aJEmqV6+egysDAAAAAAAA4CgExQa0fPlyxcbGysXFReXLl9eHH35of2kdAAAAAAAAAOMhKDaYoKAgjRs3ztFlAAAAAAAAALiHODm6AAAAAAAAAACAYxEUAwAAAAAAAIDBERQDAAAAAAAAgMERFAMAAAAAAACAwREUAwAAAAAAAIDBERQDAAAAAAAAgMG5OLoAICd8Bn4gq9Xq6DIAAAAAAACABxIzigEAAAAAAADA4AiKAQAAAAAAAMDgCIoBAAAAAAAAwOAIigEAAAAAAADA4AiKAQAAAAAAAMDgCIoBAAAAAAAAwOAIigEAAAAAAADA4AiKAQAAAAAAAMDgXBxdAJATpyd9qOToY44u455mmTDd0SUAAAAAAADgPsWMYgAAAAAAAAAwOIJiAAAAAAAAADA4gmIAAAAAAAAAMDiCYgAAAAAAAAAwOIJiAP+vvXuPi6rO/zj+nmEAuekgSoIIeEO6eMFddbutFhbeyswWTctW0y6o1ZbVlv6KTCkzWy01TXHzmvLwsd7LLlZkXlbKKNFCUVFREUjQQBFw5vdHD882qSioDHZez8ejR5xzvuecz5n8NGfefucAAAAAAAAAkyMoBgAAAAAAAACTIygGAAAAAAAAAJMjKAYAAAAAAAAAkyMoBgAAAAAAAACTIygGAAAAAAAAAJMjKEa1xcfHa8uWLZKkvLw8xcfHKzs7271FAQAAAAAAAKgym7sLgHtMmzZNJSUleu655y7L8Ro0aKD33ntPAQEBl+V4AAAAAAAAAGoOQTEuC6vVKrvd7u4yAAAAAAAAAFQDQTGUmJio8PBweXl5ad26dbLZbLrjjjsUHx9vjDl8+LBmzJihrKwsBQcHa/DgwS7HyMvL04gRI/TGG28oMjJSDodDM2fOVEZGhoqKitSgQQPFxcWpR48eNX15AAAAAAAAAC6AoBiSpNTUVPXq1UtJSUnauXOnpk+frujoaLVp00YOh0Nvvvmm7Ha7xo8frxMnTmju3LmVHs/hcCgoKEhPP/20AgIClJmZqffee092u1033XTTefcrLy9XeXm5sWyxWOTj43PZrhMAAAAAAADA2QiKIUmKiIjQ3/72N0lSSEiI1q5dq23btqlNmzbatm2bDh06pNGjR6t+/fqSpPvvv19JSUnnPZ7NZnOZkRwcHKydO3dq06ZNlQbFy5Yt09KlS43lpk2basKECZd6eQAAAAAAAAAqQVAMSVJ4eLjLcmBgoI4dOyZJOnjwoIKCgoyQWJKioqIueMy1a9fqiy++UEFBgcrKylRRUaHIyMhK9+nTp4969eplLFsslipcBQAAAAAAAIDqICiGpF9nAP+e0+ms9vE2bNig+fPna9CgQYqKipKPj49WrlypXbt2Vbqfp6enPD09q31eAAAAAAAAAFVHUIwLaty4sX7++WcVFhYqMDBQkrRz585K98nMzFSrVq0UFxdnrDty5MgVrRMAAAAAAABA9VjdXQBqv9atWyskJETTpk1Tdna2fvzxRy1evLjSfRo1aqTdu3crPT1dhw4d0uLFi5WVlVVDFQMAAAAAAACoCoJiXJDVatWoUaNUVlamF198UTNmzFD//v0r3eeOO+5Qp06dNHnyZI0ePVrFxcUus4sBAAAAAAAA1B4W56U8iBaoITtGj9TJ7N3uLqNWC5k4290l4A/EYrEoJCREhw8fvqTnlQOoOvoPcA96D3Af+g9wD3rPPDw9PdWwYcMLjmNGMQAAAAAAAACYHEExAAAAAAAAAJgcQTEAAAAAAAAAmBxBMQAAAAAAAACYHEExAAAAAAAAAJgcQTEAAAAAAAAAmBxBMQAAAAAAAACYHEExAAAAAAAAAJgcQTEAAAAAAAAAmJzN3QUAF6PhUy+pvLzc3WUAAAAAAAAAf0jMKAYAAAAAAAAAkyMoBgAAAAAAAACTIygGAAAAAAAAAJMjKAYAAAAAAAAAkyMoBgAAAAAAAACTIygGAAAAAAAAAJMjKAYAAAAAAAAAkyMoBgAAAAAAAACTs7m7AOBi5E8eq5PZu91dRq0UMnG2u0sAAAAAAADAVY4ZxQAAAAAAAABgcgTFAAAAAAAAAGByBMUAAAAAAAAAYHIExQAAAAAAAABgcgTFAAAAAAAAAGByBMUAAAAAAAAAYHIExQAAAAAAAABgcgTFAAAAAAAAAGByBMUAAAAAAAAAYHIExQAAAAAAAABgcgTFtciXX36pv//971fdsX8rLy9P8fHxys7OvuLnAgAAAAAAAHB5EBRX0bRp0xQfH6/ly5e7rN+yZYvi4+Mv+jjDhw/XmjVrLnN1AAAAAAAAAFB1BMXV4OnpqRUrVqi4uNjdpVyUiooKd5cAAAAAAAAAoBazubuAq1Hr1q115MgRLV++XA888MA5x/z0009atGiRdu/erbp166pDhw4aMGCA6tSpo8TEROXn52vu3LmaO3euJCklJcXYNz09XXPnzlVBQYGio6OVkJCgwMBAY/u6deu0evVq5eXlqWHDhurevbvi4uIk/frohxEjRuipp57Sxx9/rKysLA0bNuys+nJzczVv3jzt2rVLpaWlCgsL0/333682bdoYY4YPH67Y2Fjl5uZq8+bN8vPzU9++fdW1a1djTFZWlt577z0dPHhQTZo00b333utynuLiYs2ZM0fff/+9SktLFRQUpD59+ui2226rxisPAAAAAAAA4EogKK4Gq9Wq+++/X1OmTFH37t0VFBTksj03N1fjx49X//799fjjj+v48eOaM2eO5syZo4SEBI0aNUrPPvusYmNjXUJXSTp16pRWrVqlESNGyGKx6J133tH8+fP1xBNPSJLWr1+vlJQUDRkyRE2bNtXevXs1c+ZMeXt7q0uXLsZxFi5cqEGDBqlp06by9PTU999/73Ke0tJSxcTEqH///vL09FRqaqomTJigKVOmqEGDBsa41atXq1+/frr33nu1efNmzZo1S9ddd51CQ0NVWlqq119/XW3atNHIkSOVl5en999/3+U8S5YsUU5Ojl588UUFBAQoNzdXZWVl531ty8vLVV5ebixbLBb5+Phc1H8XAAAAAAAAANVDUFxNHTt2VGRkpFJSUvT444+7bFu+fLluvfVW9ezZU5IUEhKiwYMH6+WXX9bQoUPl7+8vq9UqHx8f2e12l31Pnz6tYcOGqVGjRpKkbt26aenSpcb2lJQUPfjgg+rUqZMkKTg4WDk5Ofrss89cguKePXsaY84lMjJSkZGRxnL//v2Vlpamb775Rt26dTPWx8TEGLOVe/furTVr1igjI0OhoaH6+uuv5XQ69dhjj8nLy0tNmjTRzz//rNmzZxv7FxQUKDIyUs2bNzfqrcyyZctcrrdp06aaMGFCpfsAAAAAAAAAuDQExZdg4MCBGjt2rO666y6X9fv27dO+ffu0fv16l/VOp1N5eXkKCws77zG9vb2NkFiSAgMDdfz4cUm/zgI+cuSIZsyYoZkzZxpjHA6HfH19XY7TrFmzSmsvLS1VSkqKvvvuOxUWFur06dMqKytTQUGBy7iIiAjjZ4vFIrvdbtSTk5Oj8PBweXl5GWOioqJc9r/zzjs1adIk7d27V23btlWHDh3UqlWr89bVp08f9erVy+WcAAAAAAAAAK4sguJLcN1116lt27ZatGiRy2ze0tJSde3aVT169Dhrn98+1uFcPDw8zlrndDqN40rSo48+qpYtW7qMsVpdfy9hnTp1Kj3PvHnztG3bNj344INq1KiRvLy8NGnSpLN+8d256nE4HJUe+7diYmI0ffp0bd26VT/88IPGjh2ruLg4DRo06JzjPT095enpedHHBwAAAAAAAHDpCIov0cCBA/Xss88qNDTUWNe0aVMdPHjQZWbw79lstioFrpJkt9sVGBioI0eO6NZbb612zZKUmZmpzp07q2PHjpJ+DaHz8/OrdIywsDCtX79eZWVlxqziXbt2nTWubt266tKli7p06aJPP/1UCxYsOG9QDAAAAAAAAKDmWS88BJUJDw/Xrbfeqo8++shY17t3b2VmZio5OVnZ2dk6fPiw0tLSlJycbIxp2LChfvzxRx09etR4lMPFiI+P1/Lly/Xhhx/q0KFD2r9/v7744gutXr26SnWHhIRoy5Ytys7OVnZ2tqZMmWLMXL5Yt9xyiyRp5syZysnJ0datW7Vq1SqXMUuWLFFaWppyc3N14MABffvtt2rcuHGVzgMAAAAAAADgymJG8WUQHx+vjRs3GssRERFKTEzU4sWL9dJLL8npdKpRo0a68cYbXfaZNWuWRo4cqfLycqWkpFzUuWJjY+Xt7a2VK1dqwYIF8vb2Vnh4uPGL8y7WoEGD9O6772rMmDEKCAhQ7969dfLkySodo06dOnr++ec1a9YsPffccwoLC9PAgQM1adIkY4zNZtOiRYuUn58vLy8vRUdH66mnnqrSeQAAAAAAAABcWRZnVaeRAm6wY/RIncze7e4yaqWQibPdXQL+gCwWi0JCQnT48OEqf9sAwKWh/wD3oPcA96H/APeg98zD09NTDRs2vOA4Hj0BAAAAAAAAACZHUAwAAAAAAAAAJkdQDAAAAAAAAAAmR1AMAAAAAAAAACZHUAwAAAAAAAAAJkdQDAAAAAAAAAAmR1AMAAAAAAAAACZHUAwAAAAAAAAAJkdQDAAAAAAAAAAmR1AMAAAAAAAAACZnc3cBwMVo+NRLKi8vd3cZAAAAAAAAwB8SM4oBAAAAAAAAwOQIigEAAAAAAADA5AiKAQAAAAAAAMDkCIoBAAAAAAAAwOQIigEAAAAAAADA5AiKAQAAAAAAAMDkCIoBAAAAAAAAwORs7i4AuBj5k8fqZPZud5dRq4RMnO3uEgAAAAAAAPAHwYxiAAAAAAAAADA5gmIAAAAAAAAAMDmCYgAAAAAAAAAwOYJiAAAAAAAAADA5gmIAAAAAAAAAMDmCYgAAAAAAAAAwOYJiAAAAAAAAADA5gmIAAAAAAAAAMDmCYgAAAAAAAAAwOYJiAAAAAAAAADA5gmJcMcOHD9eaNWvcXQYAAAAAAACAC7C5uwCzmzZtmlJTUyVJHh4e8vf3V3h4uG6++WZ16dJFVitZPgAAAAAAAIAri6C4FmjXrp0SEhLkcDhUVFSk9PR0vf/++/rvf/+r5557Th4eHu4usUoqKipks/FHCwAAAAAAALhakObVAjabTXa7XZJUv359NWvWTFFRURo7dqy+/PJLxcbGqqSkRPPnz1daWpoqKirUrFkzPfTQQ4qMjJQkpaSkKC0tTXfddZeWLFmi4uJixcTE6NFHH5WPj48kKTExUeHh4bJarUpNTZXNZlO/fv10yy23aM6cOdq8ebPq1aunIUOGKCYmRpLkcDg0c+ZMZWRkqKioSA0aNFBcXJx69Ohh1D9t2jSVlJSoRYsW+vjjj2Wz2TRt2rSzrnPdunWaP3++nnnmGbVu3frKvqgAAAAAAAAALhpBcS11ww03KCIiQlu2bFFsbKzeeusteXl56cUXX5Svr68+/fRTvfrqq5oyZYr8/f0lSUeOHNGWLVv0/PPPq6SkRP/617+0fPly3X///cZxU1NTdffddyspKUkbN27U7NmzlZaWpg4dOqhPnz5as2aNpk6dqunTp8vb21sOh0NBQUF6+umnFRAQoMzMTL333nuy2+266aabjONmZGTI19dXY8aMOef1rFixQitXrtSYMWPUokWL8153eXm5ysvLjWWLxWIE3QAAAAAAAACuDILiWqxx48bat2+ffvrpJ2VlZWn27Nny9PSUJA0aNEhpaWnavHmzunbtKklyOp0aPny4Eaz+9a9/VUZGhssxIyIi1LdvX0lSnz59tHz5cgUEBBjHuO+++/TJJ59o3759ioqKks1mU3x8vLF/cHCwdu7cqU2bNrkExd7e3nrsscfO+ciJBQsWaP369UpMTFSTJk0qveZly5Zp6dKlxnLTpk01YcKEi37NAAAAAAAAAFQdQXEt5nQ6ZbFYlJ2drdLSUg0ZMsRle1lZmXJzc43lhg0busy+tdvtOnbsmMs+4eHhxs9Wq1UBAQEu6+rVqydJOn78uLFu7dq1+uKLL1RQUKCysjJVVFQYj7z47XHPFRKvXr1apaWlev3113XNNddc8Jr79OmjXr16GcsWi+WC+wAAAAAAAAC4NATFtdjBgwcVHBys0tJSBQYGKjEx8awxvr6+xs+//6V3FotFTqfTZd3vw1yLxeKy35lg1uFwSJI2bNig+fPna9CgQYqKipKPj49WrlypXbt2uRzH29v7nNcQHR2trVu3atOmTbrnnnsqv2BJnp6exqxpAAAAAAAAADWDoLiWysjI0P79+9WzZ08FBQWpqKhIVqtVwcHBNVpHZmamWrVqpbi4OGPdkSNHLnr/Fi1aqFu3bkpKSpLVatXdd999JcoEAAAAAAAAcAkIimuBiooKFRUVyeFwqKioSOnp6Vq+fLnat2+vzp07y2KxKCoqShMnTtQDDzygkJAQFRYWauvWrerYsaOaN29+xWpr1KiRUlNTlZ6eruDgYH311VfKysqqUmDdqlUrvfDCC0pKSpKHh4d69ux5xeoFAAAAAAAAUHUExbVAenq6HnnkEXl4eMjPz08REREaPHiwOnfuLKvVKkl64YUX9MEHH2j69Ok6fvy47Ha7rr32WuOZwlfKHXfcoezsbE2ePFkWi0U333yz4uLi9N1331XpONHR0frnP/+p1157TVarVd27d79CFQMAAAAAAACoKovz9w+xBWqhHaNH6mT2bneXUauETJzt7hLwB2axWBQSEqLDhw+f9axzAFcW/Qe4B70HuA/9B7gHvWcenp6eatiw4QXHWWugFgAAAAAAAABALUZQDAAAAAAAAAAmR1AMAAAAAAAAACZHUAwAAAAAAAAAJkdQDAAAAAAAAAAmR1AMAAAAAAAAACZHUAwAAAAAAAAAJkdQDAAAAAAAAAAmR1AMAAAAAAAAACZHUAwAAAAAAAAAJmdzdwHAxWj41EsqLy93dxkAAAAAAADAHxIzigEAAAAAAADA5AiKAQAAAAAAAMDkePQErgo2G39UAXeg9wD3of8A96D3APeh/wD3oPf++C72v7HF6XQ6r3AtQLWVl5fL09PT3WUAAAAAAAAAf2g8egK1Wnl5uaZMmaKTJ0+6uxTAVE6ePKnnn3+e3gPcgP4D3IPeA9yH/gPcg97D7xEUo9bbsGGDmPgO1Cyn06m9e/fSe4Ab0H+Ae9B7gPvQf4B70Hv4PYJiAAAAAAAAADA5gmIAAAAAAAAAMDmCYtRqnp6euu+++/iFdkANo/cA96H/APeg9wD3of8A96D38HsWJw8iAQAAAAAAAABTY0YxAAAAAAAAAJgcQTEAAAAAAAAAmBxBMQAAAAAAAACYHEExAAAAAAAAAJiczd0FAOezdu1arVq1SkVFRYqIiNCQIUPUokULd5cFXDVSUlK0dOlSl3WhoaGaPHmyJKmsrEzz5s3Txo0bVV5errZt22ro0KGy2+3G+IKCAs2aNUvbt29XnTp11LlzZw0YMEAeHh7GmO3bt2vevHk6cOCAgoKC1LdvX3Xp0qUGrhCoHXbs2KGVK1dq7969Kiws1KhRo9SxY0dju9PpVEpKitatW6eSkhJFR0dr6NChCgkJMcYUFxdrzpw5+vbbb2WxWNSpUycNHjxYderUMcbs27dPycnJ2r17t+rWratu3bqpd+/eLrVs2rRJS5YsUX5+vho1aqSBAweqffv2V/5FANzkQv03bdo0paamuuzTtm1bjR492lim/4CqW7ZsmbZs2aKDBw/Ky8tLUVFReuCBBxQaGmqMqcl7TT47wiwupvcSExO1Y8cOl/26du2qRx55xFim93A+BMWolTZu3Kh58+Zp2LBhatmypdasWaPx48dr8uTJqlevnrvLA64aTZo00f/93/8Zy1br/75IMnfuXG3dulVPP/20fH19lZycrEmTJunVV1+VJDkcDr322muy2+0aN26cCgsLNXXqVHl4eGjAgAGSpLy8PL3++uu64447NHLkSGVkZGjGjBmy2+1q165djV4r4C6nTp1SZGSkbr/9dr355ptnbV+xYoU++ugjDR8+XMHBwVqyZInGjx+vt956S15eXpKkt99+W4WFhRozZoxOnz6t6dOna+bMmXryySclSSdOnNC4cePUunVrDRs2TPv379e7774rPz8/de3aVZKUmZmpKVOmaMCAAWrfvr2+/vprTZw4URMmTFB4eHjNvSBADbpQ/0lSu3btlJCQYCzbbK4fgeg/oOp27NihuLg4NW/eXKdPn9YHH3ygcePG6a233jL+kqWm7jX57AgzuZjek6TY2Fj169fPWD5zzynRe6gcj55ArbR69WrFxsbqtttuU1hYmIYNGyYvLy998cUX7i4NuKpYrVbZ7Xbjn7p160r69UPv559/roceekg33HCDmjVrpoSEBGVmZmrnzp2SpO+//145OTkaOXKkIiMjFRMTo379+unjjz9WRUWFJOmTTz5RcHCwBg0apLCwMHXr1k1/+ctftGbNGrddM1DTYmJi1L9/f5dZjGc4nU59+OGHuvfee9WhQwdFRERoxIgRKiwsVFpamiQpJydH6enpeuyxx9SyZUtFR0dryJAh2rhxo44ePSpJ+vrrr1VRUaGEhAQ1adJEN998s7p3767Vq1cb5/rwww/Vrl073X333QoLC1P//v3VrFkzrV27tmZeCMANKuu/M2w2m8t7ob+/v7GN/gOqZ/To0erSpYuaNGmiyMhIDR8+XAUFBdqzZ4+kmr3X5LMjzORCvXeGt7e3y3ufr6+vsY3eQ2UIilHrVFRUaM+ePWrdurWxzmq1qnXr1sZNBYCLk5ubq0cffVQjRozQ22+/rYKCAknSnj17dPr0aZc+a9y4sRo0aGD02c6dOxUeHu7y9cB27drp5MmTOnDggCRp165dLseQfv1KL70K/CovL09FRUVq06aNsc7X11ctWrRw6TU/Pz81b97cGNO6dWtZLBZlZWUZY6699lqXmZBt27bVoUOHVFxcbIw5Vz/u2rXril0fcDXYsWOHhg4dqieffFKzZs3SL7/8Ymyj/4DL48SJE5Jk/EVMTd1r8tkRZvf73jtj/fr1evjhh/XMM89o0aJFOnXqlLGN3kNlePQEap3jx4/L4XC4/E9Lkux2uw4dOuSeooCrUMuWLZWQkKDQ0FAVFhZq6dKleumllzRp0iQVFRXJZrPJz8/PZZ969eqpqKhIklRUVHRWH575CtFvx/z+a0X16tXTyZMnVVZW5vIVJ8CMzvTKufrkt310Zrb/GR4eHvL393cZExwc7DLmTH8WFRUZYys7D2BG7dq1U6dOnRQcHKzc3Fx98MEHSkpK0vjx42W1Wuk/4DJwOBx6//331apVK+NRKzV1r1lcXMxnR5jWuXpPkm655RY1aNBA9evX1759+7Rw4UIdOnRIo0aNkkTvoXIExQDwBxUTE2P8HBERYQTHmzZtIsAFAJjCzTffbPwcHh6uiIgIjRw5Utu3bz9rphSA6klOTtaBAwc0duxYd5cCmMr5eu/M8/OlX9/7AgMDNXbsWOXm5qpRo0Y1XSauMjx6ArVO3bp1jRkev3Wuv/UCcPH8/PwUGhqq3Nxc2e12VVRUqKSkxGXMsWPHjD6z2+1n9eGxY8eMbWf+fWbdb8f4+PgQRgP6X6+cq09+20fHjx932X769GkVFxdX2o9nli/Uj7x3Av9zzTXXKCAgQLm5uZLoP+BSJScna+vWrXr55ZcVFBRkrK+pe00+O8Ksztd759KiRQtJcnnvo/dwPgTFqHVsNpuaNWumjIwMY53D4VBGRoaioqLcWBlwdSstLTVC4mbNmsnDw0Pbtm0zth86dEgFBQVGn0VFRWn//v0uNwg//PCDfHx8FBYWJunXx1v89hhnxtCrwK+Cg4Nlt9td+uTEiRPKyspy6bWSkhKXX0KSkZEhp9Np3NhHRUXpxx9/NH7BiPRrr4WGhhrPpIuKijpnP7Zs2fKKXR9wtfn5559VXFyswMBASfQfUF1Op1PJycnasmWLXnrppbMez1JT95p8doTZXKj3ziU7O1uSXN776D2cD0ExaqVevXpp3bp1+vLLL5WTk6PZs2fr1KlT6tKli7tLA64a8+bN044dO5SXl6fMzExNnDhRVqtVt9xyi3x9fXX77bdr3rx5ysjI0J49ezR9+nRFRUUZb+xt27ZVWFiYpk6dquzsbKWnp2vx4sWKi4uTp6enJOnOO+9UXl6eFixYoIMHD+rjjz/Wpk2b1LNnT3deOlCjSktLlZ2dbdyE5+XlKTs7WwUFBbJYLOrRo4f+85//6JtvvtH+/fs1depUBQYGqkOHDpKksLAwtWvXTjNnzlRWVpZ++uknzZkzRzfddJPq168v6ddnzdlsNs2YMUMHDhzQxo0b9dFHH6lXr15GHT169ND333+vVatW6eDBg0pJSdHu3bvVrVu3Gn9NgJpSWf+VlpZq/vz52rlzp/Ly8rRt2za98cYbatSokdq2bSuJ/gOqKzk5WevXr9eTTz4pHx8fFRUVqaioSGVlZZJUo/eafHaEmVyo93Jzc7V06VLt2bNHeXl5+uabbzRt2jRde+21ioiIkETvoXIWp9PpdHcRwLmsXbtWK1euVFFRkSIjIzV48GBmZQBVMHnyZP3444/65ZdfVLduXUVHR6t///7Gc6nKyso0b948bdiwQRUVFWrbtq2GDh3q8lWh/Px8zZ49W9u3b5e3t7c6d+6sgQMHysPDwxizfft2zZ07Vzk5OQoKClLfvn25OYCpbN++Xa+88spZ6zt37qzhw4fL6XQqJSVFn332mU6cOKHo6Gg9/PDDCg0NNcYWFxcrOTlZ3377rSwWizp16qQhQ4aoTp06xph9+/YpOTlZu3fvVkBAgLp166Z77rnH5ZybNm3S4sWLlZ+fr5CQEA0cOFDt27e/YtcOuFtl/Tds2DBNnDhRe/fuVUlJierXr682bdqoX79+Lu919B9QdfHx8edcn5CQYNwH1uS9Jp8dYRYX6r2CggK98847OnDggE6dOqWgoCB17NhR9957r3x9fY3x9B7Oh6AYAAAAAAAAAEyOR08AAAAAAAAAgMkRFAMAAAAAAACAyREUAwAAAAAAAIDJERQDAAAAAAAAgMkRFAMAAAAAAACAyREUAwAAAAAAAIDJERQDAAAAAAAAgMkRFAMAAAAAAACAyREUAwAAAAAAAIDJERQDAAAAcLujR48qJSVF2dnZ7i4FAADAlAiKAQAAALhdYWGhli5dSlAMAADgJgTFAAAAAAAAAGByFqfT6XR3EQAAAABqxtGjR7VkyRKlp6frl19+UWBgoNq1a6fBgwfLZrPpyJEjWrhwobZt26by8nJFRESob9++at++vXGML7/8UtOnT9fUqVMVHBxsrN++fbteeeUVvfzyy7r++uslSYmJifrll1/0j3/8Q8nJydq1a5f8/PzUo0cP9e7d22W/30tISFCXLl2u7AsCAAAASZLN3QUAAAAAqBlHjx7VCy+8oBMnTig2NlaNGzfW0aNHtXnzZp06dUrFxcUaM2aMysrK1L17d/n7+ys1NVUTJkzQM888o44dO1brvMXFxRo/frw6deqkG2+8UZs3b9bChQsVHh6umJgYNW7cWPHx8UpJSVHXrl0VHR0tSWrVqtXlvHwAAABUgqAYAAAAMIlFixapqKhISUlJat68ubG+X79+cjqdmjt3ro4dO6axY8caYW3Xrl01atQozZ07V3/+859ltVb96XWFhYUaMWKE/vrXv0qSbr/9diUkJOjzzz9XTEyM7Ha7YmJilJKSoqioKGMcAAAAag7PKAYAAABMwOFwKC0tTX/6059cQuIzLBaLvvvuO7Vo0cIIiSWpTp066tq1q/Lz85WTk1Otc9epU0e33nqrsWyz2dSiRQvl5eVV63gAAAC4/AiKAQAAABM4fvy4Tp48qfDw8POOKSgoUGho6FnrGzdubGyvjqCgIFksFpd1fn5+Ki4urtbxAAAAcPkRFAMAAAC4LBwOxznXV+dxFQAAAKhZ3LEBAAAAJlC3bl35+Pho//795x3ToEEDHTp06Kz1Bw8eNLZLkr+/vyTpxIkTLuPy8/OrXd/vZxwDAACgZhEUAwAAACZgtVrVoUMHffvtt9q9e/dZ251Op2JiYpSVlaWdO3ca60tLS7Vu3To1bNhQYWFhkqRrrrlGkrRjxw5jnMPh0Lp166pdn7e3tySppKSk2scAAABA9dncXQAAAACAmjFgwAD98MMPSkxMVGxsrMLCwlRYWKjNmzdr7Nixuueee7RhwwYlJSWpe/fu8vf3V2pqqvLy8vTMM88Yj5Bo0qSJWrZsqQ8++EDFxcXy9/fXxo0bdfr06WrXds0118jPz0+ffvqpfHx85O3trZYtWyo4OPhyXT4AAAAqwYxiAAAAwCTq16+vpKQkderUSV9//bX+/e9/66uvvtJ1110nb29v2e12jRs3Tm3atNHatWu1aNEi2Ww2Pf/88+rYsaPLsZ544glFRUVpxYoVWrZsma6//noNGDCg2rXZbDYNHz5cVqtVs2bN0pQpU1xmLAMAAODKsjidTqe7iwAAAAAAAAAAuA8zigEAAAAAAADA5AiKAQAAAAAAAMDkCIoBAAAAAAAAwOQIigEAAAAAAADA5AiKAQAAAAAAAMDkCIoBAAAAAAAAwOQIigEAAAAAAADA5AiKAQAAAAAAAMDkCIoBAAAAAAAAwOQIigEAAAAAAADA5AiKAQAAAAAAAMDkCIoBAAAAAAAAwOT+Hyl1o2p/KeBOAAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 1600x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "colss = [\"Primary Purpose\",\"country\",\"interven_summary\",\"Study Status\",\"Sponsor\",\"category\",\"Age\"]\n",
    "\n",
    "# plotting the distribution of the above columns\n",
    "for col in colss:\n",
    "    hoz_plot(df,col,limit=15)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 357,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "cols = [\"Study Results\",\"Sex\",\"Study Type\"]\n",
    "\n",
    "for col in cols:\n",
    "    pie_chart(df,col)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 358,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['NCT Number', 'Study Title', 'Study URL', 'Study Status',\n",
       "       'Brief Summary', 'Study Results', 'Conditions', 'Interventions',\n",
       "       'Primary Outcome Measures', 'Secondary Outcome Measures', 'Sponsor',\n",
       "       'Sex', 'Age', 'Enrollment', 'Funder Type', 'Study Type', 'Study Design',\n",
       "       'Start Date', 'Completion Date', 'Last Update Posted', 'Locations',\n",
       "       'category', 'start_year', 'completion_year', 'last_year_posted',\n",
       "       'duration', 'Primary Purpose', 'country', 'description',\n",
       "       'interven_summary', 'type'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 358,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Bivariate Analysis\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 359,
   "metadata": {},
   "outputs": [],
   "source": [
    "# plotting top 10 by certain categories\n",
    "def bar_plot(df,column1,column2):\n",
    "    \"\"\"A function that plot an horizontal bar graph\"\"\"\n",
    "\n",
    "    viz_df = df.groupby([column1])[column2].sum().sort_values(ascending=False).head(10)\n",
    "\n",
    "# Extract the data for x (countries) and y (Enrollment values)\n",
    "    x = viz_df.index\n",
    "    y = viz_df.values\n",
    "\n",
    "# Choose a sequential colormap (e.g., 'Blues')\n",
    "    cmap = cm.get_cmap('Blues')\n",
    "\n",
    "# Create a horizontal bar plot with the chosen colormap\n",
    "    plt.figure(figsize=(16,8))  # Adjust the figure size as needed\n",
    "    bars = plt.barh(x, y, color=cmap(y / max(y)))\n",
    "    plt.xlabel(f\"Total {column1}\")\n",
    "    plt.ylabel(f\"{column2}\")\n",
    "    plt.title(f\"Top 10 {column1} by Total {column2}\",loc=\"left\")\n",
    "    plt.gca().invert_yaxis()  # Reverse the order to show the highest value at the top\n",
    "\n",
    "# Create a ScalarMappable object and specify the color normalization\n",
    "    norm = Normalize(vmin=min(y), vmax=max(y))\n",
    "    sm = plt.cm.ScalarMappable(cmap=cmap, norm=norm)\n",
    "    sm.set_array([])\n",
    "\n",
    "# Specify the axes for the colorbar\n",
    "    cbar = plt.colorbar(sm, ax=plt.gca())\n",
    "\n",
    "\n",
    "\n",
    "# plotting top 10 by certain categories\n",
    "def bar_plot_avg(df,column1,column2):\n",
    "    \"\"\"A function that plot an horizontal bar graph\"\"\"\n",
    "\n",
    "    viz_df = df.groupby([column1])[column2].mean().sort_values(ascending=False).head(10)\n",
    "\n",
    "# Extract the data for x (countries) and y (Enrollment values)\n",
    "    x = viz_df.index\n",
    "    y = viz_df.values\n",
    "\n",
    "# Choose a sequential colormap (e.g., 'Blues')\n",
    "    cmap = cm.get_cmap('Blues')\n",
    "\n",
    "# Create a horizontal bar plot with the chosen colormap\n",
    "    plt.figure(figsize=(16,8))  # Adjust the figure size as needed\n",
    "    bars = plt.barh(x, y, color=cmap(y / max(y)))\n",
    "    plt.xlabel(f\"Total {column1}\")\n",
    "    plt.ylabel(f\"{column2}\")\n",
    "    plt.title(f\"Top 10 {column1} by Total {column2}\",loc=\"left\")\n",
    "    plt.gca().invert_yaxis()  # Reverse the order to show the highest value at the top\n",
    "\n",
    "# Create a ScalarMappable object and specify the color normalization\n",
    "    norm = Normalize(vmin=min(y), vmax=max(y))\n",
    "    sm = plt.cm.ScalarMappable(cmap=cmap, norm=norm)\n",
    "    sm.set_array([])\n",
    "\n",
    "# Specify the axes for the colorbar\n",
    "    cbar = plt.colorbar(sm, ax=plt.gca())\n",
    "\n",
    "\n",
    "# creating a stacked bar to show relationship\n",
    "def stacked_bar(df,column1,column2):\n",
    "    plt.style.use(\"ggplot\")\n",
    "    # Calculate the percentages within each 'Study Status' group\n",
    "    df_percentages = df.groupby([column1, column2]).size() / df.groupby([column2]).size() * 100\n",
    "    df_percentages = df_percentages.unstack().T  # Transpose for plotting\n",
    "\n",
    "    # Create the stacked bar chart\n",
    "    fig,ax=plt.subplots(figsize=(18,8)) \n",
    "\n",
    "    df_percentages.plot(kind='bar', stacked=True, colormap=\"Set1\",ax=ax)\n",
    "\n",
    "    # Customize the plot\n",
    "    plt.title(\"Stacked Bar Chart of Category Distribution by Study Status (Percentages)\",loc=\"left\")\n",
    "    plt.xlabel(\"Study Status\")\n",
    "    plt.ylabel(\"Percentage\")\n",
    "\n",
    "\n",
    "    #    Show the plot\n",
    "    plt.show()\n",
    "\n",
    "\n",
    "def line_chart1(df,column1,column2):\n",
    "# line chart \n",
    "    plt.style.use(\"ggplot\")\n",
    "    enroll_year = df[[column1,column2]].groupby([column2]).sum()\n",
    "    plt.figure(figsize=(16,8))\n",
    "    plt.plot(enroll_year, label='Fatalitiy rate',marker= '.')\n",
    "    plt.title(\"Distribution of  enrollment over  the years\",loc=\"left\",fontsize=14)\n",
    "    plt.ylabel(\"count\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 360,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "line_chart1(df,\"Enrollment\",\"start_year\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 361,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "bar_plot(df,\"country\",\"Enrollment\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 362,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "bar_plot_avg(df,\"Primary Purpose\",\"duration\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 363,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x800 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "bar_plot_avg(df,\"category\",\"duration\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 364,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>category</th>\n",
       "      <th>start_year</th>\n",
       "      <th>completion_year</th>\n",
       "      <th>last_year_posted</th>\n",
       "      <th>duration</th>\n",
       "      <th>Primary Purpose</th>\n",
       "      <th>country</th>\n",
       "      <th>description</th>\n",
       "      <th>interven_summary</th>\n",
       "      <th>type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2006</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>16</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>Canada</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>: On-X valve using reduced anticoagulation|: O...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1 rows √ó 31 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                            Study Title  \\\n",
       "0  NCT00291525  Randomized On-X Anticoagulation Trial   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "\n",
       "            Conditions                                      Interventions  \\\n",
       "0  Heart Valve Disease  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "\n",
       "                          Secondary Outcome Measures  ... category start_year  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ...    heart       2006   \n",
       "\n",
       "  completion_year  last_year_posted duration Primary Purpose country  \\\n",
       "0            2022              2022       16      PREVENTION  Canada   \n",
       "\n",
       "                                         description interven_summary  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...           DEVICE   \n",
       "\n",
       "                                                type  \n",
       "0  : On-X valve using reduced anticoagulation|: O...  \n",
       "\n",
       "[1 rows x 31 columns]"
      ]
     },
     "execution_count": 364,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 365,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1800x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "stacked_bar(df,\"Study Status\",\"category\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 366,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['NCT Number', 'Study Title', 'Study URL', 'Study Status',\n",
       "       'Brief Summary', 'Study Results', 'Conditions', 'Interventions',\n",
       "       'Primary Outcome Measures', 'Secondary Outcome Measures', 'Sponsor',\n",
       "       'Sex', 'Age', 'Enrollment', 'Funder Type', 'Study Type', 'Study Design',\n",
       "       'Start Date', 'Completion Date', 'Last Update Posted', 'Locations',\n",
       "       'category', 'start_year', 'completion_year', 'last_year_posted',\n",
       "       'duration', 'Primary Purpose', 'country', 'description',\n",
       "       'interven_summary', 'type'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 366,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 367,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1800x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "stacked_bar(df,\"Study Results\",\"category\")\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 368,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1800x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "stacked_bar(df,\"Age\",\"category\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Word 2 VEC Classifier"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 369,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>category</th>\n",
       "      <th>start_year</th>\n",
       "      <th>completion_year</th>\n",
       "      <th>last_year_posted</th>\n",
       "      <th>duration</th>\n",
       "      <th>Primary Purpose</th>\n",
       "      <th>country</th>\n",
       "      <th>description</th>\n",
       "      <th>interven_summary</th>\n",
       "      <th>type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2006</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>16</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>Canada</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>: On-X valve using reduced anticoagulation|: O...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2023</td>\n",
       "      <td>2023</td>\n",
       "      <td>3</td>\n",
       "      <td>BASIC</td>\n",
       "      <td>Puerto Rico</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>DIAGNOSTIC_TEST, GENETIC</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2015</td>\n",
       "      <td>2022</td>\n",
       "      <td>2022</td>\n",
       "      <td>7</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>Germany</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>DIAGNOSTIC_TEST</td>\n",
       "      <td>: Cardiac MRI and echocardiography, laboratory...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2021</td>\n",
       "      <td>2022</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>: PICSO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>heart</td>\n",
       "      <td>2020</td>\n",
       "      <td>2021</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>India</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>COMBINATION_PRODUCT</td>\n",
       "      <td>: Furoscix Infusor</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows √ó 31 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ... category start_year  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ...    heart       2006   \n",
       "1  number of patients with treatment-related card...  ...    heart       2020   \n",
       "5  reduction of the left ventricular global longi...  ...    heart       2015   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ...    heart       2021   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ...    heart       2020   \n",
       "\n",
       "  completion_year  last_year_posted duration Primary Purpose         country  \\\n",
       "0            2022              2022       16      PREVENTION          Canada   \n",
       "1            2023              2023        3           BASIC     Puerto Rico   \n",
       "5            2022              2022        7      DIAGNOSTIC         Germany   \n",
       "7            2022              2023        1           OTHER  United Kingdom   \n",
       "8            2021              2023        1       TREATMENT           India   \n",
       "\n",
       "                                         description  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "           interven_summary                                               type  \n",
       "0                    DEVICE  : On-X valve using reduced anticoagulation|: O...  \n",
       "1  DIAGNOSTIC_TEST, GENETIC  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...  \n",
       "5           DIAGNOSTIC_TEST  : Cardiac MRI and echocardiography, laboratory...  \n",
       "7                    DEVICE                                            : PICSO  \n",
       "8       COMBINATION_PRODUCT                                 : Furoscix Infusor  \n",
       "\n",
       "[5 rows x 31 columns]"
      ]
     },
     "execution_count": 369,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 370,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "interven_summary\n",
       "DRUG                             39352\n",
       "OTHER                            10089\n",
       "DEVICE                            7097\n",
       "PROCEDURE                         6087\n",
       "BEHAVIORAL                        5788\n",
       "                                 ...  \n",
       "DRUG, Surveys, Care, OTHER           1\n",
       "Placebo, DRUG, Magnesium             1\n",
       "DEVICE, Tablet                       1\n",
       "DRUG, Score                          1\n",
       "2, 1, Only, OTHER, BIOLOGICAL        1\n",
       "Name: count, Length: 854, dtype: int64"
      ]
     },
     "execution_count": 370,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.interven_summary.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv(\"cleann.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 371,
   "metadata": {},
   "outputs": [],
   "source": [
    "def preprocess_text(text):\n",
    "    # Remove non-alphabetic characters, lowercase, and tokenize\n",
    "    text = re.sub(r'[^a-zA-Z\\s]', '', text.lower())\n",
    "    tokens = word_tokenize(text)\n",
    "    \n",
    "    # Remove stopwords\n",
    "    stop_words = set(stopwords.words('english'))\n",
    "    tokens = [word for word in tokens if word not in stop_words]\n",
    "    \n",
    "    # Lemmatize the tokens\n",
    "    lemmatizer = WordNetLemmatizer()\n",
    "    tokens = [lemmatizer.lemmatize(word) for word in tokens]\n",
    "    \n",
    "    return tokens\n",
    "df['Tokenized Text'] = df['Brief Summary'].apply(preprocess_text)\n",
    "\n",
    "# Train Word2Vec model\n",
    "wordvec = Word2Vec(df['Tokenized Text'], vector_size=300)  # Increased vector size\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 372,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Study Title: A Genomic Approach for Clopidogrel in Caribbean Hispanics\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03419325\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Kaiser Permanente Evaluation of Medically Tailored Meals in Adults With Medical Conditions at High Readmission Risk\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05166525\n",
      "Study Status: COMPLETED\n",
      "Study Title: Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by Cardiotomography\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05998525\n",
      "Study Status: COMPLETED\n",
      "Study Title: Prevention to Improve Outcomes After PVI\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05148338\n",
      "Study Status: RECRUITING\n",
      "Study Title: Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02015988\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00488033\n",
      "Study Status: COMPLETED\n",
      "Study Title: Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01019486\n",
      "Study Status: COMPLETED\n",
      "Study Title: Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02787785\n",
      "Study Status: COMPLETED\n",
      "Study Title: Clinical Decision Support Consortium\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00853619\n",
      "Study Status: UNKNOWN\n",
      "Study Title: A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00980187\n",
      "Study Status: COMPLETED\n",
      "Study Title: Continuous Positive Airway Pressure (CPAP) in Patients With Acute Coronary Syndrome and Obstructive Sleep Apnea (OSA)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01335087\n",
      "Study Status: COMPLETED\n",
      "Study Title: Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05957887\n",
      "Study Status: RECRUITING\n",
      "Study Title: Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06012266\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02632292\n",
      "Study Status: TERMINATED\n",
      "Study Title: Austrian Multivessel Taxus-Stent Registry\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00738686\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03797885\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02586155\n",
      "Study Status: COMPLETED\n",
      "Study Title: Home-based HIIT in a Primary-care Setting for at Risk Individuals: A Multidisciplinary Approach\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04553614\n",
      "Study Status: COMPLETED\n",
      "Study Title: Predicting Hypoglycaemia and Arrhythmias in the Vulnerable Patient With Diabetes and Chronic Kidney Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02315300\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00494559\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Efficacy of SGLT-2 Inhibitor in Patients With CAD and DM Undergoing PCI.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05333159\n",
      "Study Status: RECRUITING\n",
      "Study Title: Cardiac Dysfunction in Adolescents With Type 1 Diabetes: Contribution of Daily-life Glucoregulation and Impact on Cardiorespiratory Exercise Capacity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04052919\n",
      "Study Status: COMPLETED\n",
      "Study Title: Triage of Reduced Exercise Tolerance in Frail Elderly\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01148719\n",
      "Study Status: COMPLETED\n",
      "Study Title: Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05389254\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02043054\n",
      "Study Status: COMPLETED\n",
      "Study Title: Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02449330\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02748330\n",
      "Study Status: COMPLETED\n",
      "Study Title: Coronary Physiology and Its Relationship to Anatomy in Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02745821\n",
      "Study Status: TERMINATED\n",
      "Study Title: Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03871621\n",
      "Study Status: COMPLETED\n",
      "Study Title: To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02299388\n",
      "Study Status: COMPLETED\n",
      "Study Title: Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00513630\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01149421\n",
      "Study Status: COMPLETED\n",
      "Study Title: Cardiopulmonary-bypass and Reno-protective Effect of Atorvastatin Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00910221\n",
      "Study Status: COMPLETED\n",
      "Study Title: International Post-PCI FFR Extended Registry\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05672862\n",
      "Study Status: COMPLETED\n",
      "Study Title: Efficacy Study of Nicorandil on Neointima\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02328521\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03444142\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00462631\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00418288\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effects of an 8-week Vegan Diet on TMAO Levels and Post-challenge Glucose Levels in Individuals With Dysglycaemia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03315988\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of a High Protein Diet on Clinical Outcomes in Heart Failure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01423266\n",
      "Study Status: COMPLETED\n",
      "Study Title: Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03132129\n",
      "Study Status: RECRUITING\n",
      "Study Title: The Usefulness of Assessing Heart Rate Variability in Patients With Acute Myocardial Infarction\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05098977\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02023489\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Metformin as an Upstream Therapy in Atrial Fibrillation\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02931253\n",
      "Study Status: TERMINATED\n",
      "Study Title: Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01852214\n",
      "Study Status: COMPLETED\n",
      "Study Title: Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03087773\n",
      "Study Status: COMPLETED\n",
      "Study Title: Cardiovascular Risk Factors in an Ambulatory Urban Patient Population\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00486993\n",
      "Study Status: COMPLETED\n",
      "Study Title: SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05233163\n",
      "Study Status: COMPLETED\n",
      "Study Title: Canagliflozin and Myocardial Micro-perfusion\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05367063\n",
      "Study Status: RECRUITING\n",
      "Study Title: Sotagliflozin in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05562063\n",
      "Study Status: RECRUITING\n",
      "Study Title: Linking Cardiac Autonomic Dysfunction and InfLammation in Patients With Acute Coronary Syndromes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05756452\n",
      "Study Status: RECRUITING\n",
      "Study Title: Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02059005\n",
      "Study Status: COMPLETED\n",
      "Study Title: Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01465620\n",
      "Study Status: COMPLETED\n",
      "Study Title: Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01582139\n",
      "Study Status: COMPLETED\n",
      "Study Title: Early Assessment of Impaired Cardiac Function in Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05484817\n",
      "Study Status: RECRUITING\n",
      "Study Title: Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03462017\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart Failure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04071626\n",
      "Study Status: RECRUITING\n",
      "Study Title: Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01254552\n",
      "Study Status: COMPLETED\n",
      "Study Title: The DAPA-MEMRI Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04591639\n",
      "Study Status: RECRUITING\n",
      "Study Title: Influence of Vasculary Inflammation on Development of Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01839071\n",
      "Study Status: COMPLETED\n",
      "Study Title: Heart Rate Variability and Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02996539\n",
      "Study Status: COMPLETED\n",
      "Study Title: Aortic Stenosis in Subjects With Heterozygous Familial Hypercholesterolemia on Prolonged Treatment With Statins\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03310671\n",
      "Study Status: UNKNOWN\n",
      "Study Title: B-type Natriuretic Peptide and Glucose Metabolism\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01324739\n",
      "Study Status: COMPLETED\n",
      "Study Title: Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00782639\n",
      "Study Status: TERMINATED\n",
      "Study Title: Exercise Intervention on Cardiorespiratory Function in HF With DM.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04888390\n",
      "Study Status: RECRUITING\n",
      "Study Title: Thumb ECG IncidenT Atrial fibrillatioN in Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05174390\n",
      "Study Status: RECRUITING\n",
      "Study Title: Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02548650\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05029115\n",
      "Study Status: ENROLLING_BY_INVITATION\n",
      "Study Title: Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05283356\n",
      "Study Status: RECRUITING\n",
      "Study Title: Cutting Balloon Predilation Prior to Abluminus Sirolimus-eluting Stent Implantation in Patients With Diabetes Mellitus (CUT-DRESS).\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05801003\n",
      "Study Status: RECRUITING\n",
      "Study Title: Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04481997\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01475552\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of a Low Glycemic Index on Metabolic Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02356952\n",
      "Study Status: COMPLETED\n",
      "Study Title: Silent Atrial Fibrillation - Screening of High-risk Groups for Atrial Fibrillation (The Silence Study)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02893215\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Electronic Alerts for Heart Failure Prevention in Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04791826\n",
      "Study Status: RECRUITING\n",
      "Study Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00000620\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03010683\n",
      "Study Status: COMPLETED\n",
      "Study Title: Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04806633\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: The Heart Failure With Preserved Ejection Fraction (HFpEF) Pathophysiology Study.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03186833\n",
      "Study Status: COMPLETED\n",
      "Study Title: Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01440517\n",
      "Study Status: TERMINATED\n",
      "Study Title: The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Adults\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03142867\n",
      "Study Status: TERMINATED\n",
      "Study Title: Effects of a Reduction in Renal Function on Cardiovascular Structure and Function\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02973607\n",
      "Study Status: COMPLETED\n",
      "Study Title: Cardiorespiratory Parameters and Glycated Hemoglobin of Patients With Type 2 Diabetes After a Rehabilitation Program\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03094767\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Prognostic Implications of Physiologic Investigation After Revascularization With Stent\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04684043\n",
      "Study Status: UNKNOWN\n",
      "Study Title: The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05374291\n",
      "Study Status: ENROLLING_BY_INVITATION\n",
      "Study Title: The Absorption of Magnesium Oxide Compared to Citrate in Healthy Subjects\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00994006\n",
      "Study Status: COMPLETED\n",
      "Study Title: Azilsartan Medoxomil in Hypertensive pAtients With Stable Ischemic Heart Disease and DiabEtes MEllitus.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03539627\n",
      "Study Status: COMPLETED\n",
      "Study Title: Coronary Artery Calcium-guided Primary Prevention of Major Coronary Heart Disease in Asymptomatic Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05267990\n",
      "Study Status: ENROLLING_BY_INVITATION\n",
      "Study Title: Effectiveness and Implementation of the Assessment of Burden of Chronic Conditions (ABCC)-Tool\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04127383\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04739215\n",
      "Study Status: UNKNOWN\n",
      "Study Title: SGLT2 Inhibition and Left Ventricular Mass\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02728453\n",
      "Study Status: TERMINATED\n",
      "Study Title: YUKON Choice Versus TAXUS Libert√© in Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00368953\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effect of Simvastatin Combined With Ezetimibe in Patients With Stable Angina and Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03771053\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03329261\n",
      "Study Status: COMPLETED\n",
      "Study Title: Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05485961\n",
      "Study Status: RECRUITING\n",
      "Study Title: Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01955694\n",
      "Study Status: COMPLETED\n",
      "Study Title: Cardiovascular Disease Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00857194\n",
      "Study Status: COMPLETED\n",
      "Study Title: Integrated Primary Care for Diabetes and Cardiovascular Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02795910\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01252810\n",
      "Study Status: COMPLETED\n",
      "Study Title: Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03774394\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04881994\n",
      "Study Status: COMPLETED\n",
      "Study Title: Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03399994\n",
      "Study Status: COMPLETED\n",
      "Study Title: PRotective Effect on the Coronary Microcirculation of Patients With DIabetes by Clopidogrel or Ticagrelor\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02698618\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02917031\n",
      "Study Status: COMPLETED\n",
      "Study Title: Lipid Biomarkers for Diabetic Heart Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01752842\n",
      "Study Status: COMPLETED\n",
      "Study Title: Tailored Support for Type 2 Diabetes Patients With an Acute Coronary Event After Discharge From Hospital\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01801631\n",
      "Study Status: COMPLETED\n",
      "Study Title: Coronary CT Angiography in Asymptomatic Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00321542\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03715582\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01536808\n",
      "Study Status: COMPLETED\n",
      "Study Title: Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00968708\n",
      "Study Status: COMPLETED\n",
      "Study Title: Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01373216\n",
      "Study Status: COMPLETED\n",
      "Study Title: Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03977116\n",
      "Study Status: COMPLETED\n",
      "Study Title: Exercise Training in Patients With Coronary Heart Disease and Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01232608\n",
      "Study Status: COMPLETED\n",
      "Study Title: Insulin Treatment in Diabetic Older People With Heart Failure.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03665350\n",
      "Study Status: TERMINATED\n",
      "Study Title: Mobile Health Behavioral Intervention in Patients With Heart Failure and Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02918175\n",
      "Study Status: COMPLETED\n",
      "Study Title: Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01425359\n",
      "Study Status: COMPLETED\n",
      "Study Title: Personalization of CM Injection Protocols in Coronary Computed Tomographic Angiography\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03292354\n",
      "Study Status: COMPLETED\n",
      "Study Title: Expanding Paramedicine in the Community\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02034045\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Empagliflozin on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04049045\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Mediterranean Diet Intervention in Diabetic Heart Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03757845\n",
      "Study Status: TERMINATED\n",
      "Study Title: Left Atrial Distensibility to Predict Left Ventricular Filling Pressure and Prognosis in Patients With Severe Mitral Regurgitation\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01172184\n",
      "Study Status: COMPLETED\n",
      "Study Title: Telemedicine Home-based Management in Patients With CHF and Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05633784\n",
      "Study Status: RECRUITING\n",
      "Study Title: Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01035528\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Acute Effect of Phototherapy With Light Emitting Diode (LED) on Muscle and Pulmonary Oxygen Consumption on Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01889784\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Cardiac Autonomic Dysfunction and Perioperative Outcomes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05230641\n",
      "Study Status: COMPLETED\n",
      "Study Title: Personalized Exercise Therapy and Self-management Support for Patients With Multimorbidity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04645732\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03794518\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Saxagliptin and Atherosclerosis\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01552018\n",
      "Study Status: COMPLETED\n",
      "Study Title: Second-generation Drug-eluting Stents in Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03321032\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Acarbose Cardiovascular Evaluation Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00829660\n",
      "Study Status: COMPLETED\n",
      "Study Title: Lifestyle Intervention in Chronic Ischemic Heart Disease and Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03835923\n",
      "Study Status: COMPLETED\n",
      "Study Title: Sodium-glucose Transport 2 Inhibitors (SGLT2i) in HFrEF Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06065280\n",
      "Study Status: RECRUITING\n",
      "Study Title: A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01991795\n",
      "Study Status: COMPLETED\n",
      "Study Title: Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01888796\n",
      "Study Status: TERMINATED\n",
      "Study Title: The Effect of Addition of Metformin In Obese Non- Diabetic Patients With Heart Failure With Preserved Ejection Fraction\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05847244\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Perioperative Sitagliptin Medication for Reduction of the Inflammatory Response Associated With Cardiopulmonary Bypass\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05725798\n",
      "Study Status: COMPLETED\n",
      "Study Title: SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05037695\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00642174\n",
      "Study Status: COMPLETED\n",
      "Study Title: Neuromuscular Fatigue and Exercise Capacity in Patients With Type 2 Diabetes Mellitus and HFpEF\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06057623\n",
      "Study Status: RECRUITING\n",
      "Study Title: Fatty Acid Radiotracer Comparison Study in Heart Failure Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01648296\n",
      "Study Status: COMPLETED\n",
      "Study Title: The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01047735\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: The Genomic Medicine at VA Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04331535\n",
      "Study Status: RECRUITING\n",
      "Study Title: Detection of Atrial Fibrillation After Cardiac Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02793895\n",
      "Study Status: TERMINATED\n",
      "Study Title: The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01438723\n",
      "Study Status: COMPLETED\n",
      "Study Title: Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02001480\n",
      "Study Status: COMPLETED\n",
      "Study Title: Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00982358\n",
      "Study Status: COMPLETED\n",
      "Study Title: Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02370680\n",
      "Study Status: COMPLETED\n",
      "Study Title: Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04475380\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01680978\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01384058\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Inspiratory Muscle Training on Type 2 Diabetes Mellitus Patients With Inspiratory Muscle Weakness\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00815178\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Linagliptin on Endothelial Function\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02350478\n",
      "Study Status: COMPLETED\n",
      "Study Title: QoL and Stress in Parents of Children With Developmental Disabilities and Chronic Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03602378\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrs\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02611258\n",
      "Study Status: COMPLETED\n",
      "Study Title: Randomized Trial Comparing Two Sirolimus-Eluting Stents in Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04660240\n",
      "Study Status: RECRUITING\n",
      "Study Title: Optical Coherence Tomography Morphologic and Fractional Flow Reserve Assessment in Diabetes Mellitus Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02989740\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00766857\n",
      "Study Status: COMPLETED\n",
      "Study Title: Lifestyle Intervention Feasibility for Arrhythmia and Symptoms With Intermittent Fasting (LIFE AS IF)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04090840\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Influence of Probiotics in Diabetic Cardiopathies With Excessive Weight\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03904901\n",
      "Study Status: UNKNOWN\n",
      "Study Title: The Effect of Dexmedetomidine on Kidney Perfusion in Paediatric Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03425734\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02611336\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00495898\n",
      "Study Status: COMPLETED\n",
      "Study Title: Liraglutide Effects on Epicardial Fat Inflammatory Genes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03260881\n",
      "Study Status: RECRUITING\n",
      "Study Title: Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03258281\n",
      "Study Status: TERMINATED\n",
      "Study Title: DPP4 Inhibitor and Coronary Atherosclerosis in Patients Receiving Insulin Therapy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04825795\n",
      "Study Status: COMPLETED\n",
      "Study Title: Gestational Diabetes and Sleep-Disordered Breathing\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00933881\n",
      "Study Status: COMPLETED\n",
      "Study Title: Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02579499\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Coronary Artery Disease Progression in Patients With Prediabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02744976\n",
      "Study Status: COMPLETED\n",
      "Study Title: Heart Rate During Exercise in Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03917576\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01580813\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01042769\n",
      "Study Status: COMPLETED\n",
      "Study Title: PIoglitazone for PrEvention of Restenosis in Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00376870\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01765270\n",
      "Study Status: TERMINATED\n",
      "Study Title: iSGLT2 in Prevention of Acute Kidney Injury in Patients With Diabetes Mellitus Undergoing CABG Extracorporeal On-Pump\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04523064\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02539160\n",
      "Study Status: COMPLETED\n",
      "Study Title: Predicting Hypoglycaemia and Arrhythmias in the Patient With Diabetes and CKD - Validation Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02778269\n",
      "Study Status: COMPLETED\n",
      "Study Title: BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02645799\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Empagliflozin and Atrial Fibrillation Treatment\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04583813\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Randomized Clinical Trial by Conglomerates on the Efficacy of Maintenance of Physical Exercise in Myocardial Ischemia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04251611\n",
      "Study Status: COMPLETED\n",
      "Study Title: Meta-analysis of Fish Oil Supplementation and Cardiovascular Outcomes in Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04327713\n",
      "Study Status: UNKNOWN\n",
      "Study Title: SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05764811\n",
      "Study Status: COMPLETED\n",
      "Study Title: Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01722513\n",
      "Study Status: UNKNOWN\n",
      "Study Title: The Role of Nuclear Imaging in Heart Failure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02697669\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Effect of Lockdown During COVID 19 Pandemic on Liver Disease and Metabolic Parameters.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05028842\n",
      "Study Status: COMPLETED\n",
      "Study Title: Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04970719\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04944719\n",
      "Study Status: UNKNOWN\n",
      "Study Title: The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05248412\n",
      "Study Status: RECRUITING\n",
      "Study Title: Incidence of Diabetes After a COVID-19 Infection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05524792\n",
      "Study Status: COMPLETED\n",
      "Study Title: mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04923386\n",
      "Study Status: COMPLETED\n",
      "Study Title: Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04344210\n",
      "Study Status: COMPLETED\n",
      "Study Title: Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04873349\n",
      "Study Status: COMPLETED\n",
      "Study Title: Role of Tele-physical Therapy in Patients With Type 2 Diabetes Mellitus Following COVID-19 Infection.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05599893\n",
      "Study Status: COMPLETED\n",
      "Study Title: Canakinumab in Patients With COVID-19 and Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04510493\n",
      "Study Status: COMPLETED\n",
      "Study Title: Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02059005\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04365517\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Sitagliptin Treatment in Diabetic COVID-19 Positive Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04382794\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04558645\n",
      "Study Status: COMPLETED\n",
      "Study Title: Gastric Volume After Oral Ingestion of Water or Jelly in Volunteers\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05737641\n",
      "Study Status: ENROLLING_BY_INVITATION\n",
      "Study Title: Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05007236\n",
      "Study Status: COMPLETED\n",
      "Study Title: Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04695158\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Effects of Telerehabilitative Aerobic and Relaxation Exercises Patients With Type 2 Diabetes With and Without COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05411458\n",
      "Study Status: COMPLETED\n",
      "Study Title: Modulation of Gut Microbiota to Enhance Health and Immunity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04884776\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Concentrated Cross-disciplinary Group Intervention for Common Health Complaints (Including Post COVID-19 Fatigue)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05234281\n",
      "Study Status: RECRUITING\n",
      "Study Title: Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02500147\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05248412\n",
      "Study Status: RECRUITING\n",
      "Study Title: DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01588587\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04221347\n",
      "Study Status: UNKNOWN\n",
      "Study Title: VITamine D Supplementation in RenAL Transplant Recipients - VITALE\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01431430\n",
      "Study Status: COMPLETED\n",
      "Study Title: Lifestyle Intervention in Pregnant Women With PCOS\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04216485\n",
      "Study Status: COMPLETED\n",
      "Study Title: MYPP-trial: Myo-inositol Supplementation to Prevent Pregnancy Complications in Women With Polycystic Ovary Syndrome.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05524259\n",
      "Study Status: RECRUITING\n",
      "Study Title: Reproductive Endocrinology Oxford Study (RepOx)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05177562\n",
      "Study Status: RECRUITING\n",
      "Study Title: Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01675310\n",
      "Study Status: COMPLETED\n",
      "Study Title: Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02005419\n",
      "Study Status: COMPLETED\n",
      "Study Title: Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02574793\n",
      "Study Status: COMPLETED\n",
      "Study Title: Tumor Necrosis Factor-alpha and Interleukin-18 Levels in Children With Gingivitis and Type 1 Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03910205\n",
      "Study Status: COMPLETED\n",
      "Study Title: Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00923949\n",
      "Study Status: TERMINATED\n",
      "Study Title: CANA/Met in Non-diabetic Women With PCOS\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04973891\n",
      "Study Status: COMPLETED\n",
      "Study Title: Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01246739\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04308590\n",
      "Study Status: RECRUITING\n",
      "Study Title: Metformin in Infertile PCOS Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00501904\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02308137\n",
      "Study Status: COMPLETED\n",
      "Study Title: Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03520153\n",
      "Study Status: WITHDRAWN\n",
      "Study Title: Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02312661\n",
      "Study Status: COMPLETED\n",
      "Study Title: Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04554316\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Fasting Mimicking Diet (FMD) in Women With Polycystic Ovary Syndrome (PCOS)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05196568\n",
      "Study Status: RECRUITING\n",
      "Study Title: Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05306028\n",
      "Study Status: RECRUITING\n",
      "Study Title: Sitagliptin and Brown Adipose Tissue\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02294084\n",
      "Study Status: COMPLETED\n",
      "Study Title: Reducing Dexamethasone Around Docetaxel Infusion\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02776436\n",
      "Study Status: UNKNOWN\n",
      "Study Title: The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02122380\n",
      "Study Status: COMPLETED\n",
      "Study Title: The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01047735\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: The Genomic Medicine at VA Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04331535\n",
      "Study Status: RECRUITING\n",
      "Study Title: A Prospective Comparison of Suture Removal Time for Simple Surgical Defects of the Head and Neck\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02166996\n",
      "Study Status: COMPLETED\n",
      "Study Title: Screening for GDM in Women With PCOS and Controls\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02183558\n",
      "Study Status: COMPLETED\n",
      "Study Title: Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02780024\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02240381\n",
      "Study Status: TERMINATED\n",
      "Study Title: Multi-omics Analysis of Women With PCOS and Obesity Compared With Non-PCOS Obese Controls\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05468476\n",
      "Study Status: COMPLETED\n",
      "Study Title: Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01518023\n",
      "Study Status: COMPLETED\n",
      "Study Title: Metformin Combined With Chemotherapy for Pancreatic Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01210911\n",
      "Study Status: COMPLETED\n",
      "Study Title: Onco-primary Care Networking to Support TEAM-based Care\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04258813\n",
      "Study Status: RECRUITING\n",
      "Study Title: Adipose Tissue and Immune Activation in HIV\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04439448\n",
      "Study Status: COMPLETED\n",
      "Study Title: ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to Atazanavir\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02102048\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01791465\n",
      "Study Status: TERMINATED\n",
      "Study Title: Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01511016\n",
      "Study Status: COMPLETED\n",
      "Study Title: Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA¬Æ\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01591902\n",
      "Study Status: TERMINATED\n",
      "Study Title: Effect of Lockdown During COVID 19 Pandemic on Liver Disease and Metabolic Parameters.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05028842\n",
      "Study Status: COMPLETED\n",
      "Study Title: Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04970719\n",
      "Study Status: UNKNOWN\n",
      "Study Title: The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05248412\n",
      "Study Status: RECRUITING\n",
      "Study Title: Incidence of Diabetes After a COVID-19 Infection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05524792\n",
      "Study Status: COMPLETED\n",
      "Study Title: mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04923386\n",
      "Study Status: COMPLETED\n",
      "Study Title: Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04344210\n",
      "Study Status: COMPLETED\n",
      "Study Title: Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04873349\n",
      "Study Status: COMPLETED\n",
      "Study Title: Role of Tele-physical Therapy in Patients With Type 2 Diabetes Mellitus Following COVID-19 Infection.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05599893\n",
      "Study Status: COMPLETED\n",
      "Study Title: Canakinumab in Patients With COVID-19 and Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04510493\n",
      "Study Status: COMPLETED\n",
      "Study Title: COVID-19 Glycemic Control Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05977205\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04365517\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Anxiety, Depression and Eating Attitudes of Diabetes Mellitus Patients During COVID-19 Lockdown in Greece\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04700254\n",
      "Study Status: COMPLETED\n",
      "Study Title: Sitagliptin Treatment in Diabetic COVID-19 Positive Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04382794\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04558645\n",
      "Study Status: COMPLETED\n",
      "Study Title: Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05007236\n",
      "Study Status: COMPLETED\n",
      "Study Title: Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04695158\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Effects of Telerehabilitative Aerobic and Relaxation Exercises Patients With Type 2 Diabetes With and Without COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05411458\n",
      "Study Status: COMPLETED\n",
      "Study Title: Modulation of Gut Microbiota to Enhance Health and Immunity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04884776\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Concentrated Cross-disciplinary Group Intervention for Common Health Complaints (Including Post COVID-19 Fatigue)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05234281\n",
      "Study Status: RECRUITING\n",
      "Study Title: Exercise Testing to Screen for Unknown Coronary Artery Disease in Diabetic Patients: Does it Contribute to a Risk Reduction in Very High Risk Patients?\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00547872\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effect of Hyperglycemia on LV Function and Exercise Capacity in Diabetics With and Without Heart Failure.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01071772\n",
      "Study Status: COMPLETED\n",
      "Study Title: Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03125772\n",
      "Study Status: COMPLETED\n",
      "Study Title: Drug Eluting Balloon for Prevention of Constrictive Remodeling\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01690572\n",
      "Study Status: TERMINATED\n",
      "Study Title: ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02935855\n",
      "Study Status: COMPLETED\n",
      "Study Title: Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00488033\n",
      "Study Status: COMPLETED\n",
      "Study Title: Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02098447\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00659451\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Assessment of Surface Coverage of Two Types of DES in Diabetes Mellitus and Non- Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01023919\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Reservoir-Based Polymer-Free Amphilimus-Eluting Stent Versus Polymer-Based Everolimus-Eluting Stent in Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01710748\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Impact of Critical Limb Ischemia on Long Term Cardiac Mortality in Diabetic Patients Undergoing Percutaneous Coronary Revascularization\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01676519\n",
      "Study Status: COMPLETED\n",
      "Study Title: Dapagliflozin Therapy In Cardiac Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05621551\n",
      "Study Status: RECRUITING\n",
      "Study Title: Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01863147\n",
      "Study Status: COMPLETED\n",
      "Study Title: Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05838287\n",
      "Study Status: RECRUITING\n",
      "Study Title: Hepatic and Cardiac Metabolic Flexibility in Subjects With T2DM With and Without NAFLD\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04698486\n",
      "Study Status: COMPLETED\n",
      "Study Title: Contribution Of Nuclear Magnetic Resonance Imaging In The Study Of Diabetic Cardiomyopathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01295385\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Evaluation of the Functional Impact of Coronary Stenoses in Diabetics by Spectral CT\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05471687\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00819325\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04222686\n",
      "Study Status: COMPLETED\n",
      "Study Title: Predicting Hypoglycaemia and Arrhythmias in the Vulnerable Patient With Diabetes and Chronic Kidney Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02315300\n",
      "Study Status: COMPLETED\n",
      "Study Title: Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00233259\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00494559\n",
      "Study Status: COMPLETED\n",
      "Study Title: DAPAgliflozin for Renal Protection in Heart Transplant Recipients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05321706\n",
      "Study Status: RECRUITING\n",
      "Study Title: Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01021930\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02520921\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: HYbrid CoronAry Revascularization in DiabeticS\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02504762\n",
      "Study Status: COMPLETED\n",
      "Study Title: To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02299388\n",
      "Study Status: COMPLETED\n",
      "Study Title: Dapagliflozin in Diabetic Patients (Type 2) With Decompensated Heart Failure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04385589\n",
      "Study Status: COMPLETED\n",
      "Study Title: Hypoglycaemia and Cardiac Arrhythmias in Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03150030\n",
      "Study Status: COMPLETED\n",
      "Study Title: Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01422421\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Insulin Effects on Cardiac Function in Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02962921\n",
      "Study Status: COMPLETED\n",
      "Study Title: Efficacy Study of Nicorandil on Neointima\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02328521\n",
      "Study Status: UNKNOWN\n",
      "Study Title: The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00418288\n",
      "Study Status: COMPLETED\n",
      "Study Title: Efficacy of Metformin as add-on Therapy in Non-Diabetic Heart Failure Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05177588\n",
      "Study Status: COMPLETED\n",
      "Study Title: Exercise Training and Cardiovascular Function in Obesity and in Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00264589\n",
      "Study Status: COMPLETED\n",
      "Study Title: DPP-4 Inhibitors and Acute Myocardial Infarction:Effects on Platelet Function\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02377388\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluation of the Effect of SGLT-2 Inhibitors on Cardiac Remodeling in Post Myocardial Infarction Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05335629\n",
      "Study Status: RECRUITING\n",
      "Study Title: Diabetic Cardiomyopathy and Heart Failure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05571865\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02023489\n",
      "Study Status: UNKNOWN\n",
      "Study Title: An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00116207\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01916733\n",
      "Study Status: COMPLETED\n",
      "Study Title: Toe-brachial Index and Coronary Calcification in Type 1 and 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03920683\n",
      "Study Status: COMPLETED\n",
      "Study Title: Propofol Cardioprotection for Type II Diabetics\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00734383\n",
      "Study Status: COMPLETED\n",
      "Study Title: Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00723307\n",
      "Study Status: COMPLETED\n",
      "Study Title: Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00497172\n",
      "Study Status: COMPLETED\n",
      "Study Title: Sympathetic Heart Innervation in Patients With Tako-Tsubo Cardiomyopathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01524861\n",
      "Study Status: COMPLETED\n",
      "Study Title: Intraoperative Insulin Administration at Cardiac Surgery for Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04824586\n",
      "Study Status: COMPLETED\n",
      "Study Title: Measurement of Endothelial Function and Cardiac Output: New Methods\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02299960\n",
      "Study Status: COMPLETED\n",
      "Study Title: Canagliflozin and Myocardial Micro-perfusion\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05367063\n",
      "Study Status: RECRUITING\n",
      "Study Title: Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00997763\n",
      "Study Status: COMPLETED\n",
      "Study Title: Impact on Atrial Remodeling of Dapaglifozin in Patients With Heart Failure .\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04707352\n",
      "Study Status: COMPLETED\n",
      "Study Title: Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00787605\n",
      "Study Status: COMPLETED\n",
      "Study Title: Efficacy of Trimetazidine in Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05556005\n",
      "Study Status: RECRUITING\n",
      "Study Title: Predictability of Preoperative Hemoglobin A1c in Diabetic Patients Underwent Off-Pump Coronary Artery Bypass Surgery: A Retrospective Study.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03543449\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Exenatide for Stress Hyperglycemia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01969149\n",
      "Study Status: COMPLETED\n",
      "Study Title: Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04124120\n",
      "Study Status: RECRUITING\n",
      "Study Title: Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04776239\n",
      "Study Status: RECRUITING\n",
      "Study Title: Optimization of Cardioprotection in Diabetic Patients Undergoing Cardiac Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02407626\n",
      "Study Status: TERMINATED\n",
      "Study Title: COronary CoLLateralization in Type 2 diabEtic Patients With Chronic Total Occlusion\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06054126\n",
      "Study Status: RECRUITING\n",
      "Study Title: Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01556126\n",
      "Study Status: COMPLETED\n",
      "Study Title: Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00950079\n",
      "Study Status: UNKNOWN\n",
      "Study Title: SMBG Protocols Predicting Glucose Levels in Senior Diabetes Mellitus With CAD\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01954771\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02017171\n",
      "Study Status: COMPLETED\n",
      "Study Title: Heart Rate Variability and Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02996539\n",
      "Study Status: COMPLETED\n",
      "Study Title: Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04083339\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Effect of High-intensity Interval Training on Cardiac Function and Regulation of Glycemic Control in Diabetic Cardiomyopathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03299790\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Physiologic Comparison of Two Approaches to Treating Peripheral Neuropathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05577390\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Thumb ECG IncidenT Atrial fibrillatioN in Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05174390\n",
      "Study Status: RECRUITING\n",
      "Study Title: Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02617290\n",
      "Study Status: COMPLETED\n",
      "Study Title: Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01947790\n",
      "Study Status: COMPLETED\n",
      "Study Title: COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00123903\n",
      "Study Status: TERMINATED\n",
      "Study Title: Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial Function\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00943059\n",
      "Study Status: COMPLETED\n",
      "Study Title: Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04481997\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Evaluation of Myocardial Perfusion Heterogeneity Imaging in Diabetes Patients (EVADIAB)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02316054\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03313752\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01147250\n",
      "Study Status: COMPLETED\n",
      "Study Title: Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00562952\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03010683\n",
      "Study Status: COMPLETED\n",
      "Study Title: Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00233714\n",
      "Study Status: COMPLETED\n",
      "Study Title: PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01531114\n",
      "Study Status: COMPLETED\n",
      "Study Title: Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04806633\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00362037\n",
      "Study Status: COMPLETED\n",
      "Study Title: Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01440517\n",
      "Study Status: TERMINATED\n",
      "Study Title: Effect of Glucose on QTc Interval in Type 1 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01984827\n",
      "Study Status: COMPLETED\n",
      "Study Title: Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes (FREEDOM)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00086450\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01186107\n",
      "Study Status: COMPLETED\n",
      "Study Title: DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02312427\n",
      "Study Status: COMPLETED\n",
      "Study Title: Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics With Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04541797\n",
      "Study Status: RECRUITING\n",
      "Study Title: The Effect of Pioglitazone on Neointima Volume and Characteristics Observed by Optical Coherence Tomography (OCT)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01331967\n",
      "Study Status: COMPLETED\n",
      "Study Title: Sirolimus-Eluting Stent Versus Standard Stent in Diabetic\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00755443\n",
      "Study Status: COMPLETED\n",
      "Study Title: SPIRIT V: A Clinical Evaluation of the XIENCE V¬Æ Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01171820\n",
      "Study Status: COMPLETED\n",
      "Study Title: Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01747356\n",
      "Study Status: COMPLETED\n",
      "Study Title: Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01877590\n",
      "Study Status: COMPLETED\n",
      "Study Title: Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00129233\n",
      "Study Status: COMPLETED\n",
      "Study Title: Carnitine for the Treatment of Atherosclerosis.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02117661\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03693560\n",
      "Study Status: COMPLETED\n",
      "Study Title: CMR in T2DM: The NSR Cohort\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05915260\n",
      "Study Status: ENROLLING_BY_INVITATION\n",
      "Study Title: Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03329261\n",
      "Study Status: COMPLETED\n",
      "Study Title: Metformin in Heart Failure Without Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03331861\n",
      "Study Status: RECRUITING\n",
      "Study Title: Comparison of Coronary Xience V and the Cypher Select+ Stents in Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00552994\n",
      "Study Status: COMPLETED\n",
      "Study Title: Outcome of Second Generation Drug-eLuting Stents in Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01293773\n",
      "Study Status: WITHDRAWN\n",
      "Study Title: Improving Heart Health in Appalachia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01884246\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of SGLT2 Inhibitor in Diabetic Patients With Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03398577\n",
      "Study Status: UNKNOWN\n",
      "Study Title: A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04881994\n",
      "Study Status: COMPLETED\n",
      "Study Title: Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00328094\n",
      "Study Status: TERMINATED\n",
      "Study Title: Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00927394\n",
      "Study Status: COMPLETED\n",
      "Study Title: Kidney Function in Diabetics During CPB (Cardio Pulmonary Bypass)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03405532\n",
      "Study Status: SUSPENDED\n",
      "Study Title: Lipid Biomarkers for Diabetic Heart Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01752842\n",
      "Study Status: COMPLETED\n",
      "Study Title: Tailored Support for Type 2 Diabetes Patients With an Acute Coronary Event After Discharge From Hospital\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01801631\n",
      "Study Status: COMPLETED\n",
      "Study Title: Does Insulin Requirement Post Cardiac Surgery Predicts The Risk Of Developing Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04765982\n",
      "Study Status: RECRUITING\n",
      "Study Title: Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01536808\n",
      "Study Status: COMPLETED\n",
      "Study Title: Haptoglobin Polymorphism as a Determinant of Adverse Outcome After Cardiac Surgery in Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02771808\n",
      "Study Status: COMPLETED\n",
      "Study Title: Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04236609\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: A Phase I Study to Evaluate XTR003 in Healthy Chinese Volunteers\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05136391\n",
      "Study Status: COMPLETED\n",
      "Study Title: Metformin in Diabetic Patients Undergoing Coronary Angiography\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04766008\n",
      "Study Status: RECRUITING\n",
      "Study Title: Real-time Continuous Glucose Monitoring in Diabetic Cardiothoracic Surgery Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00878891\n",
      "Study Status: TERMINATED\n",
      "Study Title: Platelet Aggregation in Diabetic Patients With Acute Coronary Syndrome Treated With Different Doses of Aspirin\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05293808\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04340908\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Magnetic Resonance Diabetic Cardiac Stress Imaging\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00797082\n",
      "Study Status: TERMINATED\n",
      "Study Title: Insulin Treatment in Diabetic Older People With Heart Failure.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03665350\n",
      "Study Status: TERMINATED\n",
      "Study Title: Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01754259\n",
      "Study Status: COMPLETED\n",
      "Study Title: Short Term Effects of a Hibiscus Sabdariffa and Stevia Rebaudiana Drink on Cardiac Relaxation and Urinary Albumin Excretion in a Group of Diabetic Type 2 Subjects\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04254016\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluating DyNamic Myocardial Blood Flow QUantitation As a Cost Effective Care ModeL for DiabEtic Patients With Coronary Artery DiSease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05343884\n",
      "Study Status: RECRUITING\n",
      "Study Title: In and ex Vivo Mitochondrial Function of the Heart\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03049228\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Empagliflozin on NT-Pro Brain Natriuretic Peptide in Heart Failure Patients With Reduced Ejection Fraction\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05778084\n",
      "Study Status: RECRUITING\n",
      "Study Title: Optimized Glycemic Control in Heart Failure Patients With DM2:\"Effect on Left Ventricular Function and Skeletal Muscle\"\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01213784\n",
      "Study Status: COMPLETED\n",
      "Study Title: REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01803828\n",
      "Study Status: COMPLETED\n",
      "Study Title: Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01465828\n",
      "Study Status: COMPLETED\n",
      "Study Title: Cardiac Magnetic Resonance for Asymptomatic Type 2 Diabetics With Cardiovascular High Risk (CATCH) - Pilot Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03263728\n",
      "Study Status: COMPLETED\n",
      "Study Title: Acute Effect of Phototherapy With Light Emitting Diode (LED) on Muscle and Pulmonary Oxygen Consumption on Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01889784\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00169832\n",
      "Study Status: COMPLETED\n",
      "Study Title: Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02487732\n",
      "Study Status: COMPLETED\n",
      "Study Title: Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01686932\n",
      "Study Status: COMPLETED\n",
      "Study Title: Second-generation Drug-eluting Stents in Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03321032\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Impact of Empaglifozine on Cardiac Ectopic Fat\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03118336\n",
      "Study Status: COMPLETED\n",
      "Study Title: (ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00354341\n",
      "Study Status: COMPLETED\n",
      "Study Title: SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05037695\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Nitrate and Exercise-induced Cardiac Troponin T in Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01714674\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Neuromuscular Fatigue and Exercise Capacity in Patients With Type 2 Diabetes Mellitus and HFpEF\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06057623\n",
      "Study Status: RECRUITING\n",
      "Study Title: Short Interval Resveratrol Trial in Cardiovascular Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03762096\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide?\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02169596\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effect of Remote Ischemic Preconditioning on Elective Percutaneous Coronary Intervention in Diabetic Nephropathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02329444\n",
      "Study Status: COMPLETED\n",
      "Study Title: OCT Evaluation of Healing of COMBO Stent\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01274234\n",
      "Study Status: COMPLETED\n",
      "Study Title: Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02001480\n",
      "Study Status: COMPLETED\n",
      "Study Title: Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00982358\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00320502\n",
      "Study Status: COMPLETED\n",
      "Study Title: Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrs\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02611258\n",
      "Study Status: COMPLETED\n",
      "Study Title: Vascular Function and Biomarker Assessments in Healthy Volunteers and in Patients With Type 2 Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04744636\n",
      "Study Status: COMPLETED\n",
      "Study Title: Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01515228\n",
      "Study Status: COMPLETED\n",
      "Study Title: Motivational Interviewing and Cognitive Behavioral Therapy-based Intervention for Cardiovascular Disease Prevention Amongst American Indians With Diabetic and Depressive Symptoms\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01892124\n",
      "Study Status: COMPLETED\n",
      "Study Title: Towards Optimal Screening and Management of Coronary Artery Disease in Diabetes: TOSCANA Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05314140\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Influence of Probiotics in Diabetic Cardiopathies With Excessive Weight\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03904901\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Innovative Strategies For Risk Reduction Following CABG\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00462436\n",
      "Study Status: COMPLETED\n",
      "Study Title: Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02611336\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02607436\n",
      "Study Status: COMPLETED\n",
      "Study Title: Œ§icagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01642940\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluation of Continuous Glucose Monitoring in Patients With ACS and Type 2 Diabetes in ICU\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04822740\n",
      "Study Status: RECRUITING\n",
      "Study Title: Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03376698\n",
      "Study Status: COMPLETED\n",
      "Study Title: Metabolic Inflexibility of the Heart as a Predictor of Occurrence of Heart Failure in Patients With Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05481944\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Epicardial Fat and Clinical Outcomes After Coronary Artery Bypass Grafting in Diabetics vs. Non Diabetics\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03360981\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Metformin in Insulin Resistant Left Ventricular (LV) Dysfunction (TAYSIDE Trial)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00473876\n",
      "Study Status: COMPLETED\n",
      "Study Title: Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04328181\n",
      "Study Status: RECRUITING\n",
      "Study Title: Efficacy and Safety of Polymer-free Amphilimus-eluting Stent According to the Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05759676\n",
      "Study Status: RECRUITING\n",
      "Study Title: PIoglitazone for PrEvention of Restenosis in Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00376870\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Miami Healthy Heart Initiative a Behavioral Study on Cardiovascular Risk Factors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01152957\n",
      "Study Status: COMPLETED\n",
      "Study Title: iSGLT2 in Prevention of Acute Kidney Injury in Patients With Diabetes Mellitus Undergoing CABG Extracorporeal On-Pump\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04523064\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03560323\n",
      "Study Status: RECRUITING\n",
      "Study Title: Allopurinol and Endothelial Function in Diabetic CAD Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03385135\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Predicting Hypoglycaemia and Arrhythmias in the Patient With Diabetes and CKD - Validation Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02778269\n",
      "Study Status: COMPLETED\n",
      "Study Title: Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05972070\n",
      "Study Status: RECRUITING\n",
      "Study Title: Evaluation of Diabetic Effects on Clinical Outcomes After Sirolimus-Eluting Stents in the AsIAN Population\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00997711\n",
      "Study Status: COMPLETED\n",
      "Study Title: VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01684813\n",
      "Study Status: COMPLETED\n",
      "Study Title: Quantitative Assessment and Characterization of Microvascular Function Using Diffuse Optical Tomography\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03411213\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01604213\n",
      "Study Status: COMPLETED\n",
      "Study Title: Role of Mitochondrial Dysfunction in the Occurrence of Acute Kidney Injury (AKI) in Postoperative Cardiac Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04125069\n",
      "Study Status: COMPLETED\n",
      "Study Title: Trial of a Cardiac Rehabilitation Program Delivered Remotely Through the Internet\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00683813\n",
      "Study Status: COMPLETED\n",
      "Study Title: SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05764811\n",
      "Study Status: COMPLETED\n",
      "Study Title: Safety and Performance Assessment of Drug-Eluting Stent CRE8 in Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03842813\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04970719\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Pravastatin and Ventilatory Associated Pneumonia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00702130\n",
      "Study Status: COMPLETED\n",
      "Study Title: Epidemiologic Register on Diabetes and COVID-19 in Tunisia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05603130\n",
      "Study Status: COMPLETED\n",
      "Study Title: Tele-expertise in Patients With Diabetes Hospitalized for Covid-19 Infection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04726163\n",
      "Study Status: TERMINATED\n",
      "Study Title: Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04463849\n",
      "Study Status: COMPLETED\n",
      "Study Title: Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02081326\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04370171\n",
      "Study Status: COMPLETED\n",
      "Study Title: Gastric Ultrasound for Preoperative Assessment of Gastric Content in Diabetic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04181814\n",
      "Study Status: COMPLETED\n",
      "Study Title: Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04703036\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04912934\n",
      "Study Status: COMPLETED\n",
      "Study Title: Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04695158\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04876274\n",
      "Study Status: COMPLETED\n",
      "Study Title: Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04328181\n",
      "Study Status: RECRUITING\n",
      "Study Title: Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05366842\n",
      "Study Status: RECRUITING\n",
      "Study Title: Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04945148\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Evaluation of Safety and Efficacy of Mersina, an Ayurvedic Formulation: A Double Blind, Placebo Controlled Study in Type 2 Diabetic Patients With Secondary Failure to Oral Drugs\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00940251\n",
      "Study Status: COMPLETED\n",
      "Study Title: New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05188586\n",
      "Study Status: RECRUITING\n",
      "Study Title: Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01912612\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01981525\n",
      "Study Status: COMPLETED\n",
      "Study Title: Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02028221\n",
      "Study Status: COMPLETED\n",
      "Study Title: Dexamethasone Implant for Retinal Detachment in Uveal Melanoma\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04082962\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Effects of Bromelain and Boswellia Serrata Casperome With Centella Asiatica and Vitamins on Edema, Paresthesia and Postoperative Pain After Quadrantectomy With or Without Sentinel Lymph Node Biopsy.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04669119\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02005419\n",
      "Study Status: COMPLETED\n",
      "Study Title: Role of Adding Metformin to Neoadjuvant Chemotherapy in Patients With Breast Cancer (METNEO)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04170465\n",
      "Study Status: COMPLETED\n",
      "Study Title: EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05188573\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: dataBase for Analysis of Rectal Cancer Oncological Results\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04947020\n",
      "Study Status: RECRUITING\n",
      "Study Title: The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02394652\n",
      "Study Status: COMPLETED\n",
      "Study Title: Donepezil for Oxaliplatin-induced Neuropathy Peripheral Neuropathy: Proof of Concept Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05254639\n",
      "Study Status: RECRUITING\n",
      "Study Title: PBMT for the Prevention of CIPN\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03391271\n",
      "Study Status: COMPLETED\n",
      "Study Title: Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer (METCAP).\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02437656\n",
      "Study Status: COMPLETED\n",
      "Study Title: Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02294006\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00540904\n",
      "Study Status: COMPLETED\n",
      "Study Title: Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04758000\n",
      "Study Status: RECRUITING\n",
      "Study Title: A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03047837\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Polycystic Ovary Syndrome (PCOS): Effect Of Letrozole and Berberine\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01116167\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Metformin and Nightly Fasting in Women With Early Breast Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05023967\n",
      "Study Status: RECRUITING\n",
      "Study Title: Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00510315\n",
      "Study Status: COMPLETED\n",
      "Study Title: Interest of Pregabalin (Lyrica) on the Treatment of Reflex Earache in Head and Neck Cancer.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02924675\n",
      "Study Status: TERMINATED\n",
      "Study Title: Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01976923\n",
      "Study Status: COMPLETED\n",
      "Study Title: Heat Therapy and Cardiometabolic Health in Obese Women\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03644524\n",
      "Study Status: COMPLETED\n",
      "Study Title: Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01324180\n",
      "Study Status: COMPLETED\n",
      "Study Title: Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous Hemorrhage\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01091896\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Effect of Ambroxol in Diabetic Peripheral Neuropathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05558878\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Early Screening of Pancreatic Lesions : Development of New Imaging Tools\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04007640\n",
      "Study Status: RECRUITING\n",
      "Study Title: Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04328181\n",
      "Study Status: RECRUITING\n",
      "Study Title: SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05612269\n",
      "Study Status: ENROLLING_BY_INVITATION\n",
      "Study Title: Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02055911\n",
      "Study Status: WITHDRAWN\n",
      "Study Title: Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05411523\n",
      "Study Status: RECRUITING\n",
      "Study Title: Metformin Combined With Chemotherapy for Pancreatic Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01210911\n",
      "Study Status: COMPLETED\n",
      "Study Title: Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02216799\n",
      "Study Status: COMPLETED\n",
      "Study Title: Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01791465\n",
      "Study Status: TERMINATED\n",
      "Study Title: Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05135039\n",
      "Study Status: RECRUITING\n",
      "Study Title: Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03201939\n",
      "Study Status: SUSPENDED\n",
      "Study Title: Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA¬Æ\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01591902\n",
      "Study Status: TERMINATED\n",
      "Study Title: Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NeP\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00407511\n",
      "Study Status: COMPLETED\n",
      "Study Title: Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04970719\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Epidemiologic Register on Diabetes and COVID-19 in Tunisia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05603130\n",
      "Study Status: COMPLETED\n",
      "Study Title: Tele-expertise in Patients With Diabetes Hospitalized for Covid-19 Infection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04726163\n",
      "Study Status: TERMINATED\n",
      "Study Title: Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04463849\n",
      "Study Status: COMPLETED\n",
      "Study Title: Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02081326\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04370171\n",
      "Study Status: COMPLETED\n",
      "Study Title: Use of Remote Thermovisual Monitoring in Patients With a Previous Diabetic Foot Ulcer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05039645\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04703036\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04385095\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04905823\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04912934\n",
      "Study Status: COMPLETED\n",
      "Study Title: Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04695158\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04876274\n",
      "Study Status: COMPLETED\n",
      "Study Title: \"COVID-19 and Diabetes Outcomes\"\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04324736\n",
      "Study Status: COMPLETED\n",
      "Study Title: Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by Cardiotomography\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05998525\n",
      "Study Status: COMPLETED\n",
      "Study Title: Metabolic and Hemodynamic Effects of the Inhibitors of Type 2 Sodium Glucose Co-transporters (ISGLT2) in Diabetic Patients With Heart Failure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03741972\n",
      "Study Status: COMPLETED\n",
      "Study Title: Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05174312\n",
      "Study Status: RECRUITING\n",
      "Study Title: Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01019486\n",
      "Study Status: COMPLETED\n",
      "Study Title: Assessment of Surface Coverage of Two Types of DES in Diabetes Mellitus and Non- Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01023919\n",
      "Study Status: UNKNOWN\n",
      "Study Title: The POST-ACS Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05322200\n",
      "Study Status: RECRUITING\n",
      "Study Title: The Effect and Applicability of CBT-Based Weight Loss Treatment Model in Obese Patients With Comorbid Depression in Health Care\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04513587\n",
      "Study Status: RECRUITING\n",
      "Study Title: Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05957887\n",
      "Study Status: RECRUITING\n",
      "Study Title: Cost Effectiveness and Quality of Life in Heart Failure Patients With Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01606085\n",
      "Study Status: COMPLETED\n",
      "Study Title: Predicting Hypoglycaemia and Arrhythmias in the Vulnerable Patient With Diabetes and Chronic Kidney Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02315300\n",
      "Study Status: COMPLETED\n",
      "Study Title: Peking and Rotterdam on Mission to Reduce Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01653119\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01021930\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02748330\n",
      "Study Status: COMPLETED\n",
      "Study Title: Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03871621\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01021865\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03444142\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00724542\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01852214\n",
      "Study Status: COMPLETED\n",
      "Study Title: Dapagliflozin Effects on Mayor Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction (DAPA-AMI)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04717986\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01573949\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart Failure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04071626\n",
      "Study Status: RECRUITING\n",
      "Study Title: Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02548650\n",
      "Study Status: COMPLETED\n",
      "Study Title: Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05283356\n",
      "Study Status: RECRUITING\n",
      "Study Title: Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04481997\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Glycemic Control Using Mobile-based Intervention in Patients With Diabetes Undergoing Coronary Artery Bypass to Promote Self-management\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04192409\n",
      "Study Status: COMPLETED\n",
      "Study Title: Silent Atrial Fibrillation - Screening of High-risk Groups for Atrial Fibrillation (The Silence Study)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02893215\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05174052\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00212004\n",
      "Study Status: TERMINATED\n",
      "Study Title: Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01440517\n",
      "Study Status: TERMINATED\n",
      "Study Title: Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00698607\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Cardiorespiratory Parameters and Glycated Hemoglobin of Patients With Type 2 Diabetes After a Rehabilitation Program\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03094767\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01747356\n",
      "Study Status: COMPLETED\n",
      "Study Title: Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02916316\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01955694\n",
      "Study Status: COMPLETED\n",
      "Study Title: Cardiovascular Disease Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00857194\n",
      "Study Status: COMPLETED\n",
      "Study Title: Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01252810\n",
      "Study Status: COMPLETED\n",
      "Study Title: Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03774394\n",
      "Study Status: COMPLETED\n",
      "Study Title: Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01536808\n",
      "Study Status: COMPLETED\n",
      "Study Title: Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03977116\n",
      "Study Status: COMPLETED\n",
      "Study Title: Exercise Training in Patients With Coronary Heart Disease and Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01232608\n",
      "Study Status: COMPLETED\n",
      "Study Title: Personalization of CM Injection Protocols in Coronary Computed Tomographic Angiography\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03292354\n",
      "Study Status: COMPLETED\n",
      "Study Title: Expanding Paramedicine in the Community\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02034045\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Mediterranean Diet Intervention in Diabetic Heart Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03757845\n",
      "Study Status: TERMINATED\n",
      "Study Title: SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05037695\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03437044\n",
      "Study Status: COMPLETED\n",
      "Study Title: Influence of Probiotics in Diabetic Cardiopathies With Excessive Weight\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03904901\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03258281\n",
      "Study Status: TERMINATED\n",
      "Study Title: iSGLT2 in Prevention of Acute Kidney Injury in Patients With Diabetes Mellitus Undergoing CABG Extracorporeal On-Pump\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04523064\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02539160\n",
      "Study Status: COMPLETED\n",
      "Study Title: Predicting Hypoglycaemia and Arrhythmias in the Patient With Diabetes and CKD - Validation Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02778269\n",
      "Study Status: COMPLETED\n",
      "Study Title: BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02645799\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04944719\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04344210\n",
      "Study Status: COMPLETED\n",
      "Study Title: Role of Tele-physical Therapy in Patients With Type 2 Diabetes Mellitus Following COVID-19 Infection.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05599893\n",
      "Study Status: COMPLETED\n",
      "Study Title: Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04535700\n",
      "Study Status: COMPLETED\n",
      "Study Title: Inhaled Nitric Oxide for Preventing Progression in COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04388683\n",
      "Study Status: TERMINATED\n",
      "Study Title: Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04507867\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Telerehabilitative Aerobic and Relaxation Exercises Patients With Type 2 Diabetes With and Without COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05411458\n",
      "Study Status: COMPLETED\n",
      "Study Title: Modulation of Gut Microbiota to Enhance Health and Immunity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04884776\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02996825\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: The Digital Breast Tomosynthesis Trial in Bergen\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02835625\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Pilot Study of Etanercept in Dermatomyositis\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00112385\n",
      "Study Status: COMPLETED\n",
      "Study Title: Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02775851\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Optimization of the Surgical Care Pathway for Kidney Tumors by Digitizing Perioperative Nursing Coordination (UroCCR 126)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06047600\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04620187\n",
      "Study Status: RECRUITING\n",
      "Study Title: T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04351230\n",
      "Study Status: WITHDRAWN\n",
      "Study Title: Differential Mobility Spectrometry (DMS) Based Oral Tumor Analysis\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05902455\n",
      "Study Status: RECRUITING\n",
      "Study Title: Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04033419\n",
      "Study Status: COMPLETED\n",
      "Study Title: Differential Mobility Spectrometry (DMS) Based Skin Tumor Analysis\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05247710\n",
      "Study Status: RECRUITING\n",
      "Study Title: Tomosynthesis (TS) or Ultrasound (US) in Mammography-negative Dense Breasts (TOMUS). National Multicenter Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03033030\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02353819\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Urinary Human Papilloma Virus Test in the General Population in Brittany\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03598946\n",
      "Study Status: RECRUITING\n",
      "Study Title: A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00923520\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Tomosynthesis Trial in Bergen - Part 2\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03669926\n",
      "Study Status: COMPLETED\n",
      "Study Title: Tomosynthesis Versus Digital Mammography in a Population-based Screening Program\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02590315\n",
      "Study Status: UNKNOWN\n",
      "Study Title: pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03600350\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Integrated Intervention for Breast Cancer Survivors With Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05092477\n",
      "Study Status: RECRUITING\n",
      "Study Title: Evaluation of the Diagnostic Performance of a Bra Prototype to Detect Breast Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05574816\n",
      "Study Status: RECRUITING\n",
      "Study Title: T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04457596\n",
      "Study Status: RECRUITING\n",
      "Study Title: Induction Chemotherapy for Locally Advanced Rectal Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04838496\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03816358\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01231269\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Metformin Combined With Chemotherapy for Pancreatic Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01210911\n",
      "Study Status: COMPLETED\n",
      "Study Title: Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative HNSCC\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04681469\n",
      "Study Status: RECRUITING\n",
      "Study Title: Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care In Kisarawe, Tanzania\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03098654\n",
      "Study Status: COMPLETED\n",
      "Study Title: Implementing, a Mobile Health Application for HIV Infected and Uninfected Women With Co-morbidities in the Outpatient Setting\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04810260\n",
      "Study Status: RECRUITING\n",
      "Study Title: Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04344210\n",
      "Study Status: COMPLETED\n",
      "Study Title: Role of Tele-physical Therapy in Patients With Type 2 Diabetes Mellitus Following COVID-19 Infection.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05599893\n",
      "Study Status: COMPLETED\n",
      "Study Title: Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04535700\n",
      "Study Status: COMPLETED\n",
      "Study Title: Inhaled Nitric Oxide for Preventing Progression in COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04388683\n",
      "Study Status: TERMINATED\n",
      "Study Title: Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04507867\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Telerehabilitative Aerobic and Relaxation Exercises Patients With Type 2 Diabetes With and Without COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05411458\n",
      "Study Status: COMPLETED\n",
      "Study Title: Modulation of Gut Microbiota to Enhance Health and Immunity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04884776\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Safety and Pharmacokinetics Study of DM1157 to Treat Malaria\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03490162\n",
      "Study Status: TERMINATED\n",
      "Study Title: Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01716819\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of GLP-1 on Postprandial Lipid Metabolism\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01760772\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Prevention to Improve Outcomes After PVI\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05148338\n",
      "Study Status: RECRUITING\n",
      "Study Title: Body Weight, Sleep, and Heart Health\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03388788\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03892265\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: REDEFINE 3: A Research Study to See the Effects of CagriSema on Heart Disease in People Living With Obesity and Diseases in the Heart and Blood Vessels\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05669755\n",
      "Study Status: RECRUITING\n",
      "Study Title: Results of Coronary Artery Bypass Grafting in Obese Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04916912\n",
      "Study Status: COMPLETED\n",
      "Study Title: Interest of the Not Invasive Ventilation Used in Meadow and Post-operative of Cardiac Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02302300\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Magnesium Supplementation for Primary Prevention of Heart Failure in Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02966912\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effect and Applicability of CBT-Based Weight Loss Treatment Model in Obese Patients With Comorbid Depression in Health Care\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04513587\n",
      "Study Status: RECRUITING\n",
      "Study Title: Effect of Complex Weight-reducing Interventions on Rhythm Control in Obese Subjects With Atrial Fibrillation\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04560387\n",
      "Study Status: RECRUITING\n",
      "Study Title: Effect of Treatment of Sleep Apnea in Patients With Paroxysmal Atrial Fibrillation\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02727192\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04222686\n",
      "Study Status: COMPLETED\n",
      "Study Title: Home-based HIIT in a Primary-care Setting for at Risk Individuals: A Multidisciplinary Approach\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04553614\n",
      "Study Status: COMPLETED\n",
      "Study Title: Work, Weight, and Wellness Program: The 3W Program\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00123019\n",
      "Study Status: COMPLETED\n",
      "Study Title: Regression of Myocardial Steatosis by Nebivolol\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01358409\n",
      "Study Status: COMPLETED\n",
      "Study Title: Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02520921\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Traditional Tibetan Medicine for Patients With Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00810992\n",
      "Study Status: COMPLETED\n",
      "Study Title: Metabolic Determinants of the Progression of Aortic Stenosis\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01679431\n",
      "Study Status: RECRUITING\n",
      "Study Title: Algarve Active Ageing - Cardiac and Osteoarthritis Rehabilitation (A3-COR)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05999110\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01021865\n",
      "Study Status: COMPLETED\n",
      "Study Title: Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03669692\n",
      "Study Status: WITHDRAWN\n",
      "Study Title: Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03610321\n",
      "Study Status: UNKNOWN\n",
      "Study Title: MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02226510\n",
      "Study Status: COMPLETED\n",
      "Study Title: Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04625946\n",
      "Study Status: RECRUITING\n",
      "Study Title: Heart Attack Prevention Programme for You (HAPPY) London\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01911910\n",
      "Study Status: COMPLETED\n",
      "Study Title: Cardiac Rehabilitation for Young People\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05968521\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: The Impact Of An Intermittent Energy Restricted Diet On Insulin Sensitivity In Men and Women With Central Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02679989\n",
      "Study Status: COMPLETED\n",
      "Study Title: Exercise Training and Cardiovascular Function in Obesity and in Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00264589\n",
      "Study Status: COMPLETED\n",
      "Study Title: Polymorphisms in CD36 and STAT3 Genes and Different Dietary Interventions Among Patients With Coronary Artery Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02202265\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Blood Pressure and Central Vascular Stiffness in Obese Children. Relationship to Metabolic Disturbances and Subclinical Cardiovascular Damage. Effect of Weight Reduction\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01310088\n",
      "Study Status: UNKNOWN\n",
      "Study Title: A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healthy Participants\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05804162\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Effects of a High Protein Diet on Clinical Outcomes in Heart Failure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01423266\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effects of Stretching Training on Arterial Function and Autonomic Control\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01741766\n",
      "Study Status: COMPLETED\n",
      "Study Title: Semaglutide to Reduce Atrial Fibrillation Burden\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05209165\n",
      "Study Status: SUSPENDED\n",
      "Study Title: Psychosocial Risk Factors in Stroke and Myocardial Infarction\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02824107\n",
      "Study Status: COMPLETED\n",
      "Study Title: Increasing Physical Activity Among Mexican American Women (The Enlace Study)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00869583\n",
      "Study Status: COMPLETED\n",
      "Study Title: Targeting Obesity to Optimize Health in Cardiac Rehab (TOPCARE)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03423238\n",
      "Study Status: COMPLETED\n",
      "Study Title: Brain Tissue Integrity and Autonomic Function Alterations in Childhood OSA and ADHD, and After Adenotonsillectomy.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04732572\n",
      "Study Status: RECRUITING\n",
      "Study Title: SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04907214\n",
      "Study Status: RECRUITING\n",
      "Study Title: SORT - AF Supervised Obesity Reduction Trial for AF Ablation Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02064114\n",
      "Study Status: COMPLETED\n",
      "Study Title: Major Depressive Disorder - Understanding The Link Between The Brain And The Heart\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01568307\n",
      "Study Status: COMPLETED\n",
      "Study Title: Wearable Devices for Secondary Prevention of Ischemic Stroke\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04282993\n",
      "Study Status: UNKNOWN\n",
      "Study Title: The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00371293\n",
      "Study Status: COMPLETED\n",
      "Study Title: Secondary Prevention of Atrial Fibrilation\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03259893\n",
      "Study Status: TERMINATED\n",
      "Study Title: A Sugar-Sweetened Beverage Reduction Intervention for Native American Men\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06029517\n",
      "Study Status: RECRUITING\n",
      "Study Title: Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04320017\n",
      "Study Status: COMPLETED\n",
      "Study Title: Role of Cardiometabolic Risk Factors in Childhood Bone Development\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02355717\n",
      "Study Status: UNKNOWN\n",
      "Study Title: A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05887271\n",
      "Study Status: RECRUITING\n",
      "Study Title: Acute Effects of High Intensity Training in Pregnancy on Fetal Well-being and Blood Flow Distribution\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04288479\n",
      "Study Status: RECRUITING\n",
      "Study Title: Exposure to CARDIovascular Risk Assessed by Cardiac Adiposity in oBese adOlescents Eligible to a Residential Long-term Lifestyle Intervention by Diet and eXercise (CARDIBOX)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04310371\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Oral Contraceptives in the Metabolic Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00205504\n",
      "Study Status: COMPLETED\n",
      "Study Title: Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03574597\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04469790\n",
      "Study Status: RECRUITING\n",
      "Study Title: The Post Stroke Preventive Trial (PREVENT). A RCT Nested in a Cohort Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00253097\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Dietary Prevention of Heart Failure in Hypertensive Metabolic Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03170375\n",
      "Study Status: RECRUITING\n",
      "Study Title: LOSE-AF: Can Weight Loss Help Patients With Atrial Fibrillation?\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03713775\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in √ñrebro County\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04233515\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect on Energy Metabolism at Cellular Level of Diet Plus Treatment With Ephedrine and Caffeine in Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02048215\n",
      "Study Status: COMPLETED\n",
      "Study Title: Severe Obesity: Bariatric Surgery vs. Life-Style-Intervention\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01352403\n",
      "Study Status: COMPLETED\n",
      "Study Title: Development of Specific Diagnostic Tools for Cardiac Insufficiency With Preserved Ejection Fraction\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04699890\n",
      "Study Status: RECRUITING\n",
      "Study Title: Enhanced Neonatal Health and Neonatal Cardiac Effect Developmentally\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03517293\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Exercise on Cardiac Fat in Women With Obesity: a Pilot Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02589327\n",
      "Study Status: COMPLETED\n",
      "Study Title: DanceFit Prime: A Dance Based Physical Activity and Nutritional Intervention for Primary Care - A Feasibility Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02159014\n",
      "Study Status: COMPLETED\n",
      "Study Title: Telehealth Management in HF Disparity Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02196922\n",
      "Study Status: COMPLETED\n",
      "Study Title: PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04011800\n",
      "Study Status: RECRUITING\n",
      "Study Title: Mediterranean Diet and the Metabolic Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00988650\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluation of the Effectiveness of Breathing Control Technique on Long COVID Symptoms at the Reunion University Hospital Cardiac Coherence and Long COVID Symptoms\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05851859\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Characteristics Predictive of Success and Complications in the Use of Suture-Mediated Closure of Femoral Venous Access\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00838175\n",
      "Study Status: UNKNOWN\n",
      "Study Title: The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Adults\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03142867\n",
      "Study Status: TERMINATED\n",
      "Study Title: Plant-Based, American Heart Assoc. or Mediterranean Diets In 9-18 yo With BMI >95%, Cholesterol >169 and Their Parents\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02857543\n",
      "Study Status: COMPLETED\n",
      "Study Title: Grenada Heart Project - Community Health Action to Encourage Healthy Behaviors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02428920\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Rice Bran and Cooked Navy Beans on Cholesterol Levels in Healthy Children\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01911390\n",
      "Study Status: COMPLETED\n",
      "Study Title: Creating an Optimized Technology-Based Weight Loss Program for Cardiac Rehabilitation Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03845283\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Carnitine for the Treatment of Atherosclerosis.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02117661\n",
      "Study Status: COMPLETED\n",
      "Study Title: Chronotropic Incompetence During Exercise Testing in Obese Adolescents\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04185753\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01351753\n",
      "Study Status: TERMINATED\n",
      "Study Title: PRevalence of Obstructive Sleep apnoEa and Reduction of Promoters in AF\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05784077\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05221229\n",
      "Study Status: RECRUITING\n",
      "Study Title: The Soy Treatment Evaluation for Metabolic Health (STEM) Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05191160\n",
      "Study Status: RECRUITING\n",
      "Study Title: Regression of Fatty Heart by Valsartan Therapy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00745953\n",
      "Study Status: WITHDRAWN\n",
      "Study Title: A Behavioural Weight Loss Intervention Delivered in Cardiac Rehabilitation for Patients With Atrial Fibrillation and Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05600829\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Long-term Effects of CPAP on Lipidemia and Hs-CRP Levels in OSA Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02127177\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Impact of Obesity on Postoperative Outcomes Following Cardiac Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03248921\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02672592\n",
      "Study Status: COMPLETED\n",
      "Study Title: Ultrasound Assisted Arterial Cannulation in Small Children\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01742416\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02333591\n",
      "Study Status: COMPLETED\n",
      "Study Title: Angio-Seal¬Æ vs. Exo-Seal¬Æ for Closure of Arterial Puncture Sites\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01669382\n",
      "Study Status: COMPLETED\n",
      "Study Title: Study of Metabolic Modifications in Children With Noonan Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02383316\n",
      "Study Status: COMPLETED\n",
      "Study Title: Promoting Activity and Changes in Eating (PACE) to Reduce Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00119782\n",
      "Study Status: COMPLETED\n",
      "Study Title: Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02919345\n",
      "Study Status: COMPLETED\n",
      "Study Title: Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04717050\n",
      "Study Status: RECRUITING\n",
      "Study Title: A Cognitive Behavioral Stress Intervention for Women Who Smoke\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03077945\n",
      "Study Status: COMPLETED\n",
      "Study Title: Auricular Vagus Stimulation in Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05230628\n",
      "Study Status: RECRUITING\n",
      "Study Title: The Emirates Heart Health Project: A Family-based Diet and Exercise Intervention in Obese and Overweight Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04688684\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Factors Associated With Obesity in Adult Women: Respiratory Exchange Ratio, Heart Rate Variation and Body Image\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04029532\n",
      "Study Status: COMPLETED\n",
      "Study Title: STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00124332\n",
      "Study Status: COMPLETED\n",
      "Study Title: Rural Engagement in Primary Care for Optimizing Weight Reduction\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02456636\n",
      "Study Status: COMPLETED\n",
      "Study Title: Sleep Study-Guided Multidisciplinary Therapy for Patients Presenting With Acute Coronary Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02599298\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Prevention of Weight Gain in Early Psychoses\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01075295\n",
      "Study Status: COMPLETED\n",
      "Study Title: The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01047735\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: The Genetics of Adipose Tissue Function and Its Link to Type 2 Diabetes and Heart Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04040595\n",
      "Study Status: COMPLETED\n",
      "Study Title: Healthy Lifestyles for Children With Complex Heart Problems\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01785498\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Impact of Obesity on Cardiac Function in Pregnancy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02677558\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction and Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04847557\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Study of the Effects of Adolescent Weight Disorders (Obesity, Anorexia Nervosa) on Heart Function\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05071157\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Weight Loss on Myocardial Metabolism and Cardiac Relaxation in Obese Adults\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00572624\n",
      "Study Status: COMPLETED\n",
      "Study Title: Motivational Interviewing and Cognitive Behavioral Therapy-based Intervention for Cardiovascular Disease Prevention Amongst American Indians With Diabetic and Depressive Symptoms\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01892124\n",
      "Study Status: COMPLETED\n",
      "Study Title: Copenhagen Obesity Risk Assessment Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00655902\n",
      "Study Status: COMPLETED\n",
      "Study Title: Bariatric Surgery Evaluation and Assessment of Treatment Efficacy - Intervention Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06065124\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Lifestyle Intervention Feasibility for Arrhythmia and Symptoms With Intermittent Fasting (LIFE AS IF)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04090840\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Influence of Probiotics in Diabetic Cardiopathies With Excessive Weight\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03904901\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Obesity and Bariatric Surgery According to a Biopsychosocial Perspective.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05950698\n",
      "Study Status: RECRUITING\n",
      "Study Title: Human Cardiac Mitochondria in Acute Endocarditis and Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03690076\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Comparative Study of Haemodynamic Changes After Spinal Anaesthesia in Non-obese and Pregnant Women\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02599376\n",
      "Study Status: COMPLETED\n",
      "Study Title: Sex and Obesity: Effects on Heart Failure Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00776035\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: A Prospective Evaluation of Health Services Outcomes and Emerging Cardiovascular Disease Biomarkers\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00820313\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02956811\n",
      "Study Status: COMPLETED\n",
      "Study Title: A High-PRotein Mediterranean Diet and Resistance Exercise for Cardiac Rehabilitation: a Pilot Randomised Controlled Trial\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04272073\n",
      "Study Status: RECRUITING\n",
      "Study Title: Behavioural Weight Loss Treatment for Patients With Atrial Fibrillation and Obesity in Cardiac Rehabilitation\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05230823\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Mandibular Advancement Device for Treatment of Obstructive Sleep Apnea and Its Impact on Cardiac Remodeling\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02948894\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Bariatric Atrial Restoration of Sinus Rhythm\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04050969\n",
      "Study Status: TERMINATED\n",
      "Study Title: Trial of a Cardiac Rehabilitation Program Delivered Remotely Through the Internet\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00683813\n",
      "Study Status: COMPLETED\n",
      "Study Title: SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05764811\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evolution of Cardiovascular Function and Quality of Life in Patients Included in the SCArab√©e Therapeutic Education Program\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03669211\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Role of Nuclear Imaging in Heart Failure\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02697669\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04413838\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Suloexide in the Treatment of Early Stages of COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04483830\n",
      "Study Status: COMPLETED\n",
      "Study Title: Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04344288\n",
      "Study Status: TERMINATED\n",
      "Study Title: Nutritional Assessment of Hospitalized Patients With COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04503525\n",
      "Study Status: COMPLETED\n",
      "Study Title: Plant Stanol Esters and COVID-19 Vaccination Response\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04844346\n",
      "Study Status: TERMINATED\n",
      "Study Title: Ozone Plasma on Lung Function and Inflammatory Parameters in Pulmonary Sequelae Associated With Coronavirus 19 Infection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05089305\n",
      "Study Status: ENROLLING_BY_INVITATION\n",
      "Study Title: Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04320017\n",
      "Study Status: COMPLETED\n",
      "Study Title: Exercise and Diet for Pediatric Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05336006\n",
      "Study Status: COMPLETED\n",
      "Study Title: Inhaled Nitric Oxide for Preventing Progression in COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04388683\n",
      "Study Status: TERMINATED\n",
      "Study Title: Associations Between COVID-19 ARDS Treatment, Clinical Trajectories and Liberation From Mechanical Ventilator - an Analysis of the NorthCARDS Dataset\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04729075\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluation of the Effectiveness of Breathing Control Technique on Long COVID Symptoms at the Reunion University Hospital Cardiac Coherence and Long COVID Symptoms\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05851859\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04507867\n",
      "Study Status: COMPLETED\n",
      "Study Title: Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04396106\n",
      "Study Status: TERMINATED\n",
      "Study Title: Dietary Modulation of Gut Microbiota in Overweight/Obese Adolescents and COVID-19 Infection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05623007\n",
      "Study Status: RECRUITING\n",
      "Study Title: Diet and COVID-19 Vaccination\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05163743\n",
      "Study Status: RECRUITING\n",
      "Study Title: Epidemiological Monitoring of COVID-19 Patients Hospitalized on Reunion Island\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05413694\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05880108\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: COVID-19, Obesity and Lifestyle in Children - Role of Professionals\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05336591\n",
      "Study Status: RECRUITING\n",
      "Study Title: Evaluation of an Online Lifestyle Intervention in Mexican School Children During COVID-19 Pandemic\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04772859\n",
      "Study Status: COMPLETED\n",
      "Study Title: RADx-UP- Impact of Community Health Worker Deployment\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05863884\n",
      "Study Status: RECRUITING\n",
      "Study Title: Gastric Volume After Oral Ingestion of Water or Jelly in Volunteers\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05737641\n",
      "Study Status: ENROLLING_BY_INVITATION\n",
      "Study Title: Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04435223\n",
      "Study Status: COMPLETED\n",
      "Study Title: Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05007236\n",
      "Study Status: COMPLETED\n",
      "Study Title: Liver Injury in Patients With COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04358380\n",
      "Study Status: UNKNOWN\n",
      "Study Title: High Body Mass Index and Severity of Coronavirus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04876898\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluation of the Effect of Two Online Interventions -Watch Your Weight During the Holidays Program and the Relative 5:2 Fasting- for the Prevention of Body Weight Gain at 8 Weeks in Mexican Adults in the Covid-19 Pandemic\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05060978\n",
      "Study Status: TERMINATED\n",
      "Study Title: Vitamin D and COVID-19 Management\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04385940\n",
      "Study Status: RECRUITING\n",
      "Study Title: Modulation of Gut Microbiota to Enhance Health and Immunity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04884776\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04451694\n",
      "Study Status: UNKNOWN\n",
      "Study Title: FEnofibRate as a Metabolic INtervention for COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04517396\n",
      "Study Status: COMPLETED\n",
      "Study Title: Step up to Health, Nigeria! Impact of 2022 World Cancer Day Walk on Health Behaviors Among Nigerians\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05239325\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Omentectomy for Metabolic Syndrome in Gastric Cancer Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02641925\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Exercise Intervention in Adolescent and Young Adult Cancer Survivors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04265638\n",
      "Study Status: RECRUITING\n",
      "Study Title: Evaluation of Clinical Outcomes and Costs of a Lifestyle Intervention in Obese Infertile Women\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01483612\n",
      "Study Status: COMPLETED\n",
      "Study Title: Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00704912\n",
      "Study Status: COMPLETED\n",
      "Study Title: Serum Anti-mullerian Hormone and Polycystic Ovarian Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03237312\n",
      "Study Status: COMPLETED\n",
      "Study Title: Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue (MICROBAT)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04605848\n",
      "Study Status: RECRUITING\n",
      "Study Title: Reflexology's Effect on Polycystic Ovary Syndrome: A Pilot Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00746148\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Using Technology to Improve Physical Activity Levels Among Postmenopausal Women (The Active & Aware Study)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01837147\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01482286\n",
      "Study Status: TERMINATED\n",
      "Study Title: Lifestyle Intervention in Pregnant Women With PCOS\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04216485\n",
      "Study Status: COMPLETED\n",
      "Study Title: EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02635386\n",
      "Study Status: COMPLETED\n",
      "Study Title: Impact of Minimally Invasive and Open Liver Surgery in Different BMI-classes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05475054\n",
      "Study Status: COMPLETED\n",
      "Study Title: MYPP-trial: Myo-inositol Supplementation to Prevent Pregnancy Complications in Women With Polycystic Ovary Syndrome.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05524259\n",
      "Study Status: RECRUITING\n",
      "Study Title: Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02614859\n",
      "Study Status: COMPLETED\n",
      "Study Title: Daughters, dUdes, Mothers and othErs Fighting Cancer Together\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04132219\n",
      "Study Status: COMPLETED\n",
      "Study Title: Lactation Outcomes Among Survivors of Pediatric Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02399956\n",
      "Study Status: COMPLETED\n",
      "Study Title: Insulin Sensitivity After Breast Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05010356\n",
      "Study Status: RECRUITING\n",
      "Study Title: Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02811809\n",
      "Study Status: WITHDRAWN\n",
      "Study Title: Impact of COX2 on Sera Biomarkers From Obese Subjects\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02062255\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effect of Escitalopram in PCOS\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05840692\n",
      "Study Status: COMPLETED\n",
      "Study Title: Heritability of Polycystic Ovary Syndrome: Role of Antimullerian Hormone, Steroids and Leptin\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03483792\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02028221\n",
      "Study Status: COMPLETED\n",
      "Study Title: Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00892073\n",
      "Study Status: COMPLETED\n",
      "Study Title: Primary Ovarian Insufficiency, Polycystic Ovary Syndrome & the CardiOvascular Risk Profile\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02616510\n",
      "Study Status: COMPLETED\n",
      "Study Title: Prevalence of Polycystic Ovary Syndrome (PCOS) in Obese Premenopausal Women\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01319162\n",
      "Study Status: COMPLETED\n",
      "Study Title: Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04597710\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Efficacy and Safety of Sintilimab Combined With Regorafenib and Cetuximab / Sintilimab Combined With Regorafenib in Posterior Line Therapy of Advanced Colorectal Cancer (Regosinti)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04745130\n",
      "Study Status: RECRUITING\n",
      "Study Title: Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02001051\n",
      "Study Status: TERMINATED\n",
      "Study Title: Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01758146\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Devaluing Foods to Change Eating Behavior\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03557710\n",
      "Study Status: COMPLETED\n",
      "Study Title: Reflexology's Effect on Polycystic Ovary Syndrome (PCOS)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00744510\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Targeting Iatrogenic Cushing's Syndrome With 11Œ≤-hydroxysteroid Dehydrogenase Type 1 Inhibition\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03111810\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05903131\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Addressing Modifiable Breast Cancer Risk Factors With Project CONECT\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02871388\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Reduced Carbohydrate Diet Intervention for Polycystic Ovary Syndrome (PCOS)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01028989\n",
      "Study Status: COMPLETED\n",
      "Study Title: Short-term and Oncological Outcomes of Laparoscopic Colorectal Cancer Surgery in Obese Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04716062\n",
      "Study Status: COMPLETED\n",
      "Study Title: ObeSity Related Colorectal Adenoma Risk\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03663062\n",
      "Study Status: COMPLETED\n",
      "Study Title: Assessing Blood Pressure Remotely in Childhood Cancer Survivors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02476162\n",
      "Study Status: COMPLETED\n",
      "Study Title: Obesity, Iron Regulation and Colorectal Cancer Risk\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03548948\n",
      "Study Status: COMPLETED\n",
      "Study Title: Comparison Between Mediterranean Diet and High Protein Diet in Women With Polycystic Ovary Syndrome (PCOS)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01615848\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Effects of High-Intensity Interval Training and Strength Training On Levels of Testosterone and Physical Activity Among Women With Polycystic Ovary Syndrome.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04942366\n",
      "Study Status: COMPLETED\n",
      "Study Title: Self-Monitoring Physical Activity With a Smartphone Application and Physiotherapy Coaching in Cancer Patients.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03128333\n",
      "Study Status: COMPLETED\n",
      "Study Title: PriskA Pilot Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05785507\n",
      "Study Status: RECRUITING\n",
      "Study Title: Taste, Smell and Chemotherapy (TASTY)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01641172\n",
      "Study Status: COMPLETED\n",
      "Study Title: Impact of Nutritional Intervention in Women With Breast Cancer Under Adjuvant Chemotherapy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01331772\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Endurance and Endurance-Strength Training on Inflammatory Markers in Women With Abdominal Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03444207\n",
      "Study Status: COMPLETED\n",
      "Study Title: Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03480022\n",
      "Study Status: COMPLETED\n",
      "Study Title: Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05518929\n",
      "Study Status: RECRUITING\n",
      "Study Title: Dietary Intake, Sarcopenic Obesity, and Other Treatment-Related Outcomes in Indian Children With Acute Lymphoblastic Leukemia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03974893\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04008563\n",
      "Study Status: RECRUITING\n",
      "Study Title: Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05254249\n",
      "Study Status: RECRUITING\n",
      "Study Title: Pattern of Gene Expression in Adipose Tissue From Patients With Cushing Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01688349\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03151005\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Effect of Obesity on Surgical Outcomes and Survival for Gastric Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02800005\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Surgical Pre-habilitation in Breast Cancer.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04861220\n",
      "Study Status: RECRUITING\n",
      "Study Title: A Sugar-Sweetened Beverage Reduction Intervention for Native American Men\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06029517\n",
      "Study Status: RECRUITING\n",
      "Study Title: Improving the Treatment for Women With Early Stage Cancer of the Uterus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01686126\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Evaluation of Surgical Complications and DFS in Obese Rectal Cancer Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06056726\n",
      "Study Status: RECRUITING\n",
      "Study Title: Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02454517\n",
      "Study Status: TERMINATED\n",
      "Study Title: Exercise, Prostate Cancer and Circulating Tumour Cells\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02453139\n",
      "Study Status: COMPLETED\n",
      "Study Title: HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05526339\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Weight Loss and Breast Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05654571\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01246739\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Effects of Metformin Plus Simvastatin on Polycystic Ovarian Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01021579\n",
      "Study Status: COMPLETED\n",
      "Study Title: Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05631379\n",
      "Study Status: RECRUITING\n",
      "Study Title: Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04453306\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Weight Reduction Intervention for Breast Cancer Survivors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00774371\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05963971\n",
      "Study Status: RECRUITING\n",
      "Study Title: Reducing Breast Cancer Recurrence With Weight Loss\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01112839\n",
      "Study Status: COMPLETED\n",
      "Study Title: Structural Network on Prostate Cancer in the French Greater West Region\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03214315\n",
      "Study Status: COMPLETED\n",
      "Study Title: Organochlorine Concentration in Adipose Tissue and Pancreatic Adenocarcinoma\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04429490\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Pilot Feasibility Study of an Online Lifestyle Intervention for Overweight Breast Cancer Survivors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02861703\n",
      "Study Status: COMPLETED\n",
      "Study Title: Assessment of the Prevalence of Sarcopenia in Early Palliative Cancer Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04714203\n",
      "Study Status: COMPLETED\n",
      "Study Title: Anesthesia on Gut Microbiota and Metabolomics\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04767503\n",
      "Study Status: RECRUITING\n",
      "Study Title: Weight Loss Intervention for the Reduction of Cancer Risk and Health Disparities in Rural Ohio\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05040152\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02273206\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04577950\n",
      "Study Status: RECRUITING\n",
      "Study Title: Phenotype and Epidemiology of the Polycystic Ovary Syndrome (PCOS) in Colombia (PEP - Colombia) Study.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05926115\n",
      "Study Status: RECRUITING\n",
      "Study Title: Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04331717\n",
      "Study Status: WITHDRAWN\n",
      "Study Title: A Virtual Mindfulness and Weight Management Program to Mitigate Risk of Relapse and Improve Wellbeing in Cancer Survivors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06030427\n",
      "Study Status: RECRUITING\n",
      "Study Title: Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00306683\n",
      "Study Status: COMPLETED\n",
      "Study Title: Diet Composition, Weight Control, and Breast Carcinogenesis\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01315483\n",
      "Study Status: COMPLETED\n",
      "Study Title: Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin Resistance\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01714622\n",
      "Study Status: WITHDRAWN\n",
      "Study Title: Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04758000\n",
      "Study Status: RECRUITING\n",
      "Study Title: Gut- and Vaginal Microbiome Composition in Association With PCOS\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05706922\n",
      "Study Status: RECRUITING\n",
      "Study Title: Training Response Inhibition to Obesogenic Foods\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04659837\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Hormone Stimulation on Brain Scans for Cushing s Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01459237\n",
      "Study Status: COMPLETED\n",
      "Study Title: Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05687604\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05542407\n",
      "Study Status: RECRUITING\n",
      "Study Title: SURfit - A Physical Activity Intervention for Childhood Cancer Survivors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02730767\n",
      "Study Status: COMPLETED\n",
      "Study Title: Intranasal Oxytocin in Hypothalamic Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02849743\n",
      "Study Status: COMPLETED\n",
      "Study Title: Aromatase Inhibitor Host Factors Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01669343\n",
      "Study Status: COMPLETED\n",
      "Study Title: Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05307367\n",
      "Study Status: RECRUITING\n",
      "Study Title: Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02909933\n",
      "Study Status: COMPLETED\n",
      "Study Title: Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05773183\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Time-restricted Feeding for Treating Polycystic Ovary Syndrome (PCOS)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04580433\n",
      "Study Status: COMPLETED\n",
      "Study Title: Sex Steroids, Sleep, and Metabolic Dysfunction in Women\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00805207\n",
      "Study Status: COMPLETED\n",
      "Study Title: Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00510315\n",
      "Study Status: COMPLETED\n",
      "Study Title: SCOPE-Chinese Women Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04326660\n",
      "Study Status: COMPLETED\n",
      "Study Title: Furocyst - Poly Cystic Ovary Syndrome Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02703064\n",
      "Study Status: COMPLETED\n",
      "Study Title: Dapagliflozin Efficacy and Action in PCOS\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04213677\n",
      "Study Status: COMPLETED\n",
      "Study Title: Pancreatic Cancer and Oral Microbiome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04993846\n",
      "Study Status: RECRUITING\n",
      "Study Title: Exercise for Stable Myasthenia Gravis\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01047761\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Adipocytokines in Endometrial Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04697264\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Improving Energy Balance in Men With Prostate Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01886677\n",
      "Study Status: COMPLETED\n",
      "Study Title: Development of a Clinical Screening, Diagnostic and Evaluation Tool for Patients With Lower Limb Lymphedema: Aim 2\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05421377\n",
      "Study Status: RECRUITING\n",
      "Study Title: A Prospective Cohort Study of Myasthenia Gravis in China\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06006832\n",
      "Study Status: RECRUITING\n",
      "Study Title: Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02342730\n",
      "Study Status: COMPLETED\n",
      "Study Title: Diet and Metabolic Inflammation\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02539355\n",
      "Study Status: COMPLETED\n",
      "Study Title: High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04500392\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03383016\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04821609\n",
      "Study Status: RECRUITING\n",
      "Study Title: Effect of Combined Exercise Post-treatment Intervention in Lean Mass Recovery in Breast Cancer Survival.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01843608\n",
      "Study Status: UNKNOWN\n",
      "Study Title: A Home-Based Study to Enhance Activity in Breast Cancer Survivors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02969291\n",
      "Study Status: COMPLETED\n",
      "Study Title: Corticotrophin-releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing s Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04569591\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Central Obesity and Cancer Prevention for Chinese American Women\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03805516\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01366391\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04554316\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effects of Exercises on Total Body Health in Children With Acute Lymphoblastic Leukemia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04015882\n",
      "Study Status: COMPLETED\n",
      "Study Title: Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04717050\n",
      "Study Status: RECRUITING\n",
      "Study Title: Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02432950\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01422759\n",
      "Study Status: RECRUITING\n",
      "Study Title: Effects of Fasting Mimicking Diet (FMD) in Women With Polycystic Ovary Syndrome (PCOS)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05196568\n",
      "Study Status: RECRUITING\n",
      "Study Title: Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02611128\n",
      "Study Status: SUSPENDED\n",
      "Study Title: Sitagliptin and Brown Adipose Tissue\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02294084\n",
      "Study Status: COMPLETED\n",
      "Study Title: Time Restricted Eating With or Without a Fiber Supplement for Weight Management in Pediatric Cancer Survivors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05826184\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: A Prospective Feasibility Study for TAMIS\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02626728\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01840618\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Dietary Modifacation on Microbiota in Overweight and Obese Polycystic Ovary Syndrome Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03325023\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Effect of Lap-Band Induced Weight Loss on Serum PSA Levels\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00562341\n",
      "Study Status: WITHDRAWN\n",
      "Study Title: Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05334836\n",
      "Study Status: RECRUITING\n",
      "Study Title: Non-Invasive Ventilation Preoperative Lung Resection Surgery\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01685580\n",
      "Study Status: COMPLETED\n",
      "Study Title: Subclinical Hypothyroidism and Chronic Inflammation in PCOS\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05842096\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02122380\n",
      "Study Status: COMPLETED\n",
      "Study Title: An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05012176\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01047735\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic Treatment\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03625635\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Polycystic Ovary Syndrome (PCOS) and Sleep Apnea\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00203996\n",
      "Study Status: TERMINATED\n",
      "Study Title: NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04656496\n",
      "Study Status: RECRUITING\n",
      "Study Title: The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver Metastases\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03562234\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Using Behavioral Economics to Achieve Improved Healthy Behavior Outcomes in Breast Cancer Survivors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02938780\n",
      "Study Status: COMPLETED\n",
      "Study Title: Lactobacillus Rhamnosus and PCOS Treatment\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03902301\n",
      "Study Status: COMPLETED\n",
      "Study Title: Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03694834\n",
      "Study Status: RECRUITING\n",
      "Study Title: D-tecting Disease - From Exposure to Vitamin D During Critical Periods of Life\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03330301\n",
      "Study Status: COMPLETED\n",
      "Study Title: Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05515978\n",
      "Study Status: RECRUITING\n",
      "Study Title: Time Restricted Eating for the Treatment of PCOS\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05629858\n",
      "Study Status: ENROLLING_BY_INVITATION\n",
      "Study Title: Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02935478\n",
      "Study Status: SUSPENDED\n",
      "Study Title: Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01482702\n",
      "Study Status: COMPLETED\n",
      "Study Title: Patient-centered Communication About Healthy Weight in Early Breast Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04504201\n",
      "Study Status: COMPLETED\n",
      "Study Title: Two Different Dietary Interventions for Girls With Polycystic Ovary Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05768724\n",
      "Study Status: COMPLETED\n",
      "Study Title: Nutrition and Body Composition in Acute Lymphoblastic Leukemia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01317940\n",
      "Study Status: COMPLETED\n",
      "Study Title: Parent and Family Oriented Support Interventions for the Facilitation of Weight Loss in African American Families\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04644224\n",
      "Study Status: RECRUITING\n",
      "Study Title: Early Screening of Pancreatic Lesions : Development of New Imaging Tools\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04007640\n",
      "Study Status: RECRUITING\n",
      "Study Title: An Exercise RCT Targeting African-American Women With Metabolic Syndrome and High Risk for Breast Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02103140\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Treating Obese PCOS Patients With LSG vs. Met\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04508634\n",
      "Study Status: ENROLLING_BY_INVITATION\n",
      "Study Title: The Changes of Body Fat Distribution in Obese Patients With PCOS After LSG\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04690634\n",
      "Study Status: COMPLETED\n",
      "Study Title: Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05114798\n",
      "Study Status: RECRUITING\n",
      "Study Title: Promoting Weight-Loss in African American Cancer Survivors in the Deep South\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03150381\n",
      "Study Status: COMPLETED\n",
      "Study Title: Internet-Based Lifestyle Intervention (iLIVE) to Eradicate Obese Frailty in Prostate Cancer Survivors\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06011499\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: CEPPPIA Pilot. Experimental Center of Participative and Individualized Predictive Prevention in Auvergne\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03378895\n",
      "Study Status: COMPLETED\n",
      "Study Title: Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04290299\n",
      "Study Status: RECRUITING\n",
      "Study Title: Step up to Health, Nigeria! Impact of World Cancer Day Walk on Health Behaviors Among Nigerians\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04248881\n",
      "Study Status: COMPLETED\n",
      "Study Title: Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02860923\n",
      "Study Status: COMPLETED\n",
      "Study Title: Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01518023\n",
      "Study Status: COMPLETED\n",
      "Study Title: Rural Women Connecting for Better Health\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01441011\n",
      "Study Status: COMPLETED\n",
      "Study Title: Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01566799\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Neuromodulation for Hypothalamic Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03708913\n",
      "Study Status: WITHDRAWN\n",
      "Study Title: Evolution of Corporeal Composition in the PeriOperative Period\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02143869\n",
      "Study Status: COMPLETED\n",
      "Study Title: Nonalcoholic Steatohepatitis in HIV Mono-infection: Exploring Non-invasive Methods for Diagnosis and the Therapeutic Role of Vitamin E\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03988725\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Happy Older Latinos Are Active (HOLA) Health Promotion Study in HIV-Infected Latino Men\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03839212\n",
      "Study Status: COMPLETED\n",
      "Study Title: Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04174755\n",
      "Study Status: RECRUITING\n",
      "Study Title: Effectiveness of a Pre-adolescent Inter-generational Intervention to Address HIV and Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04307966\n",
      "Study Status: COMPLETED\n",
      "Study Title: Lifestyle Modification Programme for HIV-infected Individuals With Fatty Liver\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03913351\n",
      "Study Status: RECRUITING\n",
      "Study Title: Pharmacokinetics of Atazanavir in Special Populations\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03923231\n",
      "Study Status: COMPLETED\n",
      "Study Title: 2-5 Intermittent Caloric Restriction in HIV\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03489109\n",
      "Study Status: TERMINATED\n",
      "Study Title: Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02210715\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Camu Camu in ART-treated People Living With HIV\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04058392\n",
      "Study Status: COMPLETED\n",
      "Study Title: Pilot Study to Assess the Impact of a Mobile Health Application (App) on Clinical Outcomes and Satisfaction of Older HIV-Infected Patients, as an Emerging Tool for Care, Education and Prevention.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04137016\n",
      "Study Status: COMPLETED\n",
      "Study Title: Effect of Methamphetamine on Residual Latent HIV Disease Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03825536\n",
      "Study Status: COMPLETED\n",
      "Study Title: Adiposity and Airway Inflammation in HIV-Associated Airway Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02975258\n",
      "Study Status: COMPLETED\n",
      "Study Title: Digital Behavioral Therapy for Sleep Problems\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04308499\n",
      "Study Status: ENROLLING_BY_INVITATION\n",
      "Study Title: Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04413838\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Suloexide in the Treatment of Early Stages of COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04483830\n",
      "Study Status: COMPLETED\n",
      "Study Title: A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04395430\n",
      "Study Status: COMPLETED\n",
      "Study Title: Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04344288\n",
      "Study Status: TERMINATED\n",
      "Study Title: Nutritional Assessment of Hospitalized Patients With COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04503525\n",
      "Study Status: COMPLETED\n",
      "Study Title: Association Between BMI and COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04391738\n",
      "Study Status: COMPLETED\n",
      "Study Title: Plant Stanol Esters and COVID-19 Vaccination Response\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04844346\n",
      "Study Status: TERMINATED\n",
      "Study Title: Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04479163\n",
      "Study Status: COMPLETED\n",
      "Study Title: Ozone Plasma on Lung Function and Inflammatory Parameters in Pulmonary Sequelae Associated With Coronavirus 19 Infection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05089305\n",
      "Study Status: ENROLLING_BY_INVITATION\n",
      "Study Title: Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04320017\n",
      "Study Status: COMPLETED\n",
      "Study Title: Exercise and Diet for Pediatric Obesity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05336006\n",
      "Study Status: COMPLETED\n",
      "Study Title: COVID Protection After Transplant-Immunosuppression Reduction\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05077254\n",
      "Study Status: RECRUITING\n",
      "Study Title: COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04409847\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Effect of Low Glycemic Index Diet on COVID-19 Phobia, Biochemical Parameters and Body Image in Obesity With Insulin Resistance\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05787314\n",
      "Study Status: COMPLETED\n",
      "Study Title: Inhaled Nitric Oxide for Preventing Progression in COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04388683\n",
      "Study Status: TERMINATED\n",
      "Study Title: Associations Between COVID-19 ARDS Treatment, Clinical Trajectories and Liberation From Mechanical Ventilator - an Analysis of the NorthCARDS Dataset\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04729075\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluation of the Effectiveness of Breathing Control Technique on Long COVID Symptoms at the Reunion University Hospital Cardiac Coherence and Long COVID Symptoms\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05851859\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04507867\n",
      "Study Status: COMPLETED\n",
      "Study Title: Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04396106\n",
      "Study Status: TERMINATED\n",
      "Study Title: Dietary Modulation of Gut Microbiota in Overweight/Obese Adolescents and COVID-19 Infection\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05623007\n",
      "Study Status: RECRUITING\n",
      "Study Title: Diet and COVID-19 Vaccination\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05163743\n",
      "Study Status: RECRUITING\n",
      "Study Title: Epidemiological Monitoring of COVID-19 Patients Hospitalized on Reunion Island\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05413694\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05880108\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: COVID-19, Obesity and Lifestyle in Children - Role of Professionals\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05336591\n",
      "Study Status: RECRUITING\n",
      "Study Title: Evaluation of an Online Lifestyle Intervention in Mexican School Children During COVID-19 Pandemic\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04772859\n",
      "Study Status: COMPLETED\n",
      "Study Title: RADx-UP- Impact of Community Health Worker Deployment\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05863884\n",
      "Study Status: RECRUITING\n",
      "Study Title: Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04435223\n",
      "Study Status: COMPLETED\n",
      "Study Title: Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05007236\n",
      "Study Status: COMPLETED\n",
      "Study Title: Liver Injury in Patients With COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04358380\n",
      "Study Status: UNKNOWN\n",
      "Study Title: High Body Mass Index and Severity of Coronavirus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04876898\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Effect of Telephone and Video Counseling on Weight Loss and Quality of Life\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05276544\n",
      "Study Status: COMPLETED\n",
      "Study Title: Evaluation of the Effect of Two Online Interventions -Watch Your Weight During the Holidays Program and the Relative 5:2 Fasting- for the Prevention of Body Weight Gain at 8 Weeks in Mexican Adults in the Covid-19 Pandemic\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05060978\n",
      "Study Status: TERMINATED\n",
      "Study Title: Vitamin D and COVID-19 Management\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04385940\n",
      "Study Status: RECRUITING\n",
      "Study Title: Tele-BARICARE to Manage COVID-19-Related Distress\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05258578\n",
      "Study Status: RECRUITING\n",
      "Study Title: Modulation of Gut Microbiota to Enhance Health and Immunity\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04884776\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04451694\n",
      "Study Status: UNKNOWN\n",
      "Study Title: FEnofibRate as a Metabolic INtervention for COVID-19\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04517396\n",
      "Study Status: COMPLETED\n",
      "Study Title: Association of Diabetes and Metabolic Syndrome With Severe Malaria in Cameroon\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05685875\n",
      "Study Status: RECRUITING\n",
      "Study Title: Coronary Artery Disease Severity in Newly Diagnosed Dysglycemia\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05210972\n",
      "Study Status: COMPLETED\n",
      "Study Title: Feasibility of Prediabetes Remission in Adults With Coronary Heart Disease\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05459987\n",
      "Study Status: RECRUITING\n",
      "Study Title: Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic Effects\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03485092\n",
      "Study Status: COMPLETED\n",
      "Study Title: Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01430221\n",
      "Study Status: COMPLETED\n",
      "Study Title: Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01951339\n",
      "Study Status: COMPLETED\n",
      "Study Title: The Influence of Metformin on Chronic Heart Failure Clinical Course in Patients With Prediabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04549415\n",
      "Study Status: COMPLETED\n",
      "Study Title: Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01035528\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04475380\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Motivational Interviewing and Cognitive Behavioral Therapy-based Intervention for Cardiovascular Disease Prevention Amongst American Indians With Diabetic and Depressive Symptoms\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01892124\n",
      "Study Status: COMPLETED\n",
      "Study Title: Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02915198\n",
      "Study Status: RECRUITING\n",
      "Study Title: Coronary Artery Disease Progression in Patients With Prediabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02744976\n",
      "Study Status: COMPLETED\n",
      "Study Title: Heart Rate During Exercise in Type 2 Diabetes\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03917576\n",
      "Study Status: COMPLETED\n",
      "Study Title: Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05182970\n",
      "Study Status: RECRUITING\n",
      "Study Title: Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05867017\n",
      "Study Status: RECRUITING\n",
      "Study Title: Diet and COVID-19 Vaccination\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05163743\n",
      "Study Status: RECRUITING\n",
      "Study Title: RADx-UP- Impact of Community Health Worker Deployment\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05863884\n",
      "Study Status: RECRUITING\n",
      "Study Title: Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02537548\n",
      "Study Status: ACTIVE_NOT_RECRUITING\n",
      "Study Title: Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02811809\n",
      "Study Status: WITHDRAWN\n",
      "Study Title: An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04742751\n",
      "Study Status: RECRUITING\n",
      "Study Title: Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06050265\n",
      "Study Status: NOT_YET_RECRUITING\n",
      "Study Title: PriskA Pilot Study\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05785507\n",
      "Study Status: RECRUITING\n",
      "Study Title: Cardiometabolic Screening Program\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05386719\n",
      "Study Status: RECRUITING\n",
      "Study Title: Behavioral Economics for Activity Motivation in Adolescents (BEAM)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04874415\n",
      "Study Status: RECRUITING\n",
      "Study Title: Effect of Exercise on Cardiometabolic Profile in Women With Polycystic Ovary Syndrome\n",
      "Study URL: https://clinicaltrials.gov/study/NCT03678714\n",
      "Study Status: COMPLETED\n",
      "Study Title: Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04741204\n",
      "Study Status: WITHDRAWN\n",
      "Study Title: Effects of Metformin on Metabolic and Reproductive Outcomes in Chinese PCOS Patients\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05463627\n",
      "Study Status: RECRUITING\n",
      "Study Title: Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant\n",
      "Study URL: https://clinicaltrials.gov/study/NCT00510315\n",
      "Study Status: COMPLETED\n",
      "Study Title: Feasibility Study of the Storytelling Through Music Intervention With Bereaved Parents\n",
      "Study URL: https://clinicaltrials.gov/study/NCT06047808\n",
      "Study Status: RECRUITING\n",
      "Study Title: Sitagliptin and Brown Adipose Tissue\n",
      "Study URL: https://clinicaltrials.gov/study/NCT02294084\n",
      "Study Status: COMPLETED\n",
      "Study Title: Polycystic Ovary Syndrome Genetics and Treatment Response\n",
      "Study URL: https://clinicaltrials.gov/study/NCT01389778\n",
      "Study Status: UNKNOWN\n",
      "Study Title: Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)\n",
      "Study URL: https://clinicaltrials.gov/study/NCT04216589\n",
      "Study Status: COMPLETED\n",
      "Study Title: Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV.\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05135039\n",
      "Study Status: RECRUITING\n",
      "Study Title: Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05867017\n",
      "Study Status: RECRUITING\n",
      "Study Title: Diet and COVID-19 Vaccination\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05163743\n",
      "Study Status: RECRUITING\n",
      "Study Title: RADx-UP- Impact of Community Health Worker Deployment\n",
      "Study URL: https://clinicaltrials.gov/study/NCT05863884\n",
      "Study Status: RECRUITING\n"
     ]
    }
   ],
   "source": [
    "# Find similar words to \"covid\"\n",
    "sim_words = wordvec.wv.most_similar(preprocess_text(\"diabetes\"), topn=5)\n",
    "\n",
    "# Filter and print the matched studies\n",
    "for word, cos in sim_words:\n",
    "    matched_studies = df[df['Tokenized Text'].apply(lambda x: word in x)]\n",
    "    for index, row in matched_studies.iterrows():\n",
    "        print(\"Study Title:\", row['Study Title'])\n",
    "        print(\"Study URL:\", row['Study URL'])\n",
    "        print(\"Study Status:\", row['Study Status'])"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "dan",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
